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Abstract 
 
The type II secretion system (T2SS) is the major terminal branch of the general 
secretory pathway. It is composed of 12-15 proteins, most in multiple copies, and 
spans the inner and outer membranes of  Gram-negative bacteria. The T2SS 
secretin subunits form a large dodecameric torus-like structure in the outer 
membrane. The secretin is the only essential component in the outer membrane 
and secreted proteins and virulence factors pass through the pore in the toroidal 
secretin dodecamer and out into the environment.  
 
The interaction between the secretin and its partners plays a key role in regulation 
of the T2SS. The interaction between the so-called homology region  of the inner-
membrane protein GspC (GspC-HR) and secretin provides the structural and 
functional integrity of the secretion machinery across the two cell membranes. The 
interaction between secretin and its pilotin translocates the secretin subunits to the 
outer membrane.  
 
In this Thesis, the interactions between secretin and its partners are studied at 
molecular level. The GspC-HR structure is solved using NMR spectroscopy. Its 
interaction with secretin (GspD) is elucidated using several biochemical and 
biophysical approaches and a model of the complex is proposed. Also, the 
interaction between secretin (GspD) and pilotin (GspS) is further charicterisied. 
An 18 residues secretin sequence is identified as responsible for interacting with 
pilotin. Upon binding to the pilotin, the unstructured secretin  forms a helical 
structure.  
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Chapter 1 Introduction 1.1	  Bacteria	  secretion	  systems?
Bacterial secretion systems are responsible for the transport of proteins across the 
bacteria cell membrane. They are vital for the survival of the bacterium. Bacteria secrete 
a wide range of proteins from toxins and lytic enzymes to components of surface 
organelles such as flagella and pili. Bacteria secretion system also contribute to efflux 
pumps, which have a role in the colonization and the persistence of bacteria in the host 
and contribute to drug resistance (Piddock 2006).  
 
1.1.1 Classification of bacteria 
Bacteria can be classified according to their Gram staining. Gram-positive bacteria 
retain the dye crystal violet, which is removed with ethanol from the envelope of Gram-
negative bacteria. The different staining properties are caused by different cell envelope 
structures. Gram-positive bacteria posses a single plasma membrane (also called the 
inner membrane (IM), Figure 1.1A) surrounded by a thick cell wall (CW) layer. Gram-
negative bacteria have an additional membrane so that proteins secreted by Gram-
negative bacteria must cross the periplasm and outer membrane (OM), in addition to the 
inner membrane (IM) (Figure 1.1B).  
 
Figure1.1 Schematic representation of bacterium cell envelope. (A) Gram-positive and (B) Gram-
negative bacterium(adapt from (Pugsley 1993).  
B A 
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In Gram-positive bacteria, secreted proteins are generally translocated across the single 
membrane by the Sec pathway or the twin-arginine (Tat) pathway. While Sec and Tat 
pathways are also used by the Gram-negative bacteria, more sophisticated secretion 
systems are present to facilitate transport across the outer cell envelope.  
 
1.1.2 Architecture of the Gram-negative bacteria cell envelope 
The space between inner and outer membrane of the Gram-negative bacteria is called 
the periplasmic space. Within the periplamic space, there is a layer of cell wall formed 
by peptidoglycan. This peptidoglycan layer is responsible for the cell’s inability to 
retain the crystal violet stain upon decolorisation with ethanol during Gram staining. 
Both the inner and outer leaflets of the inner membrane are composed of phospholipids 
(Figure 1.2)(Tokuda 2009). Whereas, the outer membrane is an asymmetric bilayer 
possessing lipopolysaccharide (LPS) exclusively in the outer leaflet and phospholipid 
mostly in the inner leaflet (Mühlradt and Golecki 1975; Jaravine, Zhuravleva et al. 
2008).  
                      
Figure 1.2 Gram-negative bacteria cell envelope structure. Note that the outer membrane is an 
asymmetrical bilayer containing LPS in the outer leaflet and phospholipids in the inner leaflet. At 
least 90 lipoproteins (indicated in red) are present in E. coli, most of which are specific to the outer 
membrane. Lipoproteins are anchored to the periplasmic surface of either the inner or outer 
membrane in E. coli. Figure adapted from (Tokuda and Matsuyama 2004) 
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The outer membrane functions as a permeability barrier to hydrophobic substances 
(Nikaido 2003). As a lipid biayer, the lipid portion of the IM and OM are impermeable 
hydrophilic molecules. But there is a class of channel forming proteins, called porins, 
located in the OM which provide a non-specific diffusion channel for transporting 
nutrients, such as amino acids, sugars and ions. The presence of porins means the 
periplasmic environment changes according to the surroundings.  
 
However, the periplasm is a true cell compartment. It filled with periplasmic fluid, 
which has a gel-like consistency (Hobot, Carlemalm et al. 1984). Proteins located in the 
periplasm are all specifically targeted with a signal sequence. 
 
1.1.3 Secretion in Gram-negative bacteria 
Six different secretion pathways can facilitate protein secretion in Gram-negative 
bacteria (Thanassi and Hultgren 2000). Some secreted proteins are exported across the 
cell envelope in a single step via type I, type III, type IV or type VI pathways (Figure 
1.3). Other secreted proteins are first transported to the periplasm via Sec or Tat 
pathways and then recognized and selectively translocated across  the outer membrane 
via type II and type IV secretion system (Figure 1.3).   
 
Most of the secreted proteins reach their final destination via the general secretory 
pathway (GSP). The type II secretion system (T2SS) is the major terminal branch of the 
GSP. Proteins secreted by T2SS include proteases, cellulases, pectinases, 
phospholipases, lipases and toxins. In general these proteins are associated with 
destruction of various host tissues, which help to supply nutrients to the bacteria leading 
to bacterial growth and disease.?
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Figure 1.3 Secretion systems used by Gram-negative bacteria. In this simplified view only the basic 
elements of each secretion system are sketched. HM: Host membrane; OM: outer membrane; IM: 
inner membrane; MM: mycomembrane; OMP: outer membrane protein; MFP: membrane fusion 
protein. ATPases and chaperones are shown in yellow (Tseng, Tyler et al. 2009). 
 
1.1.4 Type II secretion pathogens 
The type II secretion system was first discovered in Klebsiella oxytoca, where it was 
shown to be required for secretion of the starch-hydrolyzing lipoprotein, pullulanase 
(d'Enfert C, Ryter A et al. 1987). Since then, this pathway has been found to be 
exploited by γ-proteobacteria, with a presence in representatives of 15 genera; 
Acinetobacter, Aeromonas, Erwinia, Escherichia, Idiomarina, Klebsiella, Legionella, 
Methylococcus, Photobacterium, Pseudomonas, Shewanella, Vibrio, Xanthomonas, 
Xylella and Yersinia (Sandkvist 2001; Peabody, Chung et al. 2003; Cianciotto 2005). It 
is now clear that T2S genes are also represented among the α-proteobacteria (e.g. 
Bradyrhizobium, Caulobacter, Gluconacetobacter, Mesorhizobium), the β-
proteobacteria (e.g. Azoarcus, Burkholderia, Chromobacterium, Ralstonia) and the δ-
proteobacteria (e.g. Bdellovibrio bacteriovorus, Geobacter sulfurreducens) (Cianciotto 
2005) and ε-proteobacteria (Bdellovibrio bacteriovirus, Geobacter sulfurreducens). In 
the majority of listed organisms, genes for all of the essential T2SS components 
(Peabody, Chung et al. 2003) have been identified, which strongly suggests the presence 
of a functional T2SS in these bacteria.  
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1.1.5 Type II secretion related disease  
There is considerable evidence for involvement of the T2SS in pathogenesis. First of all, 
the T2SS is conserved in many pathogens  where it secretes degradative enzymes, 
which reveals that the system promotes the damage of host cells and tissues. In some 
instances, individual T2SS secreted proteins have been shown to contribute to virulence. 
Prominent examples include the cholera toxin (V. cholerae), heat labile toxin (E.coli) 
and exotoxin A (P.aeruginosa) (Tauschek, Gorrell et al. 2002).  
 
Pathogens using T2SS as a major virulence pathway are responsible for a series of 
diseases (see reviews(Sandkvist 2001; Cianciotto 2005). In humans, these range from 
pneumonia (L. pneumophila and  P. aeruginosa) to urinary tract infections (E. coli) and 
watery diarrhea (V. cholerae). In plants, soft rot disease is caused by Erwinia species.  
 
In this thesis, the T2SS of Erwinia chrysanthemi, termed Out, is studied. Erwinia 
chrysanthemi is a soft rot pathogen, degrading succulent fleshy plant organs, such as 
roots, tubers, and stem cuttings, on a huge variety of economically	   important crops 
including potato, carrot and sugarcane. The tissue degrading diseases are caused by 
plant cell-wall degrading enzymes (e.g. pectate lyase, cellulase) secteted by Erwinia via 
the type II secretion system. The pathogen spreads easily under conditions of high 
humidity and free water. Disease development is highly dependent on high temperatures 
around 27-30oC(Perombelon 1991). Nowadays, with the plastic packaging, global 
warming and the high food mileage, Ewinia is spreading all over the world and causes 
one of the most disastrous post-harvest losses to the farming industry(Perombelon 
1991).  	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1.2	  Type	  II	  secretion	  system	  components	  
There are about 12-15 genes identified as essential for T2SS function. The homologous 
genes and their subsequent proteins have been designated by letter A-O and S in most 
systems. Where in Pseudomonas aeruginosa and Pseudomonas alcaligenes, letters P-Z 
and A have been used instead.  
?
In this thesis, Gsp is used to refer to general T2SS components. When referring to a 
component from a specific species, naming such as Out (Ewinia) and Pul (Kelbsiella) is 
used. When referring Pseudomonas component, the corresponding Gsp numbering 
component will be labeled as a subscript, such as P.aeruginosa GspD component is 
labeled as XcpQD. 
 
T2SS proteins assemble to form a megadalton complex that spans the entire Gram-
negative cell envelope. This complex includes a component in the cytoplasm (GspE), a 
secretin (GspD) and sometimes a pilotin (GspS) in the outer membrane and an inner 
membrane sub-complex that reaches into the periplasmic compartment and connects the 
cytoplasmic and outer membrane components (Sandkvist 2001).  
 
Protein secretion is an energy consuming process. Cytoplasmic ATPase GspE provides 
energy for the whole system. GspE belongs to the large superfamily of “secretion 
superfamily ATPases”. This superfamily involves the ATPase which functions in 
several marcomolecule transport systems, such as type II and type IV secretion. GspE is 
a Mg2+ dependent ATPase (Camberg and Sandkvist 2005; Yamagata and Tainer 2007) 
and exists as a hexamer in the functional T2SS (Yamagata and Tainer 2007). It is a 
hydrophilic protein, located in the cytoplasm when expressed alone in E. coli. It 
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achieves IM association through interacting with the IM protein GspL (Sandkvist, 
Bagdasarian et al. 1995). 
 
On the inner membrane, GspC, GspF, GspL and GspM together with the periplasmic  
GspE are likely form a large homomultimer complex (Possot, Vignon et al. 2000). This 
inner membrane subcomplex is considered to interact with the outer membrane secretin 
GspD and pseudopilin GspG. GspM is likely to function as a dimer (Abendroth, Rice et 
al. 2004), known to localize  and stabilize GspL in the complex (Michel, Bleves et al. 
1998)  and also appears to enhance the interaction between EpsE and EpsL (Sandkvist, 
Keith et al. 2000). OutF is found to co-immunoprecipitate with OutE and OutL. Co-
purification of XcpRE, XcpSF and XcpYL with histidine-tagged XcpZM by metal affinity 
chromatography have also demonstrated interactions between the T2S components ER, 
LY, MZ and FS. Possot et al. suggest that the Pul secreton components E, F, G, I, J, K, L, 
and M could all be replaced by the corresponding components of the Out secretons of 
Erwinia chrysanthemi and Erwinia carotovora, showing that they do not play a role in 
secretory protein recognition and secretion specificity (Possot, Vignon et al. 2000). 
GspC together with outermembrane secretin GspD, have been shown to involved in the 
specificity of the secretion system, and have been called the gatekeepers of the T2SS 
(Lindeberg, Salmond et al. 1996; Shevchik, Robert-Baudouy et al. 1997; Bouley, 
Condemine et al. 2001). 
 ?
Pseudopilins GspG, H, I, J and K are believed to form a piston, which actively push 
substrate through the pore. The difference between pseudopilins is limited to the 
hydrophobic part of the N-terminal α-helix. GspG is the most abundant, so called 
‘major’ pseudopilin forming majority of the pilus. Whereas GspH, I, J, K are the ‘minor’ 
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components considered involving in forming the ‘tip” of pseudopilus (Korotkov and 
Hol 2008).  
 
1.2.1 Structure of T2SS components 
In past decade, there have been great advances in understanding molecular structure of 
T2SS components (Figure 1.4 and Figure 1.5). Many crystal structures of individual 
soluble domains have been solved in the lab of Professor Wim Hol (Abendroth, Rice et 
al. 2004; Abendroth, Murphy et al. 2005; Korotkov, Krumm et al. 2006; Korotkov and 
Hol 2008; Abendroth, Kreger et al. 2009; Abendroth, Mitchell et al. 2009; Korotkov, 
Pardon et al. 2009).  The outer membrane secretin has also been studied by transmission 
electron microscopy (TEM) (Nouwen, Ranson et al. 1999; Reichow, Korotkov et al. 
2010).  
 
At the start of this work two key unknown structures were GspC homology region 
(GspC-HR) and the secretin’s pilotin, GspS. The structures of the OutC-HR and the 
GspS  are discussed in this Thesis. 
 
1.2.1 Regulation of T2SS 
The T2SS components as well as the expression of genes of secreted proteins are 
regulated by quorum sensing (QS) (Wooldridge 2009; Goo, Kang et al. 2010), which 
uses acylated homoserine lactones as autoinducers in Gram-negative bacteria (Miller 
and Bassler 2001). The small molecule autoinducer accumulates and when the cellular 
threshold is reached, they activate translational regulators. In P. aeruginosa, it is found 
that the expression of gspE-M is induced earlier than the gspCD operon. In E. 
carotovora, T2SS secreted protein Svx is also found to be regulated by QS in 
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transcription level (Corbett, Virtue et al. 2005)?
?
 
 
 
Figure 1.4 Model of the T2SS and known high-resolution conponent structures. Names refer to the 
Gsp nomenclature. In the central schematic diagram, the single-letter code is used and refers to the 
Gsp nomenclature (i.e., GspD=D). Inserts show the high-resolution structures of individual 
components and sub-complexes resolved so far. The crystal structures are shown in ribbons 
representation using Pymol (http://pymol.sourceforge.net). The colour code matches model with 
structure for each components. The PDB codes are: GspCPDZ (2I6V); GspD-Nter (3EZJ), GspE 
(1P9R); GspEnt (2D27); GspE-L (2BH1); GspFc(2VMA); GspG (1T92); GspH (2QV8); GspI-J 
(2RET); GspK-I-J (3CI0); GspL (1W97); GspM (1UV7); ExoA (1IKQ). For the secretin GspD, the 
EM map (EMDB-1763) has been used. Outer membrane (OM); Inner-membrane (IM); 
Peptidoglycan (PG). Suffixe “p”and “c” indicates a “periplasmic” and “cytoplasmic” domain 
respectively. (Durand, Verger et al. 2009) 
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Figure 1.5 High-resolution model of the T2SS. All the known high-resolution structures of 
individual components and sub- complexes are represented according to the same color-code used 
in Figure 1.2.1. The crystal structures are shown in ribbons representation and transparent surface 
using PyMOL (http://pymol.sourceforge.net). Only the domains of known structures have been 
represented, with a cartoon for the rest of the protein. The model has been built to fit with the most 
recent biological and structural data on T2SS secretons. For GspE, the hexameric model of EpsE is 
shown. The pseudopilus structure is arbitrary composed of 6xGspG, 1xGspH, 1xGspI, 1xGspJ, and 
1xGspK subunits that are packed together in a similar arrangement as the pilin subunits in type IV 
pili (Durand, Verger et al. 2009) 
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1.3 Secretins 
Secretins are a class of outer membrane β-barrel proteins, with subunit mass ranging 
from 50-70 kDa in size. The secretin subunits associate into a large and highly stable 
multimeric protein conducting channel in the OM of Gram-negative bacteria 
(Lindeberg, Salmond et al. 1996; Burghout, Beckers et al. 2004). Type II secretion 
system (T2SS), type III secretion system (T3SS) and the type IV pili system (T4PS) are 
the protein secretion systems features secretin (Figure 1.3.1). Secretin is also found in 
participating in the assembly and extrusion of filamentous bacteriophages. In Vibro 
cholerae, the secretin EspD, function in both T2SS and bacteriophage (Davis, Lawson 
et al. 2000).    
 
1.3.1 Structure of secretins 
Secretin subunits form an outer membrane pore of 50-80 Å in width which provides a 
channel for the translocation of folded proteins, assembly of oligomeric pilins or for 
DNA uptake. The opening and closing of the pore is carefully regulated to maintain the 
integrity of the outer membrane and the periplasmic contents. ?
 
The domain composition of secretins is shown in figure 1.3.2A. The C-terminal half of 
the protein contains the secretin domain, which consists largely of TM β-strands 
forming a 10 to 13 β-strands β-barrel structure in the OM. Whereas the N-terminus 
exhibits conservation within subgroups from related transport pathways (Genin and 
Boucher 1994) . The secretin N-terminus is thought to be largely free of transmembrane 
regions and to reside in the periplasm (Nouwen, Stahlberg et al. 2000). The extreme C 
terminus of the GspD, which includes the pilotin interaction sequence is also considered 
to reside in the periplasm (Daefler, Guilvout et al. 1997).  
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Figure 1.6 Secretins in Gram-negative bacteria. Schematic view of the type II and type III secretion 
systems, type IV pili system, and bacteriophage assembly system. The secretin is the major outer-
membrane component of all these systems. The insertion of secretins into the outer membrane is 
often assisted by specific lipoproteins called pilotins. The T2SS secretes exoproteins from the 
periplasm to the extracellular space in the folded form. The T2SS pseudopilus is formed by 
multiple pseudopilin subunits, and the pseudopilus is thought to act as a piston and/or plug during 
the secretion process. The T4PS is related to the T2SS in several architectural and functional 
aspects, but a key difference is that the pilus extends outside the bacterial surface. The T3SS 
transport effectors directly to the eukaryotic cytoplasm or membrane via a hollow needle. The 
inner-membrane complexes of the T2SS, T4PS and the T3SS are composed of multiple proteins 
that include at least one ATPase, which is involved in providing energy for secretion or pilus 
extension/retraction processes. The filamentous phage-assembly system is composed of a secretin 
and two inner-membrane proteins. C, cytoplasm; E, extracellular space; IM, inner membrane; 
OM, outer membrane; P, periplasm. (Korotkov, Gonen et al. 2011)  
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Figure 1.7 The secretin architecture is conserved in different secretion systems. (A) Domain 
architecture of secretins from the T2SS, the T3SS, the filamentous phage assembly system and the 
T4PBS. Members of the secretin superfamily contain a C-terminal secretin core homology 
domain17,18 (cyan). The T2SS secretins generally contain four periplasmic subdomains, termed 
N0–N3. The N0 subdomain (dark blue) is located at the N terminus and is followed by the three 
structurally homologous subdomains, N1–N3 (blue, green and dark green, respectively).A T2SS-
specific domain, termed the S-domain (gray), is located at the very C terminus. Secretins from 
other systems share a similar architecture, composed of the secretin domain and at least two 
periplasmic subdomains that are structurally equivalent to N0 and N3 of VcGspD. (B) Structural 
comparison of the VcGspD density (blue, left) to single-particle reconstructions of the T3SS in its 
closed state (middle) (EMDB 1224) and to the fully assembled T3SS needle complex in its open state 
(right) (EMDB 1617). The outer- membrane T3SS secretin sits on top of a large inner-membrane 
complex (gold, middle and right). VcGspD seems to be in its closed state (compare left panel with 
middle panel). (Reichow, Korotkov et al. 2010).  
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Several secretins have been imaged by TEM. A ring-shaped structure with large central 
channel was revealed (Figure1.7) (Koster, Bitter et al. 1997; Linderoth, Simon et al. 
1997). The secretin pore is a large structure in the OM, ranging from 12-20nm in 
diameter, with central channel ranging from 5-10 nm in diameter. The secretins in 
different secretin systems all appear to be roughly cylindrical in shape.  
 
The channel forming and oligomerisation activities appear to locate on the C-terminal 
secretin domain. The secretin domain of the secretin PulD forms heat resistant 
dodecameric complexes within less than 10 minutes in the in vitro transcription-
translation system containing liposome (Guilvout, Nickerson et al.). 
 
1.3.2 T2SS secretin 
GspD, the secretin, in T2SS is one of the non-interchangeable subunits in the T2SS and 
is the only integral outer-membrane component (Hardie, Lory et al. 1996). It exists as a 
12-14 subunit oligomer. Each subunit consists of a periplasmic N-terminal domain, 
which includes N0, N1, N2 and N3 subdomains, a transmembrane secretin domain, and 
a periplasmic pilotin interacting S domain.  
 
The C-terminal secretin domain is the most conserved domain forming the 
transmembrane pore and is responsible for oligomerisation (Guilvout, Nickerson et al.). 
At the time of writing, there is no secretin domain structure available, but it is predicted 
to comprise TM β-strands, forming a β-barrel structure (Pugsley 1993).  
 
The secretin N-terminal domain is distinct between different secretion systems. It 
extends into periplasm and is involved in a series of interactions with secreted protein as 
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well as other T2SS components. GspD was shown to interact with secreted protein 
(Lindeberg, Salmond et al. 1996; Shevchik, Robert-Baudouy et al. 1997; Bouley, 
Condemine et al. 2001) as well as the HR of GspC (Korotkov, Krumm et al. 2006; 
Login, Fries et al. 2010). Yeast two-hybrid studies shown GspJ interacts with the 
periplasmic part of GspD (Douet, Loiseau et al. 2004).  GspB has only been identified 
in a few species, in these GspB and GspD stabilized each other. GspB co-fractionates 
with then OM and can be cross-linked into a larger complex in the presence of GspD 
(Condemine and Shevchik 2000).  
 
 
 
Figure 1.8 GspD modular organization and structure. (A) Domain composition of secretin. (B) 
Crystal structure of secretin N-terminal domains. The N0, N1 and N2 structure of T2SS GspD and 
N0, N1 stucture of T3SS EscC. (Korotkov, Gonen et al. 2011).  
A 
 B 
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The crystal structure of ETEC GspC N-terminus, including N0, N1 and N2 domains, 
was solved by X-ray crystallography in the presence of a nanobody (Korotkov, Pardon 
et al. 2009). The N0 domain reveals a structure similar to the TonB-dependent receptor 
(Figure 1.8). N1, N2 domains reveal a fold similar to the eukaryotic type I KH domain, 
which are typically involved in binding RNA and DNA. However, the KH domain 
positively charged RNA/DNA binding residues are absence in N1 and N2.  The N3 
domain structure is not known, but over 15% sequence identity between N1 N3 and N2 
N3 suggests N3 is likely to have a KH domain fold as N1 and N2. It is interesting to 
note that he N0 and N1 domain of type III secretin crystal structure revealed a different 
orientation as the type II one (Figure 1.8B). The current GspD N-terminal domain 
structure is solved in the presence of nanobody, which binds both N0 and N1 and could 
have a substantial influence on the domain orientation. 
 
The S-domain of GspD is responsible for the direct interaction with GspS (Shevchik 
and Condemine 1998), which stabilizes GspD and is responsible for the transport of 
GspD to the OM (Daefler, Guilvout et al. 1997; Shevchik, Robert-Baudouy et al. 1997). 
The transportation from the periplasm to outer membrane is achieved by the Lol 
pathway with the help of a chaperone pilotin (Collin, Guilvout et al. 2011). The secretin 
is transported from periplasm to OM as individual subunits (Collin, Guilvout et al. 
2011).  
 
Several EM structures of GspD are available that give a 3D overview of oligomeric 
secretin. The detailed structure of the C domain and the S domain have yet to be 
determined, and the arrangement between the individual sub-domains and domains is 
not yet clear.  
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1.4	  Type	  II	  secretin	  and	  its	  partners	  	  
The T2SS secretin, GspD forms large homomultimeric structures in the outer 
membrane. The secretin adopts a ring shaped structure and forms a pore, through which 
secreted protein pass (Nouwen, Ranson et al. 1999; Chami, Guilvout et al. 2005; 
Reichow, Korotkov et al. 2010). Precise regulation of this channel is crucial, since an 
open pore can lead to leaking of the periplasmic contents. The localization and 
regulation of the secretin is mainly achieved through interaction with two of its partners. 
The regulation of the secretin is mainly controlled by its interaction with the inner 
membrane GspC (Lee, Wang et al. 2000; Lee, Chen et al. 2004). The localization of the 
secretin is facilitated by its pilotin GspS.  
 
1.4.1 GspC and GspD; gatekeepers of the T2SS 
GspC and GspD are the gatekeepers of the T2SS. In search of the gatekeeper of T2SS, 
Lindeberg et al. created a non-polar mutation of each of E. chrysanthemi gene in the 
OutC-M and OutS and OutB operon and attempted to complement the gene with its E. 
carotovora homologue (Lindeberg, Salmond et al. 1996). They found that all of the E. 
carotovora T2SS proteins could substitute for E. chrysanthemi proteins except for OutD 
and OutC.  
 
Later, Possot and colleagues used a similar technique and found all Pul genes except 
pulC and pulD genes could be exchanged with the Erwinia homologues without 
disrupting pullulanase secretion (Possot et al., 2000). Bouley et al suggest that the PDZ 
domain of GspC and N-terminal GspD are required for different secreted protein 
recognition (Bouley, Condemine et al. 2001). It has also been suggested that GspC and 
GspD could be interacting to dock the inner membrane subcomplex with outer 
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membrane secretin pore (Lindeberg, Salmond et al. 1996; Shevchik, Robert-Baudouy et 
al. 1997).  ?
 
1.4.2 GspC is a key player in T2SS 
GspC locates on the inner membrane and plays a key functional role in T2SS. It 
interacts with secreted proteins (Bouley, Condemine et al. 2001) as well as the outer-
membrane secretin pore (Lindeberg, Salmond et al. 1996; Shevchik, Robert-Baudouy et 
al. 1997). The interaction between GspC and GspD provides the structural and 
functional integrity of the secretion machinery across the two cell membranes. The 
interaction with the secreted protein guides the secreted protein to the section system 
and through the pore in the outer membrane. With the hydrolysis of ATP, secreted 
protein is pushed through the secretin pore to the external medium (Figure 1.9A).  
 
GspC is a transmembrane protein, which spans the inner membrane. It consist of a short 
N-terminal cytoplasmic sequence, a transmembrane segment (TMS) and a large 
periplasmic region (Figure 1.9B). On the periplasmic region, there are two defined 
regions. One is the homology region (HR), which is conserved across species and the 
other domain is involved in protein-protein interaction, which is either a PDZ domain 
(in Vibrio, Erwinia, Escherichia and others) or a coiled-coil domain (in Pseudomonas). ?
?
GspC has been shown to function as a dimer, where the TMS is responsible for dimer 
formation (Login and Shevchik 2006). Periplasmic targeting and dimerisation are 
crucial for the assembly of a functioning secretion system in vivo (Login and Shevchik 
2006).?
Chapter 1 Introduction 
 
32 
 
 
 
Figure 1.9 Schematic diagram showing the role of GspC. (A) Current understanding of GspC 
involves in interactions with GspD and secreted protein within the T2SS. (B) GspC subdomains 
GspC interact with Exo-protein as well as secretin formed by GspD in the periplasma. The docking 
between GspC, GspD and exo-protein activate the T2SS, stimulating pilus formation and protein 
secretion.   
 
The PDZ domain interacts with secreted proteins. Functional analysis of truncated OutC 
variants, carrying deletions in the periplasmic domain, revealed the PDZ domain is 
responsible for secretion specificity of some but not all proteins (Bouley et al. 2001). 
Login et al. showed that the GspC PDZ region does not interact with GspD (Login, 
B 
A 
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Fries et al. 2010). GspC PDZ structure of Vibrio cholerae (Korotkov, Krumm et al. 
2006) and Erwinia chrysanthemi (work of Drs.Fries and Hutchison in my Lab.) have 
been solved by crystallography. 
 
The homology region of GspC, GspC-HR, is essential for T2SS function. C-terminal 
truncated XcpPC (GspC of Pseudomonas aeruginosa), without the coiled-coil domain 
was able to complement XcpP deletion (Bleves, Gerard-Vincent et al. 1999). Similarly, 
GspC of Xanthomonas campestris (XpsN) was able to complement an xpsN deletion 
mutant (Lee, Chen et al. 2004). This particular C-terminal truncation (XpsNΔ159) ends 
exactly at the end of predicted HR domain. A two extra residue truncation (XpsNΔ157) 
was however inactive. In Erwinia chrysanthemi PDZ-less GspC variants, full activity 
was observed for a subset of secreted protein (Bouley, Condemine et al. 2001).  
 
Compared to the PDZ domain, there is limited structural knowledge about GspC-HR. J-
pred secondary structure prediction of GspC-HR suggested a beta-sheet dominated 
structure (http://www.compbio.dundee.ac.uk/www-jpred/). Hence, the initial motivation 
of this study was to solve the structure of GspC-HR.  
 1.5	  Secretin’s	  pilotin	  
The interaction between secretin GspD and its lipoprotein pilotin is essential for secretin 
translocation in several species. Common to T2SS, T3SS and Type IV pili is the 
observation that proper targeting of secretin to the outer membrane requires the 
presence of pilotin (Shevchik and Condemine 1998; Schuch and Maurelli 2001; 
Guilvout, Chami et al. 2006). The known examples pilotins are PulS and OutS of the 
T2SS of Klebsiella and Erwinia, InvH, MxiM and YscW of the T3SS of Salmonella, 
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Shigella and Yersinia and PilW and PilF of the T4P of Neisseria and Pseudomonas 
(Hardie, Seydel et al. 1996; Crago and Koronakis 1998; Shevchik and Condemine 1998; 
Burghout, Beckers et al. 2004; Lario, Pfuetzner et al. 2005; Koo J 2008). 
 
1.5.1 Pilotin lipidation?
Pilotin has a lipid-modified cysteine residue close to its  amino termini through which 
the protein is  anchored to the membrane. Lipoprotein precursors are sequentially 
processed to their mature forms on the periplasmic side of the inner membrane after 
their translocation across the inner membrane by Sec translocon (Hayashi and Wu 1990; 
Pugsley 1993). Analysis of signal sequences of 26 distinct lipoprotein precursors has 
revealed a consensus sequence of lipoprotein modification/processing site of Leu-(Ala, 
Ser)-(Gly, Ala)-Cys at – 3 to + 1 positions which would represent the cleavage region of 
about 75% of all lipoprotein signal sequences in bacteria. Unmodified pro-lipoprotein 
with the putative consensus sequence undergoes sequential modification and processing 
reactions catalyzed by glyceryl transferase, O-acyl transferase(s), pro-lipoprotein signal 
peptidase (signal peptidase II), and N-acyl transferase to form mature lipoprotein 
(reviewed in (Tokuda and Matsuyama 2004). 
 
In E. coli lipoproteins are anchored to the periplasmic side of either inner or outer 
membrane through N-terminal lipids depending on the lipoprotein-sorting signal 
(Pugsley 1993). Yamaguchi et al. first reviewed the importance of the residue at 
position 2 for the sorting of E.coli lipoprotein (Yamaguchi, Yu et al. 1988). They 
showed that replacement of Ser at position 2 of an outer-membrane-specific lipoprotein 
by Asp caused the protein to remain in the inner membrane.  Furthermore, replacement 
of Asp at position 2 of an inner membrane-specific lipoprotein by another residue 
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caused outer membrane localization.  For the T2SS pilotin, GspS, position 2 is not Asp 
(Figure 1.10) showing it locates on the periplasmic side of outer membrane.  
 
The attached acyl lipid is essential for Lol pathway shuttle chaperone protein (LolA) 
recognition. In T3SS, an unlipidated form of the YscW protein was not functional, 
although it still interacted with the secretin and caused mislocalization of YscC even in 
the presence of wild-type YscW (Burghout, Beckers et al. 2004). It has also been shown 
that the sorting function of PulS can be replaced by fatty acylation of the PulD N-
terminus (Collin, Guilvout et al. 2011).  
 
 
 
Figure 1.10 Biogenesis of lipoproteins. Consensus lipobox sequences are indicated with a signal 
cleavage site indicated by an arrow. X represents a residue other than Asp. Lgt, 
phosphatidylglycerol/prolipoprotein diacylglyceryl transferase; LspA, prolipoprotein signal 
peptidase (also called Spase II); Lnt, phospholipid/apolipoprotein transacylase. (Tokuda and 
Matsuyama 2004). 
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1.5.2 Lol system 
The Lol system, composed of five Lol proteins, is responsible for the transport of 
lipoproteins to the outer membrane (Tokuda and Matsuyama 2004; Collin, Guilvout et 
al. 2011). All five Lol proteins, A to E, are highly conserved in various Gram-negative 
bacteria. The system comprises LolCDE complex in the innermembrane, LolA in the 
periplasm and LolB in the outer membrane (Figure 1.11). 
?
LolA is a shuttle chaperone. It recognizes the acyl chains on lipoproteins (Tokuda and 
Matsuyama 2004; Lario, Pfuetzner et al. 2005). Lipoproteins released from periplasm 
and in the presence of LolA were found to exist as water-soluble complexes with LolA. 
Therefore, forming the complex with LolA allows lipoproteins to travel between the 
inner and outer membranes. Recently, the PulS-LolA complex was confirming that 
GspS is transported by Lol system (Collin, Guilvout et al. 2011).  
 
LolCDE, is an ABC transporter which releases lipoproteins from the inner membrane 
driven by ATP hydrolysis (Yakushi, Yokota et al. 1998).  
 
LolB is a lipoprotein on the outer membrane. Although there is no apparent homology 
between amino acid sequence of LolA and LolB, their structures are strikingly similar 
(Takeda, Miyatake et al. 2003). Lipoproteins are transferred from LolA to LolB due to 
the affinity difference between their hydrophobic cavities for lipoprotein lipid. LolB 
transfers the associated lipoproteins to the inner leaflet of outer membrane to which 
lipoproteins are anchored through three acyl chains (Tokuda and Matsuyama 2004). 
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Figure 1.11 Sorting and outer membrane localization of lipoproteins by the Lol system. ‘‘In’’ and 
‘‘Out’’ represent inner membrane-specific and outer membrane-specific lipoproteins, respectively. 
An ABC transporter, LolCDE, releases outer membrane-specific lipoproteins from the inner 
membrane, causing the formation of a complex between the released lipoproteins and the 
periplasmic molecular chaperone LolA. When this complex interacts with outer membrane 
receptor LolB, the lipoproteins are transferred from LolA to LolB and then localized to the outer 
membrane. The inner membrane retention signal Asp at position 2 inhibits the recognition of 
lipoproteins by LolCDE, thereby causing their retention in the inner membrane. (Tokuda and 
Matsuyama 2004) 
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1.5.3 Structure of pilotin 
Before this work the known pilotin structures were MxiM of the T3SS of Shigella 
flexneri and PilW/PilF(Lario, Pfuetzner et al. 2005) of the T4PS of Neisseria 
meningitides/ Pseudomonas aeruginosa.  
 
It is interesting to note that the T2SS, T3SS and T4PS secretins’s pilotin all share 
similar function but have striking different folds (Figure. 1.12).  
	  
Figure 1.12 Pilotins in Gram-negative bacteria. Ribbon representation of the T2SS, T3SS and T4P 
pilotin. The pilotin crystal structures are shown in ribbon representation. T2SS pilotin GspS (our 
Lab.), T3SS MxiM (PDB:1Y9L) and T4P pilotin PilF/W(PDB: 2FI7) were selected as represent the 
type of fold.   
 
The structure of the T2SS pilotin, GspS, revealed a nested α-helix hairpin domain. 
Whereas, T4PS pilotin, PilF/W, consists 13 helices, which form a right handed TPR 
superhelix (Kim, Oh et al. 2006). The cracked β-barrel structure of T3SS pilotin, MxiM, 
has been solved in complex with an 18 residue peptide from the cognate secretin MxiD 
and the authors propose a model for the way MxiM assists MxiD assembly (Okon, 
Moraes et al. 2008). 
 1.6	  Aims	  of	  this	  study	  
The wide spread emergence of antibiotic resistance in pathogenic bacteria requires the 
exploration of novel classes of antibacterial compounds. For virulence spreading 
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through T2SS, T3SS and T4PS, secretins offer the only passage for secreted protein or 
virulence factor to cross OM.  Hence the secretin could be an attractive target for 
intervention using drugs. 
 
From this Chapter, it is clear that although recently there have been great advances in 
understanding the molecular structure of the T2SS, the molecular structure of GspC-
HR, an essential component of T2SS gatekeeper GspC and responsible for interaction 
between GspC and GspD, is unknown. There is also relatively little knowledge about 
the key interactions involved in assembly, stability and regulation of the T2SS at the 
molecular level.?
?
Determination of the structure of GspC-HR was the initial aim of the study. The 
interaction between GspD and GspC-HR is a key event in the formation of a functional 
T2SS. In the first results chapter of this Thesis I describe how the GspC-HR structure 
was solved by NMR spectroscopy (Chapter 4). Production of soluble GspD N terminal 
domains and the interaction between GspC-HR and GspD-N0 is then described 
(Chapter 5).  
 
Since the GspS structure was solved in the lab recently in the lab, revealed a novel 
pilotin fold. The pilotin secretin interaction became most interesting. It was suggested 
that pilotin, OutS interacting with OutD C-terminal 62 amino acids(Shevchik and 
Condemine 1998). In Chapter 7, the interaction between OutS and OutD is further 
characterized.  
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Chapter 2 Material and methods 2.1	  Molecular	  biology?
2.1.1 Plasmid construction 
pGEX-6P-1 vector (GE Healthcare) containing a OutC-Peri, OutC-HR and OutD-Cter; 
pET20b (GE Healthcare) containing OutD-N0, OutD-N0N1, OutD-N1N2, OutD-N1, 
OutD-Peri and OutS were provided by our collaborator Dr. Vladimir Shevchik (Lyon).  
OutC-HR and OutD-Peri were also used as the template from which truncated 
constructs were generated.  
 
2.1.2 Bacterial strains 
E. coli alpha select competent cells (Bioline) were used for initial cloning and DNA 
purifications procedures. E. coli BL21 (DE3) competent cells (Bioline) used in 
expression of all protein constructs. The DE3 lysogen contains the T7 polymerase gene 
under the control of the LacUV5 promoter. Addition of IPTG (isopropyl-b-D-
thiogalactopyranoside) (Fisher) induces constitutive expression of T7 polymerase. For 
Expression vectors under the control of a T7 promoter, the polymerase transcribes the 
mRNA at high copy number resulting in over-expression of the desired protein. 
 
2.1.3 DNA manipulation and analysis 
Agarose gel were prepared and run according to the standard procedures (Sambrook 
2001) to separate DNA according to the size. All plasmid DNA was purified from 
overnight culture of E.coli alpha-select competent cells by peq GOLD Mini prep (peq 
lab), according to manufacturer’s instruction. Final DNA concentration was detected by 
UV spectrophotometer according to the following: 
Concentration (µg/ml)=(A260-A320) x 50µg/ml 
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Where A260 reading is where DNA absorbs light most strongly and A320 is measurement 
for turbidity. DNA purity is estimated by A260/A280 ratio. An A260/A280 ratio between 1.7 
and 2.0 generally represents a high-quality DNA sample.  
  
2.1.4 Polymerase chain reaction (PCR) 
PCR were carried out using Microcycler (MJ Research) and the Pfu polymerase 
(Novagen). All reactions were carried out in thin wall 200µl PCR tubes (Starlab) at the 
final volumn of 50ul. A typical PCR reaction setup is shown in Table 2.1 and a typical 
PCR reaction program setup is shown in Table 2.2.  
 
Reagent Volumn (µ l) 
Pfu Reaction Buffer (10x) 5 
dNTP (2.5mM) 4 
Template DNA 1 
Forward Primer 1 
Reverse Primer 1 
dH2O 37 
Pfu polymerase 1 
Total 50 
 
Table 2.1 Typical PCR reaction mixture. Where possible primers were designed to conform 
optimized parameters: GC content 40-60%, length 25-35 bases, G or C at the end of the primer.  
 
 
Step Temperature (oC) Time (Sec) 
1 95 120 
2 95 30 
3 55 60 
4 72 60 
5 Cycle step 2-4 30 times 
6 72 1min 
7 4 5min 
 
Table 2.2 Typical thermocycler program for PCR reaction. An initial 2min melt to ensure full 
priming in the first cycle. In most cases 55oC was found to be sufficient regardless of primer Tm.  
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All PCR products were purified using peq lab PCR purification kit (peq lab) according 
to manufacturer’s protocol. DNA from each reaction was eluted with 30µl of sterilized 
ddH2O. 
 
2.1.5 Restriction enzyme digestion 
In all cases when double restriction enzyme digests were performed, buffer conditions 
compatible with both enzymes were chosen (according to NEB restriction enzyme 
buffer chart). All digestions were carried out at 37oC for 2.5 hours. Typical reaction 
mixture is shown in Table 2.3.  
 
Reagent Volumn (µ l) 
dH2O 5 
Reaction Buffer (10x) 2 
BSA (20x)* 1 
DNA (up to 1 µg) 10 
Restriction enzyme 1 (10U/µ l) 1 
Restriction enzyme 2 (10U/µ l) 1 
Total 20 
 
Table 2.3 Typical restriction enzyme digest for PCR products and vectors. *BSA was used 
according to restriction enzymes chosen.  
 
Double digested DNA products were purified by electrophoresis using 1% argose gel 
(peq Lab) running in TAE buffer (40mM Tris Acetate 1mM EDTA pH 8.0). Gels were 
stained with 0.5 µg/ml ethidium bromide (Fisher) and visualized on UV-
transilluminator. The desired vector or PCR product was excised from gel using sterile 
scalpel blade and purified using Gel Extraction Kit (pEQ Lab). Each reaction was eluted 
with 30 µl H2O. 
 
Chapter2 Material and method 
43 
 
 
2.1.6 Ligation reactions 
Ligation reactions were prepared as in Table 2.4 and incubated for 15 mins at room 
temperature using DNA ligation kit (TaKaRa Bio).  
 
Reagent Volumn (µ l) 
Digested DNA  insert 7 
Digested vector 1 
TaKaRa ligation mix 8 
Total  16 
 
Table 2.4 Typical ligation reaction. An excess amount of insert DNA is added to increase the chance 
of ligation. 
 
 
2.1.7 Transformation 
All transformations of bacterial cells were carried out according to the manufactures' 
instructions supplied with competent cells (Bioline). A typical transformation was 
performed as follows: 1 µl of DNA (pre-incubated on ice, or 5ul DNA from ligation) 
was added to 50 µl of competent cells, incubated on ice for 30 mins, heat-shocked at 
42oC for 45 seconds, incubated on ice for 2 mins, incubation at 37oC shaker for 60mins 
after addition of 900µl of LB and plated on appropriate media. All plates were 
incubated overnight at 37oC. 
 
2.1.8 Protein expression 
All expression conditions were optimised, E.coli BL21(DE3) competent cells (Bioline) 
was selected, which were transformed according the manufacturer’s protocol. One 
colony from an overnight plate was used to inoculate 5ml of LB media containing the 
appropriate antibiotics. The culture was grown overnight at 37 oC and used as starter 
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culture. 5ml of starter culture was used to inoculate 1L of LB media with appropriate 
antibiotics. The culture was grown at 37 oC and induced with 1mM IPTG when optical 
density (OD600) reaches 0.6-0.8. Cells were harvested by centrifugation 4hours (2 hours 
for OutD-Cter) post induction at 5,000g for 20minutes.    
 2.2	  Protein	  purification	  techniques	  
 2.2.1 Bacterial lysis 
All bacteria lysis was done at 4 oC. Bacteria pellets were fully resuspended in 10 ml/g 
(lysis buffer /pellet) lysis buffer according to individual purification protocol and 
supplemented with 30kU/g lysozyme (Novagen) to aid lysis and reduce lysate viscosity. 
Cells were lysed by sonication (VibraCell) on ice at 60% of power with 6 bursts of 15s 
and 30s cooling in between. The soluble protein fraction was obtained by centrifugation 
at 15,000g for 15 mins.  Samples of lysed cells, soluble protein fraction and insoluble 
pellet were used for SDS-PAGE analysis. 
 
2.2.2 His tag purification 
All proteins were expressed as hexahistidine tagged fusion proteins and were purified as 
follows. Firstly, the cell pellet was lysed (as above) in Ni column binding buffer (20mM 
Tris, 400mM NaCl, 20mM imidazole pH8.0). The soluble protein fraction was then 
separated by centrifugation at 15,000g for 15 mins and applied to the pre-packed His-
Trap column (GE Healthcare). The colum is pre-equilibrated in Ni-column binding 
buffer, using a flow rate of 1ml/min. The non-specifically binding proteins were 
eliminated by washing with 20 column volumes (CV) of Ni column washing buffer 
(20mM Tris, 400mM NaCl, 20mM imidazole pH 6.5) until no more protein was in the 
flow through (tested using Bradford solution).  
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If uncleaved protein was required, the target was eluted using eluting buffer (20mM 
Tris, 400mM NaCl, 500mM imidazole, pH6.5) again until no further protein came 
through (tested using Bradford solution). The eluted fractions were checked using SDS-
PAGE.  
 
Alternatively, if the His tag was required to be cleaved off, the column was equilibrated 
with thrombin cleavage buffer ( 20mM Tris, 150mMNaCl, 2.5mM CaCl2 pH8.4). Then 
10U/ml of thrombin in thrombin cleavage buffer was loaded onto the column and 
incubated at 4oC overnight. The target protein was then eluted with 20mM Tris pH8.0. 
  
2.2.3 GST tag  purification 
In the case of OutC-HR and OutD-Cter, pGEX-6P-3 was used to produce N-terminal 
cleavable GST tagged protein.  To purify the protein using the glutathione column, the 
cell pellet was resuspended and lysed (as described in section 2.2.1) in 20mM PBS 
pH7.4. The soluble protein fraction was then applied to a bench-run column with 5ml 
glutathione Sepharose resin (GE Healthcare) pre-equlibrated with PBS. The loaded 
glutathione Sepharose resin was washed with 20 CV PBS till no further protein was 
washed off (tested by Bradford solution). 
 
If the protein was to be cleaved once eluted from the resin, the uncleaved protein was 
eluted with 20mM reduced glutathione in PBS pH7.4, until no protein come through 
(tested by Bradford solution). The eluate was then dialyzed against the PreScission 
Protease cleaving buffer. 20U PreScission Protease (GE Healthcare) was then added to 
the elutate and incubated at 4OC for 16 hours. At the end of this incubation the target 
protein is in a mixture with equal, if not greater, molar amount of GST tag and likely to 
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have more contamination than that produced by cleavage from the resin. 
	  
If the protein was cleaved on resin, buffer exchange with PreScission Protease (GE 
Healthcare) cleaving buffer (50mM Tris, 150mM NaCl, 1mM EDTA, 1mM DTT 
pH7.0) preceded the addition of 5ml of PreScission Protease cleaving buffer with 20U 
of PreScission Protease and incubation at 4OC for 16 hours. The target protein was then 
eluted with PreScission Protease buffer in 2 ml fractions. Aliquot of each elute fraction 
was checked using SDS-PAGE.  
 
2.2.4 Purifying protein from the periplasm  
OutS protein was produced with a PelB signal sequence, which targets the protein to the 
periplasm (Fries, Ihrig et al. 2007).  To purify the protein from the periplasm, the 
freshly harvested cell pellet from the expression cultures were resuspended in ice-cold 
30 mM Tris–HCl pH 8.0 with 1 mM EDTA and the periplasmic protein was extracted 
from the periplasm by addition of the same volume of ice-cold 40% w/v sucrose and 
incubation on ice for 10 min. The soluble OutS was then separated by centrifugation at 
15,000g for 15 mins. Subsequently, the extracted protein solution was dialysed against 
20 mM Tris 150mM NaCl (pH 7.0) and purified using size exclusion chromatography.  
 
2.2.5 Size exclusion chromatography 
The eluate from previous method was concentrated to 1-2ml and loaded on to a 
Superdex prep grade S75/200 HR 10/30 column (GE Healthcare) using ÄKTA purifier 
system (GE Healthcare). The column was pre-equilibrated with buffer and run at 
0.5ml/min  with 1 ml fractions collected. Fractions were checked using SDS-PAGE and 
appropriate peaks were pooled, concentrated and stored at -80oC. 
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2.2.6 SDS-PAGE  
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), is a technique 
used to separate proteins according to their electrophoretic mobility, a function of the 
length of a polypeptide chain and its charge. It was used to track the expression and 
purification of proteins. 
 
According to the size of the protein to be resolved on the gel, 12% and 18% 
polyacrylamide gels were used. The composition of the gels is given in Table 2.5. The 
gels are made by adding TEMED just before pouring the gel mixture into the Bio-Rad 
Gel cast (Bio-Rad). The resolving gel was poured into the cast first and followed by the 
stacking gel and a comb for 10 or 15 wells was inserted and before the gel was left to 
set. 
 
Solution (ml) 4% Stacking 
(1.5ml) 
12% Resolving 
(5ml) 
18% Resolving 
(5ml) 
H2O 1.02 1.65 1.3 
30% acrylamide 0.255 2 3 
1.5M Tris (pH8.8) - 1.25 1.25 
1.0M Tris (pH6.8) 0.1875 - - 
10% SDS 0.015 0.05 0.05 
10% ammonium persulfate 0.015 0.05 0.05 
TEMED 0.0015 0.002 0.002 
 
Table 2.1 Recipe for SDS-PAGE. Resolving gel are used at 12% or 18%  and stacking gel is 4% for 
either gels. 
 
Protein samples were prepared by adding equal amount of 2 x SDS protein loading 
buffer (100mM Tris, 200mM DTT, 4% SDS, 0.2% bromophenol blue, 20% glycerol) 
and protein sample and heated at 100 oC for 5 mins. Gels were run in SDS Tris-Glycine 
buffer (25mM Tris, 192mM Glycine, 0.1% SDS, pH 8.3) at 150V till the protein 
loading buffer dye ran out in a Bio-Rad Mini-Gel cell on a Bio-Rad powerPac 300 (Bio-
Rad). The gel was developed by staining in comassie blue dye (0.1% comassie blue, 
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30% methanol, 10% acetic acid) for 10 minutes on shaker and destained  in destain 
buffer (10% acetic acid, 30% methanol) until the protein bands were clearly observed.   
2.2.7 NMR sample preparation 
Recombinant uniformly 15N- 13C- labeled full length OutC-HRF3 (or OutD-N0) was 
expressed using the pET-14b vector (Novagen) in BL21(DE3) (Novagen), grown in M9 
minimal media. 1L M9 minimal media contained Na2HPO4 (6g), KH2PO4 (3g), NaCl 
(o.5g), MgS04 (0.25g), CaCl2 (0.015g), FeS04 (0.015g), thiamine (0.001g), Biotin 
(0.001g), 15NH4Cl (1g) (99% 15N from Cambridge Isotope laboratories Inc.), 13C D-
glucose (2g) (13C6 , 99% from Cambridge Isotope laboratories Inc.) and ampicillin 
(100mg). All minimal media was 0.2µm filter sterilized and 15ml induced expression 
cultures were grown at 37oC in LB as above.  
 
NMR samples contained 0.5mM (or as stated) uniformly labeled OutC- HRF3(or OutD-
N0) in 90% H2O/ 10% D2O containing 20mM Tris pH 7.0 . NMR samples were initially 
optimised against different ionic strength and pH . Protein solubility and homogeneity 
did not shown much difference againest different conditions, whereas neutral and 
alkaline buffer conditions were prefered. Therefore a no salt buffer was choosen for 
achieving lower signal to noise ratio form NMR spectroscopy. pH 7.0 was choosen as 
higher pH will speed up amide proton exchange rate reduce spectra resolution.  
 
2.2.8 Protein concentration determination 
Protein concentration was determined directly by spectroscopic analysis using UV-Vis 
spectrophotometer (HITACHI). Protein absorbance at 280nm was measured. 
Concentration was determined according to: 
                                                         A280= ε . c . l 
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Where c is the molar concentration, A280 is the absorbance at 280nm, ε is the molar 
extinction coefficient (calculated using ExPASy ProtPrama) and l is the path-length of 
the cuvette.  
 
The protein A260/A280 was measured to check DNA contaminations. A260/A280 below 0.7 
was considered to have no DNA contamination.  
 2.3	  Biochemical	  and	  biophysical	  techniques	  
2.3.1 Limited proteolysis 
Sequencing grade modified trypsin (Sigma) was used in all limited proteolysis 
experiment at a ratio to target protein of 1/1000, 1/5000, 1/10,000, 1/50,000, 1/100,000.  
All reactions were at room temperature in trypsin buffer (50mM Tris, 20mM CaCl2, pH 
8.0). The trypsin digest was followed over time by taking aliquots at various time 
intervals, terminating the reaction with 0.5mM phenylmethylsulfonyl fluoride, and 
assessing the effects by SDS-PAGE. The solubility of the digested products was also 
checked using a native gel.  
 
2.3.2 Mass spectrometry 
The trypsin digested fragments mass were detected on mass spectroscopy with the help 
of Dr Robin Maytum. To prepare sample, formic acid was mixed with the protein 
sample (~10ug/ml) to a final concentration of 1% (v/v). The sample was first bound to a 
C5 reverse-phase HPLC column and then eluted with an acetonitrile gradient. The 
eluted fractions from the HPLC column were assessed by mass spectroscopy. 
 
 
Chapter2 Material and method 
50 
 
2.3.3 N-terminal sequencing 
N-terminal sequencing of the OutC-HR fragments was by Protein & Nucleic Acid 
Chemistry Facility (University of Cambridge). 
 
2.3.4 Dynamic light scattering  
Dynamic light scattering is a technique used to determine the size distribution profile of 
small particles in suspension. In dynamic light scattering, the speed at which the 
particles are diffusing due to Brownian motion is measured. This is done by measuring 
the rate at which the intensity of the scattered light fluctuates when detected using a 
suitable optical arrangement. The rate of the scattering intensity fluctuation occurring 
depends on the size of particles. The small particles cause the intensity to fluctuate more 
rapidly than the large ones. The size of a particle is calculated from diffusion 
coefficientusing the Stokes-Einstein equiation: 
D=kBT/6πηr 
where r is the radius of the protein, kB is the Boltzmann constant, T is the temperature in 
Kelvin degrees and η is the viscosity of the solvent. In this study protein molecular size 
is caculated from the radius using raleigh sphere module.  
 
Dynamic light scattering was measured using a DynaPro Molecular sizing instrument 
running DYNAMICS V6 software. The quartz cuvettes (45 µl) were prewashed with 
1% Triton and subsequently with water and dried with compressed nitrogen air. The 
exterior surface of cuvette was wiped with ethanol and lens tissue to remove any dirt on 
the outside surface. The protein concentration used was 4mg/ml (or as stated). Each 
sample was passed through a 0.2µm filter and a minimal 20 measurements were 
recorded at 20oC.  
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2.3.5 Circular dichroism  
Circular Dichroism (CD) is an excellent method to give an indication of the secondary 
structure of the protein. Although it is not possible to give detailed residue-specific 
information as obtainable from NMR and crystallography, it can provide secondary 
structure information using only small amounts of protein and it is extremely sensitive 
to changes in secondary structure and can also be used to monitor the conformational 
changes ( for instance as a function of temperature, pH, or ionic strength). 
 
CD measures differential absorption of left- and right- handed circular polarized light. 
The far UV CD bands of protein reflect the secondary structure, such as α-helix, β-sheet 
and unordered content (Figure. 2.1). 
 
Figure 2.1 Typical far-UV CD spectra of (a) myoglobin (all-α: 4mbn.pdb); (b) prealbumin (all-β: 
2pab.pdb), and (c) acid denatured staphylococcal nuclease at pH 6.2 and 6 _C (irregular). Adapted 
from (Martin and Schilstra 2008). 
 
All samples prepared for CD were purified to the highest purity and checked at 260/280 
absorbance for DNA contamination. The final protein concentration was determined 
using absorbance at 280 nm in 6M guanidine hydrochloride (Martin and Schilstra 
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2008). Protein samples used for CD were at a concentration of 0.05mg/ml in 20mM Tris 
150mM NaCl (pH 7.0). 
  
Far-UV CD measurements were made using a Jasco J-715 spectropolarimeter equipped 
with a PTC-348WI temperature controller. Spectra were recorded in 20mM Tris, 
150mM NaCl (pH7.0) at 15 ⁰C using 1mm path length fused silica cuvettes, The spectra 
are presented as  differential absorbance after baseline subtraction. 
 
2.3.6 Fluorescence spectroscopy 
Fluorescence spectroscopy is a type of electromagnetic spectroscopy which analyzes 
fluorescence from a sample of light, usually ultraviolet light, that excites the electrons in 
molecules of certain compounds and causes them to emit light of a lower energy. 
Aromatic residues are good natural fluorescence probes for protein studies. For 
tryptophan, the emission spectra usually peak between 310-350nm, depending on the 
local environment, the more exposed tryptophan tend to peak more towards 350nm and 
have higher signal. 
  
Fluorescence data were collected using a Jasco FP-6300 Spectrefluoremeter.  To avoid 
exciting tyrosyl side chains, an excitation wavelength of 295nm was used. Emission 
spectra were recorded at 15 ⁰C in steps of 2 nm from 310 to 400 nn. The fluorescence 
signal at 340 nm was plotted to calculate Kd. Samples are prepared in 20mM Tris, 
150mM NaCl, pH7.0. OutS spectra was measured at 1µM in buffer, 50µM of OutD691-
708 prepared in 1µM OutS was titrated into OutS solution. 
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2.3.7 Preparation of OutC and OutD coexpression pull down assays 
The cell pellet from 1L of culture was resuspended in 30 ml of Tris-Fix buffer (50 mM 
Tris, 150 mM NaCl, 1 mM EDTA pH 7.5) and sonicated. The soluble and insoluble 
protein fractions were separated by centrifugation at 15,000 g for 15 mins. The GST-
OutC77-162 produced appeared to be insoluble. Therefore, the insoluble protein pellet 
was then resuspended in 5 ml of 8 M urea and topped up with 20 ml of Tris-Fix buffer 
gradually with mixing. The urea refolded soluble protein is separated from the insoluble 
protein by centrifugation at 15,000 g for 15 min. 
 
Subsequently, the urea refolded soluble protein was loaded onto 5 ml pre-equlibrated Ni 
chelating beads (GE healthcare) and incubated at room temperature with mixing for 20 
mins. Non-specific binding proteins were washed off using 50 ml of Washing Buffer 
(50mM Tris, 400mM NaCl, 20mM imidazole pH6.5). Protein was eluted using 5 ml of 
Eluting Buffer (50mM Tris, 400mM NaCl, 20mM imdiazole pH6.5).  
 
2.3.8 Thermofluor 
Thermofluor is a high-throughput protein stability test. In this case, protein OutC-HRF3 
and OutD-N0 are used to test the stability of the proteins in different buffer conditions. 
The buffer that gives the higher melting point tends to provide the protein with better 
stability. 
 
Protein folding/ unfolding was monitored by the dye SYPRO-Orange (Invitrogen). The 
SYPRO-orange signal is highly quenched in an aqueous environment. As the protein 
unfolds, hydrophobic surfaces that are buried in the native protein become exposed to 
solvent and Sypro-orange binds to these hydrophobic sites resulting a signal. 
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Thermofluor analysis exploited a qPCR machine with 96 well PCR detection plate (AB 
gene AB-1100).  The screened buffer conditions are shown in Figure 2.6. For each 
screen mixture a 25µl of screen mix was prepared, including 12.5µl screening buffer, 
5µl 25xSypro orange (Invitrogen, prepared by mixing 5µl of 5000x stock with 955µl of 
water) and 7.5µl protein (starting with 5mg/ml and diluting if necessary). The screen 
was between 25-95 OC with one degree intervals. For each temperature, a 45 second 
incubation time was given between measurements. The emission signal was measured 
at 525nm. 
 
 
 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 1 2 3 4 5 6 7 8 9 10 11 12 
B 13 14 15 16 17 18 19 20 21 22 23 24 
C 25 26 27 28 29 30 31 32 33 34 35 36 
D 37 38 39 40 41 42 43 44 45 46 47 48 
E 49 50 51 52 53 54 55 56 57 58 59 60 
F 61 62 63 64 65 66 67 68 69 70 71 72 
G 73 74 75 76 77 78 79 80 81 82 83 84 
H 85 86 87 88 89 90 91 92 93 94 95 96 
 
Table 2.2 Conditions used in 96 well thermofluor buffer screen. (A) Buffer conditions used in the 
screen. (B) Numbering system of the 96 well plates.  
 
  1 2 3 4 5 6 
  
100mM Na-
Acetate pH 4.5 
100mM Bis-
Tris pH 5.5 
100mM Na-
Citrate pH 
6.5 
100mM 
HEPES pH 
7.5 
100mM 
Tris/HCl pH 
8.5 
100mM 
CHES pH 9.5 
A 0mM NaCl             
B 150mM NaCl         
C 500mM NaCl         
D 150mM NaCl 10% Glycerol 10% Glycerol 10% Glycerol 10% Glycerol 10% Glycerol 10% Glycerol 
E 150mM NaCl 5mM B-OG 5mM B-OG 5mM B-OG 5mM B-OG 5mM B-OG 5mM B-OG 
F 150mM NaCl 50mM Glycine 50mM Glycine 
50mM 
Glycine 
50mM 
Glycine 
50mM 
Glycine 
50mM 
Glycine 
G 150mM NaCl 50mM Arg+Glu 
50mM 
Arg+Glu 
50mM 
Arg+Glu 
50mM 
Arg+Glu 
50mM 
Arg+Glu 
50mM 
Arg+Glu 
H 150mM NaCl 100mM Urea 100mM Urea 100mM Urea 100mM Urea 100mM Urea 100mM Urea 
A 
B 
 Chaper3 NMR Spectroscopy: Materials and Methods 
55 
 
Chapter 3 NMR Spectroscopy: Materials and Methods 3.1	  Overview	  
There are two techniques used routinely to determine protein structure: X-ray 
crystallography and nuclear magnetic resonance (NMR) spectroscopy. X-ray 
crystallography is the direct measurement of the diffraction from the protein crystal to 
calculate, subject to solving the phase problem, the electron density and from that the 
protein structure. In contrast NMR spectroscopy uses a number of techniques including 
establishing the chemical shifts measured for each nuclear magnetic active atom and 
measuring proton-proton distances to determine the protein structure. 
 
Both X-ray crystallography and NMR spectroscopy have their limitations. X –ray 
crystallography is dependent on the production of diffracting protein crystals, which is 
rate limiting as it can involve extensive crystallization screens and optimization of 
conditions. Structure determination by NMR is limited by the size of the protein. As the 
size of the protein of interest gets bigger, the difficulty involved in solving the structure 
increases dramatically.  
 
NMR is also a very sensitive method to measure the time dependent changes of a 
protein. Therefore, it offers a great way to explore protein/ligand interactions and 
protein dynamics.  
 3.	  2	  NMR	  spectroscopy	  	  
3.2.1 Spectroscopy 
NMR spectra were acquired at 150C on Varian Inova 800 and 600 and Bruker Avance 
700 and 600 MHz spectrometers, all equipped for 1H/15N/13C triple-resonance 
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experiments. The Bruker spectrometers were controlled by TOPSPIN software 
(http://www.bruker-biospin.com/topspin3.html) and the Varian spectrometers by 
VNMR software (http://www.varianinc.com/cgi-bin/nav?products/nmr/software/).  
 
All NMR spectra were processed using NMRPipe (Delaglio, Grzesiek et al. 1995) and 
analyzed using Computer-Aided Resonance Assignment (CARA) version 1.5.5/NEASY 
(http://www.nmr.ch/).  
 
15N singly or 13C- and15N-doubly isotropically labeled protein were used to record 
various spectrum. Protein used to record 3D experiments was around 0.5mM. Sample 
concentrations ranging from 25µM to 0.5mM were used to record 2D spectra depending 
on the nature of the experiment and the time available.  
 
1H-15N Heternuclear Single Quantum Coherence (HSQC) spectra and 1H-15N Sofast-
HMQC were used for purposes such as sample evaluation, thermal melt analysis, 
titration experiments and for assignment.  
 
Various 3D experiments (shown in Table 3.1) were used for backbone assignment, side-
chain assignment and to generate distance restraints for OutC-HRF3. Backbone 
assignment was done for OutD-N0 and OutD-Cter. The buffer conditions used for 
OutC-HRF3 and OutD-N0 was 20mM Tris pH7.0 and 10% D2O. The buffer conditions 
used for OutD-Cter was 20mM Tris, 150mM NaCl pH7.0 and 10% D2O.  
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Table 3.1 Summary of the types of NMR spectra recorded during this work.  
 
3.2.2 Spectral analysis and resonance assignment 
Standard triple resonance backbone assignment of protein using HNCACB and 
CBCACONH spectra was used (Figure 3.1). The idea is that the HNCACB spectra 
correlates each NH group with the chemical shift of the current residue’s CA and CB 
(strongly) and that of neighboring residue’s CA and CBs (weakly). The CBCA(CO)NH 
spectra only correlates the NH group of the current residue to the preceding CA and CB 
chemical shifts. By comparing both these spectra, the current residue and its preceding 
CA CB resonances can be identified. The succeeding amide proton chemical shift was 
identified using the chemical shifts of the preceding CA CB to search for the amide 
giving same chemical shift within the current residue’s CA, CB on HNCACB spectra. 
For proline residues, where amide proton is absent, CBCAHA and HACA(CO)N were 
used to help with CA CB and HA identification. Assignment of side-chain resonances 
was achieved by using HCCH-TOCSY, 1H-13C NOESY and 1H-15N NOESY spectra.  
 
 
?
Experiment Purpose of experiment 
1H NMR Sample evaluation 
1H-15N HSQC Reference spectrum 
1H-15N HMQC Titration 
HNCACB  
CBCA(CO)NH Backbone assignment 
HNCO  
HNCA  
CBCAHA  
HACA(CO)N Side-chain assignment 
HCCH-TOCSY  
1H-15N NOESY Distance restraints 
1H-13C NOESY  
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Figure 3.1 Resonance assignment using HNCACB and HN(CA)CO spectra.?
?3.3	  Dynamic	  studies	  by	  NMR	  	  
NMR measured chemical shift depends on the local magnetic field. If there is molecular 
motion, then there is different shielding at different time points which creates different 
chemical shifts.  By using this property, NMR can be used to study protein dynamics. 
 
NMR is sensitive to rather slow molecular motions. NMR relaxation studies can 
therefore provide detailed information pertaining to the internal dynamics occurring in 
proteins. It is well established that despite the close packing in globular proteins, there 
are substantial fluctuations on the picosecond time scale. Different physical processes 
are responsible for the relaxation of the components of the nuclear spin magnetization 
vector M parallel and perpendicular to the externally applied magnetic field B0. These 
two principle relaxation processes are termed longitudinal (or T1, spin-lattice) relaxation 
and transverse (or T2, spin-spin) relaxation.  The measurement of 15N relaxation rate is 
particularly useful for obtaining dynamic information, as the relaxation of these nuclei 
is governed predominantly by the dipolar interaction with directly bound protons. 
Therefore by measurement of 15N relaxation parameters, the hydrodynamic properties 
of protein can be gained.  
HNCACB strips  CBCA(CO)NH strips  
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15N T1, T2 and 1H-15N NOE enhancement relaxation experiments were performed at 
600MHz (at 15oC) using standard acquisition methods (Kay LE 1989).  
 
3.3.1 Longitudinal and transverse relaxation 
T1 and T2 values are sensitive to different motional frequencies. T1 relaxation times 
provide motional properties with a frequency of approximately 108-1012s-1, while T2 
values, in addition to depending on motions occurring at these high frequencies, are also 
sensitive to dynamics on the micro and millisecond time scale.  By obtaining both T1 
and T2 relaxation values, it is possible to obtain dynamic motion information over a 
large frequency range.  
 
For small molecules or unstructured region of proteins, which reorient rapidly in 
solution, the T1 and T2 relaxation times are similar (Figure 3.2). As the protein becomes 
larger and more structured, it tumbles more slowly in solution. 
 
 
Figure 3.2 Schematic representation of T1, T2 and NOE relaxation times as a function of correlation 
time (Kay LE 1989). 
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The ratio between the average T1 and T2 relaxation values for a given molecule can be 
used to calculate its rotational correlation time (τc) as follows: 
                                                 τc=(4πνN) (6T1/T2 -7)1/2 
Where  νN is the atom resonance frequency in Hz, the 15N resonance frequency is 
60,000,000Hz when measured at 600MHz spectroscopy.  
 
τc is the time it takes the particle to rotate by one radian. It depends on the particle size. 
As a general rule of thumb, the τc of a monomeric protein in solution in nanoseconds is 
approximately 0.6 times its molecular weight in kDa. Moreover, when calculated 
correlation times are similar throughout the protein backbone this suggests isotropic 
motion of the protein molecule. 
 
3.3.2 The Nuclear Overhauser Effect (NOE)?
The Nuclear Overhauser Effect (NOE) is a phenomenon observed by cross relaxation 
between dipolar coupled spin systems. It is exceptionally important tool for structural 
studies. 
 
For dynamic studies, transient NOE experiments were used. 15N NOE is 5 to 30 times 
more sensitive to internal dynamics than T1 and T2. Residues located on loops can show 
shorter NOE than any of the non-terminal residues. Intense negative NOEs suggest 
contributions from rapid internal motions and can usually be observed for the terminal 
residues. In multidomain proteins, the backbone correlation time can also give some 
assessment of the degree of intra-domain association, such as for the same protein size, 
domains arranged in a “beads on a string” manner gives shorter correlation time than 
those of a single domain or domains with strong inter-domain contacts. If the dipolar 
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interaction is considered exclusively, for rigid proteins tumbling isotropically the 
maximum NOE possible is +0.82 (Kay LE 1989). 
 
For structure calculations, NOE restraints were obtained form 3D 13C- and 15N-edited 
NOESY-HSQC spectra. From these experiments, homonuclear 1H-1H NOEs can be 
clearly assigned even in overcrowded regions. The intensities of the peaks reflect the 
distance between two protons. Based on the available chemical shift assignments, the 
NOE data are essential for the secondary and tertiary structure calculations.  
 3.4	  Secondary	  structure	  prediction	  by	  TALOS	  
The initial protein NMR structural characterization began with prediction of the 
secondary structure. It is well established that when a polypeptide chain forms 
secondary structure, the amino acid residues display a characterized chemical shift 
change in relation to their standard random coil values (Wishart and Sykes 1994). 
Namely, the chemical shifts of CA nuclei experience an up-field shift when present in 
β-strand structure and a down-field shift when in α-helices.  
Protein backbone chemical shifts are exquisitely sensitive to local conformation, such as 
bond angles. The protein backbone dihedral angels (φ and ψ , Figure 3.3) are 
characteristic to the secondary protein structure, this correlation is well presented as 
Ramachandran plot (Ramachandran, Ramakrishnan et al. 1963). By using the inverse of 
this relation, TALOS+ searches the input protein sequence in a data base of 200 proteins 
for the 10 best matches to the secondary chemical shits of given residual in a target 
protein along with its two flanking neighbours (a residual triplet). If there is a consensus 
φ and ψ angle among the 10 best database matches, then database triplet structures are 
used to predict the secondary structure of the target residues. TALOS incorporates the 
                                                       Chapter 3 NMR spectroscopy: materials and methods 
62 
 
assignments of 15N, 1H, 13Cα, 13Cβ, Hα, Hβ and 13C chemical shifts of each amino acid 
for secondary structural prediction (Figure 3.4). 
 
Figure 3.3 Protein dihedral angels. Peptide bond (ω) phi (φ) and  psi (ψ)torsion angles are shown. 
 
 . 
Figure 3.4 Schematic representation of the calculations by the TALOS+ program (Shen Y 2009) 
 3.5	  Residual	  dipolar	  coupling	  	  
Residual dipolar coupling (RDC) is an NMR parameter that provides a measure of 
dipolar interaction between a pair of atoms, such as 1H-15N (Bax and Grishaev 2005). In 
solution, RDCs are averaged to zero as they are very sensitive functions of the time-
averaged orientation of the corresponding internuclear vectors and thereby offer highly 
precise structural information. RDC can be measured in partially aligned protein 
samples, which can be achieved using a diluted liquid crystalline phase. The alignment 
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happens in very non-invasive manner so that the resulting residual dipolar coupling is 
about 1000 times smaller than the original dipolar coupling interaction, providing 
orientation information without affecting the shape and dynamics of the protein. 
 
OutC-HRF3 anisotropic liquid crystalline state was achieved according to Rückert and 
Otting’s method (Rückert and Otting 2000). Lα phase crystals were prepared by 
dissolving C5E8 in 90% 20mM Tris (pH7.0)/10%D2O, and adding n-octanol in 
microlitre steps to the desired final molar ratio under vigorous shaking. The solution 
was biphasic at low alcohol concentrations and became instantaneously transparent and 
opalescent upon crossing the Lα phase boundary. The Lα phase is relatively viscous 
immobilizing any small air bubbles presence in solution.  Equal volumes of 0.5mM 15N 
labeled OutC-HRF3 were mixed with the Lα phase solution to achieve the final 
anisotropic sample. The presence of an ordered lamellar phase was monitored by 
observation of quadrupolar splitting of the 2H NMR signal of the solvent.  
 3.6	  ARIA	  1.2	  
ARIA 1.2 (Ambiguous Restraints for Iterative Assignment) is the program used for 
OutC-HRF3 structure calculation (Linge, Habeck et al. 2003). Due to the high 
complexity of the assignment problem, most of the NOEs cannot be directly converted 
into an unambiguous inter-proton distance. ARIA takes structural information 
including, torsion angles, hydrogen bonds, residual dipolar coupling and identified 
unambiguous NOE list together with 1H-15N-NOESY and 1H-13C-NOESY peak list and 
calibrated peak intensity. The program uses the input data to automatically assign NOE 
peaks and calculate the structure. The parameters used for structure simulation are 
shown in Appendix 2.  
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3.7	  NMR	  titration	   	  
NMR titration is achieved by recording a 1H-15N HSQC/ 1H-15N Sofast-HMQC spectra 
of the labeled protein. In serial titrations, cross titrations were performed to eliminate 
the dilution of the labeled protein. In cross titration, two samples were prepared; one 
sample was labeled protein only and the second sample had the same concentration of 
labeled protein and a high equivalent (i.e. 10 equivalents) of unlabeled titration partner. 
During the titraion the concentration of labeled protein did not change, so it was not 
necessary to correct for dilution.    
 3.8	  HADDOCK	  
The program HADDOCK is a protein-protein docking algorithm which uses 
biochemical and biophysical information to provide a model of the protein-protein 
complex (Dominguez, Boelens et al. 2003). It uses experimental data (i.e. chemical shift 
perturbation data, site specific mutagenesis data).  The information on interacting 
residues is introduced as ambiguous interaction restrains (AIRs) to drive the docking. In 
the case of NMR titration data, the active residues correspond to all residues showing a 
significant chemical shift perturbation upon complex formation as well as high solvent 
accessibility in the free form of protein. The passive residues correspond to the residues 
that show a less significant chemical shift perturbation and/or that are surface neighbors 
of the active residues with high solvent accessibility (>50%).  The AIRs files are 
generated by entering active and passive residue on http://www.nmr.chem.uu.nl/ 
haddock/. 1000 docking structures were generated for each calculation. The output 
structures are ranked according to their intermolecular energy. The best 100 structures 
were used for the water structure refinement. 
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Chapter 4: Solution structure of OutC-HRF3 4.1	  Overview	  
In order to understand the function of the GspC homology region at the molecular level, 
the structure of OutC-HRF3 (104 residues, 11.1kDa, sequence shown in Figure 4.2 and 
Appendix1) was solved by NMR spectroscopy. A combination of manual and automatic 
methods were employed for the structure determination. Manual structure calculations 
were performed using constraints derived from 1H-15N and 1H-13C NOESY spectra, 
hydrogen bonds that were detected from the direct HNCO measurement, residual 
dipolar coupling measurements on a weakly aligned liquid crystalline media and 
backbone torsion angle restrains derived from TALOS. ARIA 1.2 was used for 
automatic structural calculation using unassigned NOE peaks, chemical shifts and 
hydrogen bonds. Residual dipolar couplings were introduced into the final round of 
structure calculation. The CS-ROSETTA predicted structure is consistent with final 
structure ; the OutC-HRF3 is revealed to possess a β−sandwich like fold.  
 4.2	  OutC-­‐	  HRF3	  structure	  identification	  
GspC is a biotropic protein. It has a short N terminus located in cytoplasm, a 
transmembrane segment and a long C-terminal region located in the periplasmic region. 
Within the periplasmic region, there are two domains involved in function: the 
homology region and a domain involved in protein protein interactions, which is in 
most cases a PDZ domain, or a coiled-coil domain.  
 
The OutC-HR construct was provided by the colabrator Dr. Shevchik (University of 
Lyon); it consists of the periplasmic region of OutC, but excludes the PDZ domain. A 
series of cystallization trails were carried out with no crystal being obtained.  
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Limited proteolysis is a technique with a good track record of helping to identify folded 
domains amenable for structural studies. The folded segments or domains of a protein 
are more resistant to proteolysis than the loops between domains because potential 
cleavage sites are less accessiblein the folded domains.. This technique was applied to 
OutC-HR to identify the more structured part. The protease trypsin (Sigma) was used to 
challenge OutC-HR. There are three major fragments obeserved in the result of limited 
proteolysis (Figure 4.1A), OutC-HRF1, OutC-HRF2, and OutC-HRF3. As the order of 
OutC-HRF1 and OutC-HRF2 appeared; OutC-HRF1 shows up first and then OutC-
HRF2 is starting to appear only when most of OutC-HR converted to OutC-HRF1; the 
OutC-HRF2 is a digested product from OutC-HRF1. Similar pattern also apply to OutC-
HRF2 and OutC-HRF3, OutC-HRF3 is a further digested product of OutC-HRF2. 
Therefore, truncations happen in a temporal order, with the exposed sites cleaved first. 
From the temporal order of occurrence on the SDS-PAGE the corresponding fragment 
in the native gel was established. Native-PAGE was used to confirm that the proteolytic 
fragments obtained were soluble and not aggregating (Figure 4.1B).  
 
The N-terminal protein sequences of the three proteolytic fragments were characterized 
by sequencing (Cambridge University sequencing service) and mass spectroscopy. The 
corresponding molecular masses and sequences are shown in Figure 4.2.  
 
 
 
 
?
?
?
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Figure 4.1 Limited proteolysis of OutC-HR. (A), SDS-PAGE of OutC-HR after limited proteolysis. 
(B), native PAGE of OutC-HR after limited proteolysis. The trypsin to Out-HR ratio ranges from 
1/1000 to 1/100,000. The incubation time as indicated.  
?
?
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Fragment N-terminal 
starts from 
Mass detected from 
mass spec (Da) 
Calculated 
mass (Da) 
Region 
OurC-HR -- -- 16773.4 42-190 
OutC-HRF1 57 14330.5 14329.7 57-190 
OutC-HRF2 57 12588.6 12587.9 57-177 
OutC-HRF3 77 10344.2 10343.4 77-177 
 
 
 
        40         50         60         70         80         90  
QGPLGSPNSR GNAPVSSVQI TPAQARQQPV TLNDFTLFGV SPEKNKAGAL DASQMSNLPP  
 
       100        110        120        130        140        150  
STLNLSLTGV MAGDDDSRSI AIISKDNEQF SRGVNEEVPG YNAKIVSIRP DRVVLQYQGR  
 
       160        170172    (180/264)(190/272) 
YEVLGLYSQE DSGSDGVPGA QVRDGQRQDI YMEFGGDE 
  
 
 
 
 
 
 
Figure 4.2 Sequencing results reveal the sequence of the putative domains. (A) Summary of the N-
terminal sequencing and mass spectroscopy results. (B) OutC-HR construct sequence. Sequence 
identity of identified protein. OutC residues numbered in black, N-terminal sequencing detected 
residues in red, residues in OutC-HR in green.  (C) Schematic diagram of OutC constructs. 
HRF2 , HRF3 end 
 
HRF1 end 
 
HRF1 , HRF2 
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4.3	  OutC-­‐HRF3	  expression 
4.3.1 Sub-cloning outC-hrf3 
In the expectation that the smaller fragments corresponded to  the more structured 
regions, OutC-HRF2 and OutC-HRF3 were chosen to be made recombinantly for 
further structural studies. Both corresponding sequences were cloned into pET-14b. The 
pET-14b vector carries a cleavable N-terminal His tag sequence, which facilitates 
protein purification. The ligation between outC-hrf3 insert and pET-14b vector was 
checked by Xho1 Blp1 double digestion (Figure 4.3A). The nucleic acid sequence was 
checked by sequencing (MWG). 
 
?
 
 
 
 
Figure 4.3 Cloning, expression and purification of OutC-HRF3. (A) Cloning of outC-hrf3. (B) 
Expression and purification of OutC-HRF3. (C) Gel-filtration trace of OutC-HRF3 on S200 HR 
10/30 column. 
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4.3.2 OutC-HRF3 expression 
The OutC-HRF3 expression was achieved in E coli BL21 (DE3). OutC-HRF3 encoding 
pET-14b vector was transformed into to BL21 (DE3) cells. Cultures (1 liter), inoculated 
by 5ml overnight culture, and were grown at 37oC in Luria broth (LB) containing 500µg 
ampicillin until the absorbance at 600nm reached 0.6. The recombinant protein 
expression was induced by adding 1mM IPTG and growing for a further 4 hrs at 37oC .  
 
4.3.3 OutC-HRF3 purification 
As the pET-14b expression vector produces recombinant protein with an N-terminal 
His-tag, a Ni-HiTrap affinity column (GE Healthcare) was used to purify the soluble 
protein. After loading the soluble protein fraction from the cell lysate, the column was 
washed with low pH low imidazole buffer and then thrombin-containing buffer.The 
OutC-HRF3 was produced with His tag cleaved off by incubate in thrombin protease 
containing buffer overnight. Protein was then eluted from the column by washing with 
buffer.  
 
As shown in Figure 4.3B the protein eluted from the Ni column has relative high purity 
of OutC-HRF3 with the only visible contamination at around 70kDa. Since the size of 
the contamination is much greater than OutC-HRF3, size exclusion chromatography 
was used for further purification. After size exclusion chromatography the OutC-HRF3 
fraction, as judged by SDS-PAGE, had a purity of at least 95%. 
 
The OutC-HRF3 elutes from the S200 column at 72.2% column volumn (C.V.), 
consistent with a molecular weight of 9KDa. With the OutC-HRF3 calculated mass of 
10.343kDa, the size exclusion column result suggests the OutC-HRF3 present in 
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solution as a monomer. On the other hand, OutC-HR with size of 18kDa elutes at 61.2% 
C.V. indicating the size around 35kDa. Since there is no evidence that OutC-HR exists 
in a dimeric form without the trans-membrane segment, the early elution of OutC-HR 
from the size exclusion column suggests the OutC-HR contains unstructured 
polypeptide that causes it to behave anomalously. In contrast to this, the OutC-HRF3, 
limited proteolysis fragment obtained from HR is more compact and structured.  
 
To check that the recombinantly produced OutC-HR fragments maintain their structure 
as produced by proteolysis, SDS-PAGE and Native-PAGE were employed to compare 
both denatured and native states (Figure 4.4 ). The recombinantly produced OutC-HRF2 
and OutC-HRF3 run similarly to the corresponding proteolytic fragments on both SDS-
PAGE and Native-PAGE. The similarity on SDS-PAGE indicated they are similar in 
molecular weight. Whereas the similarity on Native-PAGE means they have similar 
charge to mass ratio and hints they fold in same way.  
 
As observed in Figure 4.4, freshly produced OutC-HR showed a smeary band, 
indicating it is prone to degradation. The prepared OutC-HRF3 sample was found to be 
stable at 4oC for at least 6 month. 	  	  4.4	  Dynamic	  light	  scattering	  
Dynamic light scattering (DLS) is an established technique in the field of protein 
crystallography. It measures hydrodynamic size, polydispersity and aggregation of 
protein samples and gives a general idea of the ability of the protein to form crystals.  
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Figure 4.4 Comparision of recombinantly produced OutC-HRF2 and OutC-HRF3 and proteolysis 
fragments. (A) SDS-PAGE. (B) Native-PAGE. Lane 1, OutC-HR. Lane 2, purified pET14b OutC-
HRF2 recombinantly produced protein. Lane3, purified pET14b OutC-HRF3 recombinantly 
produced protein.  Lanes 4, 5 and 6 proteolysis of OutC-HR with trypsin. OutC-HRF3* is the 
recombinantly produced His tagged OutC-HRF3.  
 
The OutC-HRF3 sample shows a polydispersity of 14.4%, which indicates OutC-HRF3 
is monodisperse in solution (Figure 4.5). The average molecular mass calculated from 
the radius of the protein is approximately 14kD, which confirms that OutC-HRF3 is 
present in the solution as homogenous subunit. It is generally considered that protein 
with monodispersity of 20% or less is very likely to form crystals. The OutC-HRF3 
DLS result suggests it can be crystallized. 
       
 Radius(nm) %Pd MW-­‐R(kDa) %Int 
Peak1 1.65211 14.4 14 85 
Peak2 14.4235 20.9 1734 15 
 
Figure 4.5 OutC-HRF3 DLS summary. 14.4% polydispersity, radius 18.5 nm and molecular weight 
14kDa. 
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4.5	  OutC-­‐HRF3	  solution	  structure 
OutC-HRF3 protein was put into crystallization trails. Crystal screens was carried out 
with commercial screens: including Hampton Research screen I and II, Wizard 
crystallization screen I and II, using mannual hanging drop as well as robotic sitting 
drop technique. Crystallization temperature was chose at 18oC, which is consistent with 
DLS experiment condition. However, no crysal was obtained. The solution structure 
was therefore solved by NMR spectroscopy.  
 
4.5.1 Determining the architecture of OutC-HRF3 using NMR spectroscopy 
To ensure that the OutC-HRF3 maintained the structure as in its functional form, the 
OutC-HRF3 1H-15N HSQC spectra was collected and compared with the OutC-Peri 
spectra (Firgure 4.6). The 1H-15N HSQC of OutC-HRF3 reveals a set of well dispersed 
peaks, where almost all peaks overlay well with OutC-Peri peaks. Protein chemical 
shifts are very sensitive to local electron environment and the excellent overlap between 
OutC-HRF3 and OutC-Peri shows that the HR domain structure is independent of the 
rest of the periplasmic region of OutC. There will be very few or no contacts between 
the HR and PDZ domains of OutC. This result is consistent with the “beads on a string” 
model of the domain architecture of the periplasmic region of OutC proposed by Login 
et al. (Login, Fries et al. 2010). Most importantly, this result confirms that OutC-HRF3 
retains the functional structure of OutC-Peri.  
 
The OutC-HRF3 1H-15N HSQC spectra was assigned. The construct contained an 
additional 7 residues in a tag (see Appendix 1 for sequence). The 7 residues are present 
at the N-terminus of the protein and are consequence of the thrombin cleavage site. The 
OutC-HRF3 backbone amide proton was fully assigned, except the 7 residues in the tag 
and 5 prolines in the sequence (Figure 4.7). 
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Figure 4.6 Comparison of OutC-HRF3 and OutC-Peri spectra. 2D 1H-15N HSQC of OutC-HRF3 
(black) and 2D 1H-15N HSQC of OutC-Peri (black). Both spectra acquired at 15°C on Bruker 
600MHz in 20mM Tris (pH7.0) and 10% 2H2O.  
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Figure 4. 7 1H-15N HSQC spectrum of OutC-HRF3. The spectrum was acquired on a Bruker 
600MHz NMR spectrometer at 15oC in 20mM Tris (pH 7.0) and 10% 2H2O. 
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4.5.3 OutC-HRF3 secondary structure prediction 
The OutC-HRF3 protein structure determination began with a secondary structural 
prediction using TALOS+ (Shen and Bax 2007; Shen Y 2009). Protein backbone 
chemical shift is exquisitely sensitive to local conformation. By using the inverse of this 
relation, TALOS+ compares the input protein sequence with a data base of 200 proteins 
and selects the 10 best matches to the secondary chemical shifts of given residual in a 
target protein along with one extra residue on each side (a residual triplet). If there is a 
consensus φ and ψ angle among the 10 best database matches, then database triplet 
structures is used to predict φ and ψ angles of the central residue. 
 
TALOS+ incorporates the assignments of 15N, 1H, 13Cα, 13Cβ, Hα, Hβ and 13C 
chemical shifts of each amino acid residue for secondary structure prediction.  It also 
uses the Random Coil Index (RCI) derived method to predict S2 backbone chemical 
shifts. OutC-HRF3 secondary structural prediction reveals a very short helical structure 
at the N-terminus and followed by six β-strands. The RCI S 2 reflects the internal 
picosecond-nanosecond motion (Berjanskii and Wishart 2005). Since S2 value 
significantly varies for the mobile region, the predicted OutC-HRF3 S2 value suggests 
the N-terminal 12 residues and C-terminal 18 residues are flexible.  
 
OutC-HRF3 shows a structure formed of predominantly β-sheet structure: with short 
helix at N-terminus and followed by 6 beta-strands. This is consistent with the 
secondary structure prediction done by J-pred (http://www.compbio.dundee.ac. 
uk/www-jpred/), which successfully predicted the 6 beta-strands.  However, the helical 
region is not highly conserved across species.  
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Figure 4.8 Secondary structure prediction of OutC-HRF3. (A) TALOS+ predicted Phi Psi angels 
for residues which significant matches of Phi and Psi angels were made. (B) Secondary structure 
predicted by Phi and Psi torsion angles.  (C) TALOS+ predicted RCI-S2 (upper panel) and 
secondary structure (lower panel) for OutC-HRF3 (cyan beta-sheet; red, helix). 
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For the structural calculations presented in the following sections, TALOS derived 
φ and ψ dihedral angle restraints were incorporated with a TALOS factor of 2 and 
TALOS error of 20 in the final ARIA structure calculation.  
 
4.5.5 Relaxation studies  
The TALOS+ predicted S2 value gives an idea of the internal dynamics of OutC-HRF3, 
more detailed relaxation studies were carried out to further investigate its hydrodynamic 
properties.  
 
 The T1, T2, and 1H-15N-NOE relaxation profiles of OutC-HRF3 are shown in Figure 
4.9. In each relaxation profile, missing residues correspond to prolines, overlapped 
peaks or peaks with extremely weak intensity. The structured domain of OutC-HRF3 is 
defined in the T2 and 1H-15N-NOE relaxation profiles, as being formed by residues 22-
88. This agrees with TALOS+ predicted secondary structure region and S2 value. In this 
structured region of OutC-HRF3 the T1 relaxation time is ∼784.24±2.34 ms, T2 
relaxation time is ∼87.05±0.436 ms, 1H-15N-NOE relaxation is 0.72. Using these 
relaxation data, the correlation time of OutC-HRF3 measured at 15 oC is 8.6 ns.  The 
correlation time of 8.6ns indicates that OutC-HRF3 behaves in solution as an isolated 
subunit, agreeing with size-exclusion and DLS data.  
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Figure 4.9 T1,T2 and NOE relaxation value of OutC-HRF3. Acquired at Varian 600MHz at 15oC in 
20mM Tris (pH 7.0) and 10% 2H2O. 
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4.5.6 CS-ROSETTA structure prediction 
It has long been recognized that chemical shifts are strongly influenced by local 
conformation. To date, interpretation of isotropic chemical shifts in protein structure is 
largely based on empirical correlations gained from the mining of protein chemical 
shifts deposited in Biological Magnetic Resonance Data Bank (BMRB), in conjunction 
with the known corresponding 3D structures. Chemical-Shift-ROSETTA (CS-
ROSETTA) is a robust protocol to exploit this relation for the de novo protein structure 
generation for proteins no larger than 15kDa, by using as input parameters the 13CA, 
13CB, 13C', 15N, 1HA and 1HN NMR chemical shifts. These shifts are generally 
available at the early stage of conventional NMR structure determination procedure.  
However, CS-ROSETTA has a tendency to slightly lengthen the elements of secondary 
structure and include residues that were clearly disordered as judged by the NMR data. 
This is due to the program energy selection process favors the formation of intra-
molecular hydrogen bonds, and a tendency to generate secondary structure for 
disordered region is therefore not surprising.  
 
The OutC-HRF3 structure was predicted using CS-ROSETTA with the chemical shifts 
available at the early stage of the structure determination. 10,000 structures were 
generated and the best 1000 structures selected by energy. The energy of the best 1000 
structure is plotted against the lowest energy structure (Figure 4.10). The root-mean-
square deviation (RMSD) of the 10 lowest energy structures  is within 3Å, which 
suggest the structures predicted by CS-ROSETTA converged successfully and are 
reliable. The best 200 structures are very similar and share same structure fold.  
 
CR-ROSETTA predicts OutC-HRF3 adopts a beta-sandwich fold (Golovanov et al 
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2006):  with 2 beta sheets, each composed of three hydrogen-bonding anti-parallel 
strands (Figure 4.11). When using this predicted OutC-HRF3 structure as input to Dali 
database server (Holm and Rosenstrom 2010), the only hit with similar structure was 
PilP, with Z score of 6.4 and backbone RMSD of 1.9 Å.	  PilP is	  a pilotin from typeIV 
secretion system. Although the exact function of PilP is not understood, it occupies a 
similar location to OutC-HRF3 located on the inner-membrane and reaching into 
periplasma to interact with the secretin in the outer-membrane (Drake, Sandstedt et al. 
1997). As OutC-HRF3 shares a similar function and interacts with T2SS secretin, the 
predicted OutC-HRF3 structure is highly likely to be correct and could be the first PilP-
like structure discovered (Figure 4.12). 
                   ?
Figure 4.10 CS-ROSETTA structures energy plot. The 2000 lowest energy structures were plotted 
according to the lowest energy structure. 10 lowest energy models all differ by less than 3Å. 
 
The CS-ROSETTA predicted OutC-HRF3 structure is show in Figure 4.11. The protein 
adopts a beta-sandwich-type fold. A short 310 helix is formed at the N-terminus, which 
is also found in PilP (Golovanov et al).  
 
In the OutC-HRF3 predicted structure the characteristic β4 strand found in PilP, which 
is also revealed as highly conserved strand in the type IV PilP equivalent proteins in 
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other species, is replaced by a more flexible loop. The two key residues involved in 
forming hydrophobic core are I113 and V144. I 133 is conserved between the OutC-
HRF3 and PilP . V144 substituted by a similar hydrophobic residue  Ile. The CS-
ROSETTA predicted structure was later confirmed to be correct using the standard 
NOE based structure determination procedure (detailed below). 
 
4.5.7 Hydrogen bond restraints 
Hydrogen bonds stabilize protein structure. It is very informative for structure 
calculation and refinement. Indirect hydrogen bond measurement by quadrupole 
coupling constant (Liwang and Bax 1997) was unsuccessful due to rapid backbone 
amide exchange with solvent deuterons for almost all residues. Fortunately, OutC-
HRF3 hydrogen bonds can be measured by direct trans-hydrogen bond (N-H…O=C) 
scalar coupling (Cordier and Grzesiek 1999). Compared to the indirect D2O exchange 
method, this method is relatively difficult to perform and gives few hydrogen bonds but 
the result is more precise.  
 
In Figure 4.13 the OutC-HRF3 standard HNCO spectra is overlaid with the results of 
the OutC-HRF3 long-range JNC’ HNCO spectra. The chemical shifts of NH(n) and CO(n-1) 
on the standard HNCO spectra allow identification of the residue, n. If the residue HN is 
involved in hydrogen-bonding a CO group, the hydrogen-bonding partner CO can be 
identified from the chemical shifs of the NH and CO on the long range JNC’ HNCO 
experiment. The NH shift will be in common and the different CO shift for the 
hydrogen binding carbonyl allows identification of the long-range CO.  28 hydrogen 
bonds were measured in OutC-HRF3 and these are listed in Appendix 3. Hydrogen 
bond restraints were included in the final structure calculation.  
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Figure 4.11 Two views of CS-ROSETTA predicted OutC-HRF3 structure. The hydrophobic core 
residue I 113 and V144 are colored in red and blue. The structure comprises a beta-sandwich fold. 
 
 
 
  
Figure 4.12 Comparison of OutC-HRF3 and PilP structure. OutC-HRF3 shows a longer linker 
between the  310 helix and β1 strand,  shorter β6 and β7 strand and b4 is replaced by a loop (L4). 
PILP(69-181) OutC-HRF3 
 
OutC-HRF3 
 PilP  
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Figure 4.13 OutC-HRF3 hydrogen bond measurement. OutC-HRF3 standard HNCO experiment 
(in red), showing omega bond. OutC-HRF3 long-range JNC’ HNCO experiment (in black), showing 
hydrogen bond between residues. Identified peaks are labeled as (HN chemical shift, CO chemical 
shift). 
 
4.5.8 Residual dipolar coupling 
Residual dipolar coupling (RDC) measured in diluted liquid crystalline phase provides 
important restraints for molecular structure determinations by NMR spectroscopy, 
which cannot be obtained otherwise. Dipolar coupling is a through-space interaction, 
which arises between any two magnetically active nuclei. Residual dipolar coupling is a 
useful method to provide independent information on how each dipole is orientated 
related to the molecular coordinate frame and in turn, to each other. It depends on 
distance, orientation and dynamics. As a result of Brownian motion, dipolar couplings 
average to zero under isotropic conditions and are only observed under anisotropic 
conditions.  
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For two dipole-coupled nuclei, A and B, the observable dipolar coupling in solution, 
DAB can be expressed as: 
                                   DAB(θ,φ) =AαAB{(3cos2θ−1)+3/2R(sin2θ cos2φ)} 
AαAB and R are the axial and rhombic components, respectively, of the molecular 
alignment tensor, A in the principle coordinate frame.  
 
To use RDC in any type of structure refinement, good estimates for AαAB and R in must 
be available. The AαAB and R value for OutC-HRF3 were calculated to be 0.5 and 7 
using maximum likelihood method (Warrena and Moore 2002). 
 
As shown in Figure 4.14 the measured HN-N residual dipolar coupling in OutC-HRF3 
can be plotted as a linear function. This indicates the calculated structure agree with the 
RDC measurements. The RDC measured with greater standard deviation is normally 
located on the flexible regions of the structure, such as loops connecting the strands.  
?
Figure 4.14 Correlations between calculated OutC-HRF3 NMR structure and experimental 
measured RDC. 
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4.5.9 Resonance assignment of OutC-HRF3 
Though analysis of the various triple resonance spectra outlined in Section 3.1 the 
assignment of OutC-HRF3 backbone and side chain resonances was achieved. In total, 
OutC-HRF3 contains 1373 potentially assignable atoms. Assignment of several subsets 
of atoms such as the side chain NH2 groups of Arg residues, Lys NH3+ groups and in 
many cases the hydroxyl protons of Ser and Thr residues, were not possible.  
 
The overall OutC-HRF3 assignment statistics are shown in Table 4.1. The core region 
revealed by the relaxation study and including the β-sandwich fold, residues 22-87, has 
the highest proportion of assigned atoms (83.7%). 
OutC-HRF3 
Total number 
of atoms 
Number of 
unassigned atoms 
% 
Assignment 
Full length (1-104) 1373 304 77.8 
Core residues(22-87) 918 150 83.7 
 
Table 4.1 OutC-HRF3 assignment statistics. 
 
4.5.10 NMR structure calculation 
ARIA1.2 was used for OutC-HRF3 structure calculation. TALOS calculated dihedral 
angles (Appendix 5), H-Bond (Appendix 3), RDC (Appendix 4), and manually 
identified unambiguous NOE files together with 1H-15N-NOESY and 1H-13C-NOESY 
peak lists were used for structure calculation.  
 
The NOE intensity is inversely proportional to the 106 power of the distance, for the 
residues in flexible region, the NOEs measured favor the conformation that gives strong 
NOEs and could not represent the dynamics of the flexible region. Therefore, NOEs 
involved in the flexible region residues were excluded from the calculation by deleting 
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the flexible region assignment. According to relaxation data, residues 22 -87 behave as 
the stable structural core of the protein. The NOE peak intensities from 13C-NOE and 
15N-NOE spectra were used in the ARIA calculation with spectral calibration 
(qcali=ture in run.cns).  
 
4.5.11 OutC-HRF3 solution structure evaluation 
OutC-HRF3 NMR relaxation measurement revealed that the structured region 
comprised 65 residues, OutC-HRF322-87. A high percentage sequence-specific NMR 
signal assignment was achieved using a combination of 3D triple resonance experiments 
using 15N, 13C-labeled OutC-HR, and 3D NOSEY-HSQC, TOCSY-HSQC using 15N-
labeled protein. The 1912 experimental nuclear Overhauser effect (NOE) distance 
restraints were obtained using 13C or 15N -edited NOE spectroscopy (NOESY) spectra, 
and 76 φ and ψ torsion angle restraints were derived from secondary chemical shift 
analysis using the TALOS algorithm. Twenty eight hydrogen bonds were 
experimentally measured. The structure of OutC-HRF3(22-87) was determined with high 
precision: the pairwise RMSDs for the 20 conformers of the final ensemble were 0.46Å 
and 1.26 Å for the backbone and heavy atoms respectively. The structural quality, as 
assessed by the standard  for the backbone. NMR statistics summarised in Table 4.2. It 
is significant that even the loop regions connecting the anti-parallel β-strands are well-
determined in this structure (Figure 4.16). The only disallowed residue from 
PROCHECKnmr  is Asp36, located on a sharp turn between β1 and β2. In the core 
structure region, the calculated final 20 structures and best rosetta model has a RMSD 
within 1.5 Å.  
 
The architecture of the central 65 residues is β-sandwich-like comprising two three-
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stranded (up-down-up) anti-parallel β-sheets with short hairpin loops connecting 
adjacent β-strands within the two sheets and a longer loop between the two sheets 
(Figure 4.15). The angle between the strands in the two β-sheets is approximately 
45⁰.To both the N- and C- terminal ends of the β-sandwich there are approximately 20 
residues which are less regular in structure although to the N-terminal end of the 
structure there is a short 310-helix. 
 
The two β-sheets composing the HR domain seem largely independent and are 
connected through several hydrophobic interactions (Figure 4.15), involving Val31, 
Ala42, Ile44, Ile66, Ile69, Val74 and Val76.  
 
In the OutC-HRF3  folded state there is quite an uneven charge distribution. There is a 
large hydrophobic patch on one side of the protein, mainly formed by β1 and β2 strands 
(Figure 4.17). This provides a large platform for hydrophobic interaction. The other side 
of the OutC-HRF3 displays a mix of positive, negative and hydrophobic patches. The 
function of these feature during the assembly and action of T2SS has yet to be 
discovered. 
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  OutC-HRF3 
NMR distance and dihedral constraints  
   Distance constraints  
     Total NOE 1912 
     Intra-residue 629 
     Inter-residue  
        Sequential (|i-j|=1) 373 
        Medium-range (|i-j| ≥ 2 ≤ 4) 166 
        Long-range (|i-j| ≥ 5) 744 
     Hydrogen bonds (experimental measured)  28 
     Hydrogen bonds(observed in over 50% of structures)  64 
   Total dihedral angle restraints (TALOS) 76 
       Φ 38 
       Ψ 38 
  
Structure statistics  
   Violations (mean ± SD)  
     Distance constraints (>0.5) (Å) 1.6±0.55 
     Dihedral angle constraints (>5)(deg) 1.9±1.9 
   Deviations from idealized geometry  
     Bond lengths (Å) 0.005± 0.0001 
     Bond angles (deg) 0.671± 0.011 
     Impropers (deg) 0.748± 0.024 
   Average pairwise r.m.s.d. (Å)a  
     Backbone 0.46±0.11 
     Heavy 1.26±0.20 
RMSD from the mean structure (Å)a 0.33±0.07 
  
Residues in most favored regions [A,B,L]b 60.70% 
Residues in additional allowed regions[a,b,l,p]b 33.90% 
Residues in generously allowed regions [~a,~b,~l,~p]b 3.60% 
Residues in generously disallowed regions [~a,~b,~l,~p]b 1.80% 
 
 
Table 4.2 Experimental data and structural statistics for 20 energy minimised structure of OutC-
HRF3 a. Pairwise RMSD and RMSD from the mean structure were calculated among the 20 lowest 
energy structures from 50 refined structures (amino acid residues 22 to 87).b Structure quality was 
analyzed with PROCHECK-NMR over structured regions (amino acid residues 22-87). 
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                 10        20        30        40        50        60        70        80  
E.chrysanthemi  AGALDASQMSNLPPSTLNLSLTGVMAGDDDSRSIAIISKDNEQFSRGVNEEVPGYNAKIVSIRPDRVVLQYQGRYEVLGL 
E.carotovora    
SAVNDAALSGDIPLSSLNISLTGVLASEDAKRSIAIIAKDSQQYSRNVGDAVPGYEAKIVTISADRVVLQYQGRYEALHLK.pneumoniae    
PAPTDATHLNQVPVSSLKLRLTGLLASSNPARSIAIIEKGNQQVSLSSGDTIPGYDARIVAILPDRIIVNYQGRKEAILL 
V.cholerae      APVVEQPVVVDAPKTRLSLVLSGVVASNDAQKSLAVIANRGVQATYGINEVIEGTQAKLKAVMPDRVIISNSGRDETLML 
E.coli          RAQETMPSLSNDLLSGEDLDVRGILYSSVAEHSVAIFAHNNRQFSLSVGEKVPSYDATISAIFSDHIVINYQGKTVSLPL 
                                    β1               β2              β3                           β4             β5              β6    
 
 
 
 
Figure 4.15 Structure of OutC-HRF322-87. (A) Structure of OutC-HRF3 in ribbon representation 
with hydrophobic core residues shown in stick representation. (B) Family sequence alignment of 
GspC-HR Position of the secondary structure as indicated, with conserved residues in red 
background, semi-conserved residues in red and hydrophobic core residues underlined.   
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Figure 4.16 Sausage representation of best 20 calculated OutC-HRF3 structures. Secondary 
structure is shown in color, α-helix in red, β-sheet in cyan. The diameter of the sausage reflects the 
dynamics of the protein in solution, which is plotted according to the residue Cα  Τ2 relaxation 
profile.  
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Figure 4.17 OutC-HRF3 electrostatic distribution. (A) β1 and β2 strand of OutC-HRF3 form a 
continuous hydrophobic surface. (B) OutC-HRF3 electrostatic distribution (shown in arbitrary 
PyMOL unit).    	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                   β1                β2            β3     β4          β5         β6                      β7       
OutC-HRF3  STLNLSLTGVMAGDDDSRSIAIISKDNEQFSRGVNEEVPGYNAKIVSIRPDRVVL---------QYQGRYEVLGL 
PilP       SLENMRYVGILKSGQ--KVSGFIEAEGYVYTVGVGNYLGQNYGRIESITDDSIVLNELIEDSTGNWVSRKAELLL 
           *  *:  .*:: ..:  :  .:*. :.  :: **.: :    .:* **  * :**         :: .*   * * 	  
Figure 4.18 OutC-HRF3 and PilP comparisons. (A) Secondary structure, surface, surface 
electrostatic distribution comparisons , shown in arbitrary PyMOL unit. The conserved residue is 
shown in stick representation.  (B) Sequence alignment, with secondary structure highlighted in 
colour. 
A 
B 
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4.6	  Summary	  and	  discussion	  
In this chapter, the OutC-HR solution structure was solved by NMR spectroscopy. A β-
sandwich fold was revealed. GspC-HR is the second structure having this fold. The 
other protein sharing this fold is the inner-membrane lipoprotein PilP from the type IV 
secretion system. PilP shares many similarities with GspC-HR including its location at 
the inner membrane, extending into the periplasm, interacting with an outer membrane 
secretin. They share a hydrophobic patch between strands β1 and	  β2 . It is plausible that 
PilP and GspC interact with their secretin’s in a similar way. At the moment, there is no 
molecular details of how PilP interacts with its cognate secretin. However, both the 
GspC-HR and PilP interaction with secretin are essential for assembly of a functional 
secretion system. The interaction between OutC-HRF3 and its secretin OutD is further 
investigated in the following chapters. 
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Chapter 5 Study of the interaction between OutC-HRF3 and OutD-N0  
 5.1	  Overview	  
The OutC homology region (HR) is the only highly conserved region of GspC across all 
species. It plays a key role in maintaining the functional T2SS. The OutC-HR has been 
shown to interact with two sites on the OutD N-terminal region, docking the inner 
membrane components with the outer membrane secretin subunits (Login, Fries et al. 
2010). It may also interact with secreted proteins. When the PDZ domain of OutC is 
deleted, the system loses the ability to secrete pectate lyases (Bouley, Condemine et al. 
2001) but the system can still secrete other proteins revealing that the PDZ domain is 
not the only domain involved in the recognition of proteins to be secreted.  When the 
OutC-HR is deleted the system loses the ability to secrete all proteins. This may due to 
the involvement of OutC-HR in the assembly of the inner and outer membrane 
components. In this Chapter the interaction between OutC-HR and OutD N-terminal 
domains is studied. OutD-N0 domain is identified as being solely responsible for the 
interaction with OutC-HR. The interaction was studied with several techniques. A 
model of the interacting domains is proposed using the NMR titration result.  
 5.2	  Production	  of	  OutD	  domains	  
The OutC-HR interaction with OutD occurs in the periplasm.  To locate the interacting 
domains, different OutD N-terminal periplasmic derivatives were produced for 
interaction studies (Figure 5.1). 
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Figure 5.1 Schematic diagram of OutD and its truncated derivatives used in this study. N0, N1, N2 
and N3 are the N-terminal periplasmic domains. 
 
5.2.1 Cloning of pET-14b outD-n0  
Before receiving pET20b outD-n0 construct, a pET-14b outD-n0 construct was 
originally produced and used for early NMR studies. pET-14b outD-n0 construct was 
producing using the pET-20b outD-peri, provided by Dr Shevchik (University of Lyon) 
as the template. The outD-n0 PCR product was produced with two restriction sites 
NdeI(5′) and BamHI(3′) and cloned into a pET-14b vector (Figure 5.2). DNA 
sequencing (MWG) was used to confirm the construct was correct.  
 
Figure 5.2 Construction of the pET14b-outD-n0. 
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5.2.2 Expression and purification of OutD derivatives. 
OutD constructs in pET20b including outD-n0, outD-n0n1, outD-n1n2, outD-n1 and 
outD-peri (Figure 5.1),were provided by Dr Shevchik (Lyon).  All the plasmids were 
transformed into E. coli BL21 (DE3) cells (see section 2.1.7 for transformation 
protocols) for protein production. Cells were grown at 30⁰C until the OD 600 nm 
reached 0.6 and then grown at 30oC for 3 hours with 1mM IPTG (see section 2.1.8 for 
conditions and protocol).   
 
Each of these recombinantly produced proteins had an non-cleaveable C-terminal 
hexahistidine tag and they were initially purified using His Trap HP column (GE 
Healthcare) (see 2.2.2 for details) and further purified using a size exclusion column. 
The OutD derivatives all eluted from the size-exclusion column at volumes 
corresponding to the subunit mass, which indicated the proteins did not aggregate in the 
conditions used (20mM Tris, pH 7.0 or 5mM NaAc 150mM NaCl pH5.5). This 
observation supports the view that the periplasmic region of OutD is not responsible for 
oligomerisation. The purified proteins (Figure 5.3) were subsequently used for 
interaction studies with OutC-HRF3 by NMR titration.  
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Figure 5.3 Expression and purification of OutD N-terminal proteins (A) Expression and 
purification of pET-14b OutD-N0. (B) OutD-N0 S200 column size exclusion trace measured at A280. 
(C) Purified OutD N-terminal proteins. Corresponding proteins obtained after size exclusion 
chromatograph. 
A 
 B 
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5.3	  OutC-­‐HRF3	  interacts	  with	  OutD-­‐N0	  
The outC and outD genes are organized on a single operon (He, Lindeberg et al. 1991) 
and an interaction between OutC and OutD is known to be important for assembly of a 
functional T2SS.  
 
Login et al. have shown that in NMR titration using 15N-labeled OutC periplasmic 
region (OutC-hpa) the spectral peaks corresponding to the PDZ domain do not suffer as 
much intensity loss as the rest of the protein when unlabeled OutD periplasmic region 
(OutD-peri) is added (Login, Fries et al. 2010). To investigate if the N0 domain is 
involved in binding, OutD-N0 was used, in place of the OutD-peri used in the published 
experiment. OutD-N0 gives very similar effect to that seen with OutD-peri when titrated 
into labeled OutC-hpa. The 1H-15N HSQC spectrum of OutC-hpa shows some of the 
peaks loose significant intensity (Figure 5.4), whereas others loose less intensity. The 
peaks with greatest intensity loss overlay well with the OutC-HRF3 peaks (Figure 5.4B 
and Figure 5.5). This result supports the view that  the OutC-HRF3 and OutC-PDZ 
domains are arranged in a “beads on a string” manner. The titration confirms that OutC-
HRF3 interacts with OutD-N0.  
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Figure 5.4 OutC-hpa titration with OutD-N0. (A) Overlay of 15N OutC-hpa spectrum (green) with 
15N-OutC-hpa with 2 equivalents of OutD-NO (red). (B) Spectra from (A) overlay with OutC-HRF3 
spectrum (navy). Spectra acquired at 15°C on Bruker 700MHz in 20mM Tris (pH7.0) and 10% 
2H2O.  
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Figure 5.5 The intensity plot of OutC-hpa amide groups during the OutD-N0 titration. OutC-HRF3 
residues are labeled.  
 
 
5.3.1 OutC-HRF3 does not interact N1 or N2 of OutD 
To investigate if OutD N1 and N2 are involved in the interaction with OutC-HRF3, 
OutD-N1N2 was titrated into 15N OutC-HRF3. The 2D-HSQC of labeled OutC-HRF3, 
with addition of 24 equivalents of OutD-N1N2, showed no obvious peak broadening or 
peak shifts (Figure 5.6) suggesting there is no interaction with the N1 and N2 domains. 
However, the possibility of the hinge between N0 and N1 being involved cannot be 
excluded.  
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Figure 5.6 15N OutC-HRF3 titration with OutD-N1N2. Blue spectra, 25mM 15N OutC-HRF3. Red 
spectra 25mM 15N OutC-HRF3 titrated with 600mM OutD-N1N2. (A) Overlay of 1D spectrum. (B) 
Overlay of HSQC spectra.  
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5.4	  NMR	  study	  of	  OutD-­‐N0	  
In order to understand the interaction between OutC-HR and OutD N-terminal domain 
at the molecular level, different OutD constructs, corresponding to different N-terminal 
subdomain(s) were produced, expressed, purified and tested against the OutC-HRF3. 
The OutD-N0 domain was found to interact with OutC-HR. Therefore a combination of 
NMR studies and structure modulation were employed using OutD-N0. The OutD and 
OutD-N0 structures are modulated according to the known GspD structure. The OutD-
N0 NMR structural studies were continued to pave the way to understand the interaction 
at the molecular level.  
 
5.4.1 Backbone assignment of OutD-N0 
The backbone assignment for 65 out of 80 residues of OutD-N0 was achieved (see 
section 3.1.2 for methodology;  Figure 5.7). The assignment was poor for residues 
located on β1 and β3 (Figure 5.19)  because these residues showed very weak 
intensities and can hardly be observed in 3D spectra. Further experiments with higher 
field strengh spectrometer and longer aquisation time could help with assignment of 
these missing residues. However, as α1	  and	  α2	  were	  well	  assigned,	  for	  N0.	  These	  two	  helices	  was	  used	  to	  alocated	  and	  confirm	  interaction	  surface.	   
 
5.4.2 OutD-N0 secondary structure prediction 
The OutD-N0 backbone chemical shifts were used to predict the secondary structure 
using TALOS+. The predicted secondary structure is consistent with the available 
GspD-N0 secondary structure (Figure 5.8), consisting of two α-helixes and 5 short β-
strands. The predicted secondary structure is consistent with the known GspD-N0 
secondary structure (Figure 5.8B).  
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Figure 5.7 1H-15N HSQC spectrum of OutD-N0. The spectrum was acquired at 600MHz at 15⁰C in 
20mM Tris (pH 7.0) and 10% 2H2O. 
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Figure 5.8 Secondary structure prediction of the OutD-N0. (A) TALOS+ predicted OutD-N0 
secondary structure. (B) Sequence and secondary structure alignment of OutD-N0 and the only 
known structure GspD (PDB code: 3EZJ from Vibio cholera).  
 
5.4.3 Relaxation study 
The protein backbone dynamics of OutD-N0 were investigated using 15N relaxation 
measurements. T1, T2 and 1H-15N-NOE relaxation experiments were performed to 
understand internal dynamics at different frequencies and aspects.   
 
The T1, T2 and 1H-15N-NOE relaxation profiles for OutD-N0 are shown in Figure 5.9. In 
the relaxation profile, missing residues correspond to proline residues, overlapped peaks 
or peaks with extremely weak intensity. The OutD-N0 domain is a well defined 
structure with T1 and T2 stable throughout the sequence. The N-terminal showed higher 
T2 and lower NOE than average, indicate the flexibility at the N-terminus.  
 
Using the average T1 and T2 value from the well structured region, from residue 15 to 
78, the OutD-N0 correlation time was calculated to be 9.37 ns. For a 10kDa protein, the 
correlation time of 9.37 ns, indicates the protein is well structured and behaves as a 
subunit in solution. However, the OutD-N0 correlation time is slightly longer than 
OutC-HRF3(11 kDa, 8.59 ns) and EspC-HR (11kDa, 8.68), all of similar molecular 
weight, this likely reflects the shape of the different domains.  
B 
A 
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Figure 5.9 OutD-N0 T1,T2 and NOE relaxation, acquired at 15⁰C on Varian 600 MHz. 
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5.4.4 OutD-N0 structure modulation 
The OutD-N0 chemical shift based secondary prediction is consistent with the known 
GspD-N0 structure region. Sequence identity between OutD-N0 and GspD-N0 is 52%, 
This indicates that both N0 domain share similar fold. Therefore SWISS-MODEL 
(http://swissmodel.expasy.org/) and 3D-JIGSAW (http://bmm.cancerresearchuk.org/ 
~3djigsaw/) were used to generate an OutD-N0 model according to sequence alignment 
and homology with the GspD-N0 structure (PDB:3EZJ). The structures of OutD-N0 
generated by two different servers are based on the same known structure. Therefore are 
very similar with backbone RMSD of 0.25Å (Figure 5.10). The generated models give 
some idea of the molecule backbone orientation. The sidechain arrangement are not 
necessarily_represented.  .
?
Figure 5.10 Homology based OutD-N0 structure prediction. SWISS-MODEL generated structure 
in green. 3D-JIGSAW generated structure in cyan.  
 
5.4.5 GspD N0 and N1 domain arrangement  
The periplasmic region of the GspD structure has been solved in the presence of 
nanobody (Korotkov, Pardon et al. 2009). The nanobody binds to both N0 and N1 
(Figure 5.11), sharing a total buried surface 1896 Å. This contact is large compared to 
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the N0 and N1 contact surface of 1180Å.  Therefore the N0, N1 domain orientation in 
the crystal structure is not necessary reflecting the in vivo domain orientation.  
 
 
 
 
 
 
Figure 5.11 Interaction between Peri-GspD and the nanobody. (A) Structure of the peri-
GspD:nanobody dimer with nanobody in orange, CDR1 in green, CDR2 in purple, and CDR3 in 
red, with the peri-GspD subdomains (B) An ‘‘open book’’ representation of the peri-GspD:Nb7 
interface with foot- prints in colors according to interacting partner (CDR3 footprint, red; frame- 
work, orange; N0 subdomain, cyan; N1 subdomain, light blue). Figure adapted from (Korotkov, 
Krumm et al. 2006) 
 
To confirm the interaction persists in solution NMR titration was used to examine the 
interaction between OutD-N0 and OutD-N1N2 (Figure 5.12). When OutD-N1N2 was 
titrated into 15N-labeled OutD-N0, the signal intensity of OutD-N0 became weaker with 
addition of more OutD-N1N2. The signal loss behaves in a fast exchange manner, 
suggesting that the interaction is weak.  
? ?
A B 
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Figure 5.12 1H- 15N HSQC of OutD-N0 in the absence and the presence of OutD-N1N2. 15N OutD-
N0 was used at 25µΜ , OutD-N1N2 concentration as indicated. Titrations were in 20mM Tris, 
150mM NaCl, pH7.0 using Bruker 600 at 15OC.   
 ?
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To investigate the solution orientation of N0 and N1 domains the OutD-N0 and OutD-
N0N1 1H-15N HSQC were measured separately at 15⁰C in 20mM Tris pH 7.0 (Figure 
5.13). From the spectra, peaks belong to N0 domain can be recognized on the OutD28-
221 spectrum. However there is slight peak shifting when comparing the peaks 
belonging to N0 on the OutD-N0N1 spectrum and OutD-N0. The peak shifts are likely 
induced by the presence of the N1 domain next to N0. To locate the contact surface on 
N0 according to chemical shift changes, chemical shift variations (Δδav) due to 
presence of the N1 domain were calculated according to (Pellecchia, Sebbel et al. 1999; 
Korotkov, Pardon et al. 2009):  
Δδav={0.5[Δδ (1H)2 +(0.2Δδ (15N))2]}1/2   
where Δδav is the combined chemical shift perturbation and 1H and 15N are the proton 
and nitrogen chemical shifts in parts per million (ppm) for the backbone amide of each 
residue.  
 
OutD-N0 peak and the closest OutD-N0N1 peak were used to calculate Δδav for 
individual residue. Plotting the residues in OutD-N0 domain with Δδav greater than 1 
ppm, a patch is revealed (Figure 5.14). In the presence of the N1 domain, the patch has 
the most chemical shift changes are likely to locate close to the interface between N0 
and N1.  N0 showed greater chemical shift changes are considered to be at or closer to 
the N1 domain. However, this patch does not locate at the N0 N1 interface within the 
crystal structure in the presence of nanobody. Therefore the interaction between N0 and 
N1 in GspD N-terminal crystal structure could be induced by presence of nanobody or 
crystal packing. The assignment of Out-N0 was not complete on β1	   and	  β3	   region.	  However,	   the	  α1	  and	  α2	  region	  is	  relatively	  complete.	   If	  we	  do	  expect	  the	  N0	  N1	  contact	   observed	   in	   crystal	   structure,	   residues	   located	   on	  α2	   should	   have	   given	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greater	  Δδav than the other  residues. 	   
 
 
Figure 5.13 Overlay of 1H-15N HSQC spectrum of OutD-N0 (red) and OutD-N0N1(green) spectrum.  
Both spectra were acquired at Bruker 600MHz at 15⁰C in 20mM Tris (pH 7.0) and 10% 2H2O. 
                                 
Figure 5.14 Δδav is a weighted average of the 15N and 1HN chemical shift. The easily recognized N0 
peaks were paired and Δδav are calculated. The residues with Δδav>1ppm are shown in navy as 
spheres and residues with 0.5 <  Δδav <  1 ppm are shown in cyan as sticks. OutD-N1 domain (in 
orange) was superimposed to the OutD-N0 according to the orientation? seen in the homologous 
(PDB: 3EZJ) crystal structure.  
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5.5	  Interaction	  study	  of	  OutC-­‐HRF3	  and	  OutD-­‐N0	  by	  NMR	  	  
To identify the interaction surface between OutC-HRF3 and OutD-N0, a series of 
titrations between these two proteins were made using the changes in the 1H-15N HSQC 
spectra.  
 
When titrating OutD-N0 into 15N OutC-HR3 or vice versa, a loss of intensity of all the 
peaks was observed (Figure 5.15 and Figure 5.16). There was no dilution between 
titration points because the OuC-HRF3 concentration was maintained as described 
Chapter 3.7. The peak weakening effect is most likely caused by the increase in the size 
of the proteins after complexation, which slow down the tumbling of the molecule.  
 
 The diminution of peak intensitiesare accompanied with peak shifts (Fig. 6.13) in the 
titration experiments. Interaction between OutC-HRF3 and OutD-N0 appeared to be 
weak, as addition of 10 equivalents of OutD-N0 did not saturate the interaction and the 
peak weakening effect was still observable (Figure 5.15 ). However, the titration results 
show the interaction behaves consistently when titrating OutC-HRF3 in OutD-N0 or the 
other way round (Figure 5.15 and Figure 5.16). The peak shifts indicate the proteins are 
behaving in a fast exchange manner.  
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Figure 5.15 15N HSQC of OutC-HRF3 in the absence and the presence of OutD-N0. OutC-HRF3 
was used at 250 µM.  
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Figure 5.16 1H- 15N HSQC of OutD-N0 in the absence and the presence of OutC-HRF3. OutD-N0 
was used at 25 µM.  
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To check if the interaction between OutC-HRF3 and OutD-N0 is disturbed by the 
presence of OutD-N1N2,  OutD-N1N2 was titrated into 15N OutC-HRF3 and OutD-N0 
mixture (Figure 5.17). With addition of 8 equivalents of OutD-N0, the OutC-HRF3 
HSQC signal is weakened. Then with the further addition of 270µM of OutD-N1N2, 
which is over ten times higher than the 25µM OutC-HRF3 and more than one 
equivalent of OutD-N0 concentration, no obvious changes were observed. From this 
experiment, if OutD-N1N2 interacts OutD-N0 in similar manner as OutC-HRF3, the 
significantly higher concentration OutD-N1N2 would have displaced OutC-HRF3 and 
restore spectra signal loss. Hence, I can conclude that OutD-N1N2 does not compete 
with OutC-HRF3 for OutD-N0 binding.   
  
Both OutC-HRF3 and OutD-N0 HSQC showed some peaks shifting when titrating with 
the other (Figure 5.18). This indicates that there are some local structural changes when 
OutC-HRF3 interacts with OutD-N0. Mapping the peaks shifted in the titration on the 
NMR OutC-HRF3 structure and computer generated OutD-N0 model, allows the 
interaction surfaces to be identified (Figure 5.19).  
 
The residues that show chemical shift changes are mainly located on β1 of OutC-HRF3 
and α2 and β3 of OutD-N0 (Figure 5.19). The interaction surfaces on both molecules 
comprise hydrophobic patches. Hence it is vealy like that OutC-HRF3/ OutD-N0 
interaction is driven by hydrophobic interactions. To use the interaction surfaces from 
both proteins and assemble the complex, further experiments needed to be done to 
confirm the orientation of both proteins in the complex.  
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Figure 5.17 Effect of OutD-N1N2 on the OutC-HRF3 and OutD-N0 mixture.  The effect was 
monitored by recording 15N HSQC of OutC-HRF3. 15N OutC-HRF3 was measured at 25µM. The 
sample composition was as labeled. All sample prepared in 20mM Tris 50mM NaCl pH7.0.  
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Figure 5.18 15N labeled OutC-HRF3 titrated with non-labeled OutD-N0. Overlay of six 1H-15N 
HSQC spectra of OutC-HRF3 with ratio to OutD-N0 of 1:0 (Blue), 1:0.2 (Navy), 1:0.4 (Purple), 
1:0.6 (Magenta), 1:0.8 (Pink), 1:1 (red). OutC77-172, 0.2mM. B 15N labeled OutD-N0 titrated with 
OutC-HRF3. Overlay of two 15N OutD-No HSQC with ratio of 15N OutD-N0 to OutC-HRF3 of 1:0 
(black) and 1:2(red) 15N OutD-N0 ,0.2mM. 
A 
B 
 Chapter 5 Study of the interaction between OutC-HRF3 and OutD-N0  
 
118 
 
                      
  
Figure 5.19 Interaction surface identified by chemical shift perturbation (A) OutD-N0 interaction 
surface in orange with unassigned residues in blue. (red). (B) OutD (orange) and OutC-HRF3 
(magenta) interaction surface in cartoon, surface and electrostatics plots (shown in arbitrary 
PyMOL unit). 
 	  
A 
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5.6	  Model	  of	  OutC-­‐HRF3	  and	  OutD-­‐N0	  interaction	  by	  HADDOCK	  
Haddock was use to dock OutC-HRF3 and OutD-N0 according to the titration result 
(Dominguez, Boelens et al. 2003). The residues involved in the interaction were 
introduced as Ambiguous Interaction Restraints (AIRs) to drive the docking process.  
 
The OutD-N0 interaction region is located between α2 and β3. The OutC-HRF3 
interaction region is located at β1 strand. HADDOCK docks the OutC-HRF3 β1 strand 
between α2 and β3 of OutD-N0, which leads to β1, β3 from OutD-N0 and β1, β2, β3 
from OutC-HRF3 forming a continuous antiparallel β-sheet. The complex is mainly 
stabilized by hydrophobic interactions, involving hydrophobic patches formed byV31 
M32 A33 of OutC-HRF3 and I38 F54 V58 V61of OutD-N0.  
 
Looking into GspD-N0 structure (Figure 5.21), it consists two hydrophobic surfaces, 
one between α2 and	   β3  the other one between  α1 and	   β2. Here the NMR titration 
result suggest that OutC-HRF3 docks on the hydrophobic surface between α2 and 
β3.  However,  in recent GspC-GspD co-crystallisation structure, The hydrophobic path 
between α2 and	  β3 of GspD is occupied by the GspD-N1 domain, where GspC-HR is 
docking on to the hydrophobic path between α1 and	  β1(Korotkov, Johnson et al. 2011). 
It is intresting to note that the interactions between both GspD-N0/GspC-HR and GspD-
N0/GspD-N1 are all mainly coordinated by hydrophobic interactions, with no salt 
bridges or hydrogen bonds.  With hydrophobic interactions the partner could be easily 
swapped during conformational changes in the assembled secretion system. 	  
?
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OutC-HRF3        10        20        30        40        50        60        70        80  
E.chrysanthemi  AGALDASQMSNLPPSTLNLSLTGVMAGDDDSRSIAIISKDNEQFSRGVNEEVPGYNAKIVSIRPDRVVLQYQGRYEVLGL 
E.carotovora    SAVNDAALSGDIPLSSLNISLTGVLASEDAKRSIAIIAKDSQQYSRNVGDAVPGYEAKIVTISADRVVLQYQGRYEALHL  
K.pneumoniae    PAPTDATHLNQVPVSSLKLRLTGLLASSNPARSIAIIEKGNQQVSLSSGDTIPGYDARIVAILPDRIIVNYQGRKEAILL 
V.cholerae      APVVEQPVVVDAPKTRLSLVLSGVVASNDAQKSLAVIANRGVQATYGINEVIEGTQAKLKAVMPDRVIISNSGRDETLML 
E.coli          RAQETMPSLSNDLLSGEDLDVRGILYSSVAEHSVAIFAHNNRQFSLSVGEKVPSYDATISAIFSDHIVINYQGKTVSLPL 
                                    β1               β2              β3                           β4             β5              β6    
 
OutD-N0               10        20        30        40        50        60        70          
E.chrysanthemi  EFSASFKGTDIQEFINTVSKNLNKTVIIDPTVRGTISVRSYDMMNEGQYYQFFLSVLDVYGFSVVPMDNGVLKVIR 
E.carotovorum   EFSASFKGTDIQEFINTVSKNLNKTVIIDPSVSGTITVRSYDMMNEEQYYQFFLSVLDVYGFTVIPMDNNVLKIIR 
E.coli_O157     EFSANFKDTDIQEFINTVSKNLHKTVIINPDVQGTITVRSYDMLNEEQYYQFFLSVLDVYGFAVVDMHNGILKVVR 
K.pneumoniae    EFSASFKGTDIQEFINTVSKNLNKTVIIDPSVRGTITVRSYDMLNEEQYYQFFLSVLDVYGFAVINMNNGVLKVVR 
V.fischeri      DFSASFKGTDIQEFINIVGRNLEKTIIVDPSVRGKVDVRSYDLLNEEQYYQFFLSVLEVYGYAVVEMDSGILKVIK 
V.cholerae      EFSASFKGTDIQEFINIVGRNLEKTIIVDPSVRGKVDVRSFDTLNEEQYYSFFLSVLEVYGFAVVEMDNGVLKVIK 
                      β1                          α1              β2                           β3                                     α2                     β4                β5    
 
 
 
Figure 5.20 HADDOCK generated OutC-HRF3 and OutD-N0 interaction module. (A) OutC-HRF3 
OutD-N0 complex in cartoon representation. (B) individual protein interaction surface plot. The 
OutC-HRF3 (cyan) residues involved in interaction is shown in red. OutD-N0 (green) residues 
involved in the interaction are shown in orange. (C) GspC-HR and GspD-N0 sequence alignment.  
 
 
B A 
C 
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Figure 5.21 Comparision of GspC/GspD (PDB:3OSS) structrue and HADDOCK OutC-
HRF3/OutD-N0 structure.  
 
In recent paper, the available GspD crystal structure is fitted on to EM envelope 
(Reichow, Korotkov et al. 2010). However, there are a few limitations to this study. 
Firstly, the current available GspD periplasmic region structure is solved in the presence 
of nanobody. The presence of the nanobody is creates contact surface to form a crystal 
lattice. However, the nanobody contacts both N0 and N1 domain with a total buried 
surface of 1896Å2. This contact is large compared to the N0 and N1 contact surface of 
1180Å2. The N0 N1 is treated as a complex in generating the dodecamer. The 
equivalent N0 N1 domain structure present in the secretin of type III secretion secretin 
showed a high sequence similarity but different orientation (Spreter, Yip et al. 2009). So 
N0 and N1 domains probably may not have the relative orientation seen in the 
nanobody crystal structure and further investigation is required. Secondly, the fitting 
ignored the domain integration between different monomers, as observed in Type IV 
secretin, there is massive domain integration present, the domain not only interacts the 
neighboring subunit but also the domains some distance away. 
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5.7	  Interaction	  study	  of	  OutC-­‐HRF3	  and	  OutD-­‐N0	  by	  thermofluor	  
Thermofluor is a high-throughput protein stability test. In this case, protein OutC-HRF3 
and OutD-N0 were used to test the stability of the proteins in different buffer 
conditions. The buffer that gave the higher melting point tends to provide the protein 
with better stability. 
 
Protein folding/unfolding was monitored using the dye SYPRO-orange (Invitrogen). 
The fluorescence of SYPRO-orange  is highly quenched in an aqueous environment. As 
the protein unfolds, hydrophobic surfaces that are buried in the native protein become 
exposed to solvent and SYPRO-orange binds to these hydrophobic sites and the 
fluorescence signal from the dye increases. 
 
OutD-N0 alone gave good signals at the lower pH values of 4.5 and 5.5. Whereas the 
OutC-HRF3 did not show as good affinity for SYPRO-orange, and gave at least 3-4 fold 
less signal than OutD-N0 (Figure 5.20 A, B). OutD shows melting around 60OC. OutC-
HRF3 shows melting around 50OC. This result is consistent with the melting experiment 
done by NMR.  
 
Thermofluor experiments used buffers made for crystallization purposes. The highest 
melting temperature for OutD-N0 was measured at pH 9.5. At pH values above 7.5, the 
amide proton exchange rate is high and it is difficult to study interaction by NMR. The 
next highest melting temperature was pH 5.5. Hence, to investigate the protein-protein 
interaction, a buffer around pH 5.5 was chosen to optimize the wavelength for measured 
signal and measurement time. Titration at pH 5.5 with or without 150mM NaCl gave 
very similar results to titration at pH7.0.  
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Figure 5.22 Thermofluor plots. (A) Thermofluor plot of OutD-N0. (B) Thermofluor plot of OutC-
HRF3. (C) Thermofluor plot of a mixture opf OutC-HRF3 and OuD-N0. (D) Thermofluor plot of 
all the proteins using condition C2 (100mM BisTris 500mM NaCl pH5.5). 
 
 
When OutC-HRF3 and OutD-N0 were mixed the traces develop a shoulder and the 
melting temperature is shifted 10⁰C higher. These provides further evidence for the two 
proteins are interacting. 
 5.8	  OutC-­‐HRF3	  and	  OutD-­‐N0	  interaction	  by	  His	  Trap-­‐pull	  down	  assay	  	  
The NMR titration results suggest the OutC-HRF3 and OutD-N0 interaction is very 
weak. Dr Shevichik (Lyon) provided evidence that when OutC and OutD expressed 
together, OutD-N0 can be pulled out with several GST-OutC constructs (OutC144-158, 
OutC128-172) using a glutathione column. In an attempt to stimulate the OutC and OutD 
complex formation, OutC-HRF3 and OutD-N0 co-expression construct was made (by 
A 
D C 
B 
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Dr Shevichik), which co-express N-terminus GST tagged OutC-HRF3 and C-terminus 
His-tagged OutD-N0.  
 
Unfortunately GST tagged OutC-HRF3 and the majority of OutD-N0 produced are 
insoluble. Hence, urea was added to solublilize both proteins. Buffer was then gradually 
added into urea suspension stimulate protein refolding, this might mimic the in vivo 
chaperone activity. Both OutC-HRF3 and OutD-N0 can be solubilised and refolded into 
soluble protein in buffer without detergent. Since urea is present in the solution and high 
salt is used in the washing solution to eliminate the contamination and non-specific 
bindings, a Ni column was selected for the pull down assay. As shown in Figure 5.22(A) 
OutC-HRF3 can be pulled out with His tagged OutD-N0 using this method. This 
indicates that OutC-HRF3 and OutD-N0 refolding was successful and both protein can 
form a complex through refolding.  
 
It is noticed that the eluate from the Ni-column contains more His tagged OutD-N0 than 
pulled out OutC-HRF3 partner and OutC-HRF3 is also present in quantity in the Ni 
column flow-through. This suggests the interaction is weak, which is further supported 
by the observation that the complex dissociates during size exclusion chromatography 
(Figure 5.21B). The pull-down assay however gives further independent support for the 
OutC-HRF3 interaction  with OutD-N0.  
?
?
?
?
?
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Figure 5.22 OutC-HRF3 OutD-N0 Ni column pull down assay. (A) SDS-PAGE analysis. (B) Size 
exclusion trace of Ni column eluate, using a Superdex 75 column.  
 
B 
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5.9	  Summary	  and	  discussion	  
 
In this Chapter, several techniques were employed to explore the interaction between 
OutC-HRF3 and OutD-N0. The experiments are all first carried out at 20mM Tris 
pH7.0 and later repeated at 50mM NaAc 150mM NaCl pH5.5. These conditions are all 
biologial relevant therefore the results reflect the interaction in vivo.  
 
One of the reason for study the GspC/GspD interaction by NMR is that the interaction is 
very weak, with estimated Kd in the mM range. Since in vivo, OutD is a dodecameric 
complex, the weak interaction observed with OutC-HRF3 and Out-N0 subunits is 
anticipated to be significantly stronger when they interact cooperatively in the oligomer. 
The affinity between the monomers may not reflect the actual affinity between OutC 
and OutD in vivo in the context of the assembled secretion system. The studies 
described here give an indication of which residues could be involved in the interaction 
and allow a model of the interaction to be proposed.  Since obtaining the HADDOCK 
model, our collaborator Dr Shevchik et al. have successfully isolated OutC-
HRF3G54C/OutD-N0S39C complex in vivo through disulphide cross-linking. This 
validates the proposed model of interaction.  
 
The recent GspC/GspD structure (Korotkov, Johnson et al. 2011) structure suggest that 
GspC interacts with a different hydrophobic patch on GspD-N0. The difference between  
models are mainly caused by the presence of GspD-N1 pre-occupied the GspC-HR site 
we proposed. When the site is pre-occupied with GspC-HR, first the GspD-N1 do not 
seems to compete with GspC-HR (from this work, Figure 5.17). This suggest the 
affinity between GspD-N0/GspC-HRF3 and GspD-N0/GspD-N1 are comparable. It is 
also shown the force between these interactions are through hydrophobic surfaces. 
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These properties make these interactions are inter-interchangeable  through 
rearangement between these subunits during the conformational changes.   
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Chapter 6 Interaction between OutS and OutD  
 6.1	  Overview	  
The other protein known to interact with the secretin (GspD) of the type II secretion 
system is the pilotin (Gsps), whose role is to guide the secretin to the outer membrane.  
Since OutC-HRF3 shares a closely similar structure with the type IV pilotin PilP, the 
T2SS pilotin is of additional interest.  
 
I initiated the GspS structure determination and involved in early stage of structure 
determination, including protein purification, DLS, CD and crystal screen. The project 
was then passed to Saima Rehman. The crystal structure of the pilotin was solved in our 
Laboratory in December 2010, I was also involved in the X-ray data collection at ESRF, 
Grenoble. Our collaborator Dr.Shevchik provided constructs to overproduce the pilotin 
and the C-terminal part of the secretin from which it was known to interact. The 
plasmids harbored the Erwinia chrysanthemi OutS (pilotin) and the C-terminal 62 
residues of the (OutD-Cter secretin). The OutD C-terminal 62 residues had previously 
been shown to involve in the interaction with OutS (Shevchik, Robert-Baudouy et al. 
1997). In this Chapter, the interaction between pilotin OutS and secretin OutD-Cter is 
studied by CD and NMR spectroscopy. 
 6.2	  Bioinformatic	  studies	  of	  OutS	  and	  OutD-­‐Cter	  
GspS (called OutS and PulS in Erwinia and Klebsiella respectively) is the only 
identified pilotin in the type II secretion system. It is a liproprotein transported by Lol 
system from the inner membrane to the outer membrane. GspS interacts  with secretin, 
GspD to achieve correct targeting and insertion of the secretin into the outer membrane. 
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In the absence of pilotin PulS, secretin PulD is mislocated to the inner membrane 
(Guilvout, Chami et al. 2006).  The only available type III secretion pilotin revealed a 
predominant β strand structure forming  the cracked β barrel structure (Lario, Pfuetzner 
et al. 2005).  Lario and colleagues suggested that all pilotins would have the same fold 
or maintain critical structural fratures (Lario, Pfuetzner et al. 2005).   
 
The results of previous sequence comparisons using GspS and its interacting partner 
OutD-Cter have been published (Shevchik, Robert-Baudouy et al. 1997). Here,we can 
see from secondary structure prediction using J-pred (http://www.compbio.dundee. 
ac.uk/www-jpred/) that the GspS structure is predicted to be mainly helical (Figure 
6.2A). Since the only known pilotin of similar size (~10kDa, i.e.PilP, MxiM) are all 
have β-strand dominated structure (Lario, Pfuetzner et al. 2005; Golovanov, 
Balasingham et al. 2006), the GspS structure is a curiosity and could be a novel pilotin 
structure. Therefore, the crystal structure of OutS was determined in our lab. The OutS 
structure revealed a novel nested α-helical architecture with one helical hairpin 
perpendicular to the second providing a concave surface for secretin-binding. The most 
similar arrangement of OutS α-helices is found in P40 nucleoprotein with a DALI score 
of 6.0 and sequence identity 5% (Figure 6.2). OutS has a concave surface that plausibly 
could bind secretin peptide.  When OutS is compared with p40 nucleoprotein, the 
corresponding surface in P40 nucleoprotein is occupied by a helix. This suggests that 
OutS could bind to a helical structure present in the OutD-Cter peptide. The secondary 
structure of OutD-Cter is predicted to be three helices which agrees well with this 
hypothesis (Figure 6.2). 
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Figure 6.1 Schematic diagrams of OutD C-terminal derivatives used in this Chapter. The dotted 
line  represents region is expressed in cell but later cleaved-off by the protease.  
 
 Secondary -------HHHHHHHHHHHHHHH-----  --------  -------HHHHHHHHHHHHHHHHHHHHH------ 
                     10        20          30          40        50        60 
                      |         |           |           |         |         | 
OutS_Echr ---MHVSSLKVVLFGVCCLSLAACQTP--APVKNTAS--RSAASVPANEQISQLASLVAASKYLRVQCERSDL 
OutS_Pcar ---MSLSLSKFSALTLLCVTLAGCQQTGTSAHKGTVAGQSSAVTVSPNDQLNQLSSLVAATRYLKSKCNRSDL 
GspS_Ecol MMGNILKKLNCIASLLVLVTISGCHQS--PSIHKQAT-------VPPSEQLEQMASIVSATRYLKMRCNRSDL 
PulS_Koxy ------MRNFILFPMMAVVLLSGCQQN--RPTTLSPA-------VSGQAQLEQLASVAAGARYLKNKCNRSDL 
GspS_Ymol ----MLSTTRKLFWFLPLVLLTGCQQP-MNKTIKPTA-------Q---QQIKQLSALVAGAHYLQKNCQRAEV 
GspS_Spro ---MQRMLRSFSFAAAAVVLLAGCQQTALQPQTQPSL-------T---AQLDQLSALLAGSQFLRQHCARTDI 
 
 
Secondary  --HHHHHHHHHHHHHH----H  HH----HHHHHHHHHHHHH----HHHHHHHHHHH-HHHHHHHH--- 
             70        80          90       100       110       120       130 
              |         |           |         |         |         |         |     
OutS_Echr  PDDGTILKTAVNVAVQKGWDT--GRYQSLPQLSENLYQGLLKDGTPKATQCSSFNRTMTPFLDAMRTVR-- 
OutS_Pcar  PDDATVMNVALTVAKQRGWNV--ASYQALPQRSESLYQGLLKDSTPKETQCSEFNRTLTPFIDAIRSRG-- 
GspS_Ecol  PDEQSILNVANRIAIGKGWQS--LTQEDIRKHSDDIYVRLTRDSTPEYIKCREFNRRLVPFIGELLARGRG 
PulS_Koxy  PADEAINRAAINVGKKRGWAN--IDANLLSQRSAQLYQQLQQDSTPEATKCSQFNRQLAPFIDSLRDNK-- 
GspS_Ymol  PDEAVLLKTARSLAASRHWDTRAPAYKLLGEQSQARYQALVKENETDKSMCTELNLLMVDFVDEAQRNIK 
GspS_Spro  PDDASLQRSAIGMAQQRGWNTQPAEYRQLPVRAQQRYQQLQQDGTPLQQKCAALNTSTARFIAAAQSDARQ 
 
Secondary  ---------HHHHHHHH---HHHHHHH------   ---------- -----HHHHHHHHHHHH------ 
              650       660       670          680        690       700       710 
                |         |         |            |          |         |         | 
OutD_Echr  TIIRDPGQFQEASINKYRSFNNEQQQQRGEGNG---VLDNNTLRLS-GGNTYTFRQVQSSISDFYKPEGR 
OutD_Pcar  SIIRDRSQYQSASASKYHSFNAEEEKQREANGGKANLLDNDLLRLPEGGNAYTFRQVQSSIVAFYPAGGK 
GspD_Ecol  TIIRERDGFRHASAEKYQSFNQEQVQSRGKETT-ALTLNEEQLRLSPDQDDTAFRKVKAAIAAFYAQEM- 
PulD_Koxy  TVIRDRDEYRQASSGQYTAFNDAQSKQRGKENND-AMLNQDLLEIYPRQDTAAFRQVSAAIDAFNLGGNL 
GspD_Ymol  TIIREQDSYTDLSEQRLDKFQQEQNRDRPASGQ---RINENLNNIL--SDGRSLQDLRNDVSAFYSKGA- 
GspD_Spro  TVIRSTEEYAQESMRKAARFRSLDAQPLPLKTH----AEAQLDRVG-STENGTFQRIQRQIDAFYPRGEL 
 
Figure 6.2 Family sequence alignment of GspS (A) and the C-terminal region of cognate GspD (B). 
Position of the α-helices is indicated by pink H (predicted by Jpred for GspD).  Shown are the GspS 
and GspD homologs of Erwinia chrysanthemi 3937, Q01567 and Q01565; Pectobacterium 
carotovorum, C6DAR0 and C6DAQ5; Escherichia coli O157:H7, Q7BSV3 and Q9ZGU0; Klebsiella 
oxytoca, P20440 and P15644; Yersinia mollaretii, C4S9G3 and C4S9F5; Serratia odorifera, D4E1I4 
and A8GJQ5.  Identical residues are in red, strongly similar and weakly similar residues are in 
green and blue respectively. 
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6.3	  Expression	  and	  purification	  of	  OutS	  	  
To produce sufficient quantities of soluble GspS for structure study, a recombinant form 
of Ewinia chrysanthemi OutS, which corresponding to residue 27 to 133 expressed in 
pET20b vector was kindly provided by Dr Vladimir Shevchik (University of Lyon). 
Residues 1 to 26 corresponding to a N-terminal lipoprotein sequence were eliminated in 
this construct. Instead, the pET20b vector provides a PelB sequence to the recombinant 
protein, which facilitates the protein’s transportation to the periplasmic region where the 
PelB sequence is cleaved during the transport process. It is crucial for recombinantly 
produced OutS to be transported to the periplasmic region, which mimics its native 
functional environment and provides a non-reducing environment for OutS internal 
disulphide bond formation and protein folding.  The transportation of OutS to 
periplasmic region also made OutS purification straight forward by osmotic shock 
(described in 2.2.3) (Fries, Ihrig et al. 2007)) 
 
OutS pET 20 vector was transformed into E.coli BL21 (DE3) cells. The expression can 
be induced by 500µM of IPTG. OutS production in LB media can reach about 5mg per 
liter. However, OutS cannot be produced in M9 media following similar procedure. 
This is owing to the transportation of OutS from cytoplasm to outer membrane is 
operated by ATP hydrolysis which is required for Sec system function (Driessen 1992; 
Pugsley 1993). Limited nutrient in the M9 media could not support a functional sec 
system. Several altered methods were tried and OutS production can be achieved in M9 
media with the addition of 20mg ATP per liter during induction.  
 
OutS can be extracted by single step sucrose osmotic shock (described in 2.2.3). The 
separated sucrose soluble protein was then concentrated and purified on size exclusion 
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column. OutS elutes at 13.38 ml on S75 column, consistent with OutS being a monomer 
in solution (Figure 6.3).  
 
 
 
 
 
Figure 6.3 Purification of OutS (A) Purification of OutS (B) OutS S75 column size exclusion trace 
at 280nm. OutS elution peak as indicated.   
 6.4	  Expression	  and	  purification	  of	  OutD-­‐Cter	  
For structural studies OutD-Cter, a recombinant form of the OutD C-terminal 62 
residues expressed in pGEX-6P-3 vector was kindly provided by Dr Vladimir Shevchik 
(University of Lyon). (Shevchik, Robert-Baudouy et al. 1997). The pGEX-6p-3 vector 
provides an N-terminal GST tag for the recombinant protein, which helps with protein 
A 
B 
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solubility as well as aiding purification. OutD-Cter also contains an N-terminal non-
cleavable His tag for further purification. 
 
6.4.1 Purification of OutD-Cter* with GST tag 
OutD-Cter* was purified using a glutathione column followed by a size exclusion 
column (described in 2.2.3 and 2.2.5) allowing  OutD-Cter* can be produced in high 
purity. 
 
The OutD-Cter* band is smeary on SDS-PAGE (Figure 6.4A). It turns out OutD-Cter* 
produced by this method is a mixture of OutD-Cter and OutD-Cter-cleaved (Figure 
6.4C).  However, the OutD-Cter* produced is found to be useful for NMR studies.  
 
6.4.2 Purification of OutD-Cter with His tag and GST Tag 
Ideally, a pure preparation of OutD-Cter is required for circular dichroism and NMR 
studies. Since OutD-Cter-cleaved is cleaved from the C-terminus and is missing the 
non-cleavable C-terminus His tag further purification can be achieved using the His tag.  
 
As shown in Figure 6.5A OutD-Cter full can be purified to a relatively high purity after 
Ni affinity column, glutathione column and size exclusion column purification. The 
purified protein is still prone to proteolysis and likely to be cleaved at R685 site and 
produce OutD-Cter*. Therefore, the purified protein was stored at -80OC to minimize 
any protease activity and protein degradation.  
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              1       10649                                685                     710 
              ⏐        ⏐⏐                                   ⏐                      ⏐  
OutD-Cter     GPLGSPNSRVDPGQFQEASINKYRSFNNEQQQQRGEGNGVLDNNTLRLSGGNTYTFRQVQSSISDFYKPEGR 
               Tag 
OutD-Cter-cleaved  GPLGSPNSRVDPGQFQEASINKYRSFNNEQQQQRGEGNGVLDNNTLR 
 
 
 
Figure 6.4 Purification of OutD-Cter* (A) SDS-PAGE analysis. (B) uv absorbtion of eluant from 
the S75 column.  OutD-Cter* elution peak is indicated (C) Sequence of the OutD-Cter and its 
cleaved derivative OutD-Cter-cleaved sequence.  
 
 
 
A 
B 
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Figure 6.5 Purification of OutD-Cter (A) SDA-PAGE. (B) OutD-Cter S75 column size exclusion 
trace at 280nm. OutD-Cter elution peaks are indicated.  
 	  6.5	  Biophysical	  studies	  of	  OutS	  and	  OutD-­‐Cter	  
Dynamic Light Scattering (DLS) was used assess if the OutS produced was suitable for 
structural studies. Since there was no structural information about OutS and OutD-Cter, 
CD experiments were used to determine the secondary structure contents of both 
proteins individually and in complex.  
 
A 
B 
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6.5.1 OutS DLS 
DLS was used to check whether the OutS produced is properly folded, not aggregating 
and suitable for crystallography studies. The result showed it behaved as a 15kDa 
protein with polydispersity of 13.9% this indicates that OutS produced by this method is 
folded and behaves as monomer in solution (Figure 6.6). It is generally accepted that 
proteins with polydispersity of less than 20%, have a very good chance of crystallizing. 
With 13.9% polydispersity, OutS is crystallized good candidate.  Crystallization trails 
led to the growth of diffracting crystals from which the crystal  structure was 
determined.  
 
 Radius(nm) %Pd MW-­‐R(kDa) %Int 
Peak1 0.05844 0 0 2.6 
Peak2 1.88112 13.9 15 97.4 
 
Figure 6.6 OutS DLS summary. OutS was measured at 10mg/ml in 20mM Tris pH7.0 at 20OC. 
 
6.5.2 OutS  CD  
The far UV-CD spectrum gives good indication of secondary structure. The OutS CD 
spectra (Figure 6.7) peaked at 190nm and dipped at 210 and 225nm, showing OutS is 
predominantly  an α-helical protein. This CD result is consistent with the secondary 
structure prediction.  
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6.5.3 OutD-Cter CD 
CD was measured using OutD-Cter to give a general idea of OutD-Cter secondary 
structure. In 20mTris, 150mM NaCl, pH7.0, OutD–Cter gives a typical disordered 
spectra with a dip at around 197 nm (Figure 6.8). To check whether OutD-Cter is 
capable of forming helical structure as predicted by J-pred, 2,2,2-trifluoroethanol (TFE) 
was added to OutD-Cter solution. TFE is an alcohol with low-dielectric constant and 
can induce stable conformation that resembles of the interior of a protein. In the 
presence of a low concentration of TFE (16%), part of OutD-Cter started to fold into α-
helical structure (Figure 6.8). This provides support for the J-pred prediction. 
 
 
Figure 6.7 Far-UV CD spectrum of OutS . The spectrum was measured at 20OC in 20mM Tris, 
150mM NaCl pH7.0 using 2mg/ml OutS. 
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Figure 6.8 Far-UV CD spectra of OutD-Cter (black) and in the presence of 16% (green), 28% 
(blue) and 37% (red) of TFE. 0.05mg/ml (~1.1µM) OutD-Cter was used for the experiment and 
measured at 20oC in 20mM Tris 150mM NaCl pH7.0.  
 
 
6.5.4 Interaction studies of OutS and OutD-Cter by CD 
OutD-Cter is unstructured on its own and predicted to adopt a principally helical 
structure by J-pred. In the presence of TFE, OutD-Cter is able to form a helical 
structure. To determine if helical structure can be induced in OutD-Cter by the presence 
of OutS, CD spectra were recorded for the mixture of OutD-Cter and OutS. The CD 
spectra were measured using 0.044mg/ml (0.55µM) of OutD-Cter and 0.06mg/ml 
(0.55µM) of OutS in 20mM Tris, 150mM NaCl, pH7.0, separately. As suggested by 
NMR titration, the OutS and OutD form complex in a 1:1 ratio (see section 6.7), an 
equal volume of OutD-Cter and OutS sample was taken and mixed to record the CD 
spectra. The OutD-Cter and OutS mixed sample with the final concentration of both 
proteins halved, therefore data were mulitiplied by two to compensate the signal loss by 
dilution. In Figure 6.9, OutD-Cter and OutS spectra are shown; the red spectrum is the 
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additive sum of the two spectra. This shows the OutD-Cter and OutS mixture spectra in 
the absence of the secondary structure changes. The actual spectrum of the OutD-Cter 
and OutS mixture is shown in blue. The actual mixture spectrum shows a further dip at 
210 and 225nm and peaked higher at 190nm. To quantify the secondary structure of the 
OutS and OutD-Cter mixture spectrum, the actual measured spectra has 41.5% (77 
residues) of helical and 7.2% of β-strand content, whereas the sum of the independent 
OutS and OutD-Cter spectra has 34.8% (65 residues) of helical content and 7.7% beta 
strand content. The quantified result provided strong evidence of new helical formation, 
when mixing the two proteins together. As the OutS structure is solved, the residues in 
helical conformation can be determined as about 68 out of total 107 residues in OutS 
construct. In the mixture of OutS (107 residues) and OutD-Cter (87 residues) (1:1), 
assuming the secondary structure of OutS does not change but that of the unstructured 
peptide does, the OutS secondary content should be around 36% (68 out of 185 
residues) and is consistent with 34.8% measured. As the Kd of the interaction was not 
measured, the percentage of complex formation was unknown. Assuming neglidgible 
change in the OutS secondary structure content, at least 12 residues (assuming 100% 
complex formation) from OutD-Cter form helical structure when the peptide is bound to 
OutS. 
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Figure 6.9 Far-UV CD spectra of OutS and OutD-Cter mixture. Far UV spectrum of OutS (black), 
OutD-Cter (green) and OutS and OutD-Cter mixture (blue). The additive sum of OutS and OutD-
Cter is shown in red. OutS and OutD-Cter both measured at 0.55µM. The mixture of OutS and 
OutD-Cter was made by mixing equal amount of OutD-Cter and OutS samples and measured at 
same condition. As the OutS and OutD mixture both diluted by half, the CD data were multiplied 
by two compensate the dilution factor.  	  6.6	  NMR	  study	  of	  OutS	  and	  OutD-­‐Cter	  
CD data gives preliminary evidence of the OutS and OutD-Cter interaction. NMR 
spectroscopy was used to gain more detailed information. Initially OutS and OutD-Cter 
were measured individually to pave the way for the interaction study.   
 
6.6.1 OutS 2D HSQC spectrum  
The OutS spectrum is well dispersed and the peaks are sharp (Figure 6.10). This shows 
that OutS behaves as homogenous monomer. The number of peaks shown on the 
spectrum reflects the actual backbone amide protons of OutS. Therefore, the 
experimental condition is useful for further experiment, such as HN based 3D 
experiments for backbone assignments.  
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Figure 6.10 1H-15N HSQC spectra of OutS. The spectrum was acquired at Bruker 600MHz at 15oC 
in 20mM Tris 150mM NaCl (pH 7.0) and 10% 2H2O. 
 
6.6.2 OutD-Cter 2D HSQC spectrum 
According to OutD-Cter* 1H-15N HSQC spectra, all backbone amide protons appear in 
the region between 7.5ppm to 8.5ppm. This indicates that the OutD-Cter peptide is 
unstructured in solution. The number of backbone amide protons appearing in the 2D 
HSQC is correct for the number of backbone amide proton present in the protein.  
The unstructured nature of the OutD-Cter peptide makes it susceptible to protease 
activities in vivo. With a closer look at the OutD-Cter 1H-15N HSQC, two sets of peaks 
can be seen to be present in the spectrum, one set of very intense peaks and one set of 
weaker peaks. During the backbone assignment, peaks with strong intensities are 
residues upto residue R685, which indicates there is a cleaved derivitives present in the 
OutD-Cter*. It is no surprise as arginine is the cleavage site for many proteases. From 
the intensities of the peaks after R685, the full length OutD-Cter protein present in the 
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sample is much less than the cleaved version. It is also observed that the cleavage is 
carried out in vitro. It has been observed that the full length OutD-Cter is completely 
cleaved into OutD-Cter cleaved after 48hours at 15oC (Figure 6.11 A). The cleaved off 
26 residue peptide are relatively insoluble as precipitation is observed in the sample and 
no additional peaks are observed for the peptide in the HSQC spectrum. 
 6.7	  Interaction	  between	  OutS	  and	  OutD-­‐Cter*	  
The OutS and OutD-Cter interaction was initially shown by Dr. Shevchik (Shevchik, 
Robert-Baudouy et al. 1997) using a pull down assay. NMR titrations were used to 
better understand the interaction at a molecular level.   
 
Cross titrations between OutS and OutD-Cter* were carried out. The labeled protein 
was titrated with unlabeled partner and the structural changes of the labeled protein 
during titration were monitored by recording the 2D HSQC spectrum. When OutD-Cter 
was titrated into 15N labeled OutS, about a third of OutS peaks showed shifting (Figure 
6.12). On the other hand, when titrating OutS into 15N OutD-Cter*, only a few of the 
OutD-Cter* peaks shifted, while the majority of OutD-Cter* remained unchanged 
(Figure 6.13). From the titration result, it is likely that OutS interacts with a small patch 
on the OutD-Cter peptide, but the binding of the peptide has effects throughout the OutS 
. 
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Figure 6.11 1H-15N HSQC spectra of OutD-Cter* and backbone assignment (A)1H-15N HSQC 
spectra of OutD-Cter(Black) and OutD-Cter cleaved (Red). (B) OutD-Cter* backbone amide 
proton assignment. The OutD-Cter-cleaved sample is obtained by leaving OutD-Cter sample at 
15OC for 48 hrs. Spectra was acquired at Bruker 700MHz at 15oC in 20mM Tris 150mM NaCl (pH 
7.0) and 10% 2H2O. 
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The interaction between OutS and OutD-Cter appears to be strong. Upon titration of the 
unlabeled partner protein, a new and well dispersed set of signals were observed in the 
15N-HSQC spectrum of the OutS (Figure 6.12). The peaks corresponding to the “apo” 
form became weaker and a new set of spectrum corresponding to the “bound” form 
appeared and become more intensified. The co-presence of the “apo” and “bound” form 
showed that the interaction between OutS and OutD-Cter behaves as slow exchange and 
indicates the tight binding between the two proteins. Since the titration experiments 
used 25µΜ labeled OutS with addition of 1.3 equivalents of OutD-Cter, all the OutS 
shifted to the “bound” state, the stoichiometry of the complex would be a 1:1 ratio.   
 
The 1H-15N HSQC spectra of OutD-Cter*, a mixture of OutD-Cter and OutD-Cter-
cleaved, showed poorly dispersed amide proton spectra, diagnostic of a predominantly 
unstructured peptide (Figure 6.11). Since OutD-Cter was produced recombinantly, it is 
co-produced with an in vivo proteolysis fragment OutD-Cter-cleaved. As OutD-Cter-
cleaved was present predominantly in the OutD-Cter sample, the residues represent this 
region showed intense peaks (Figure 6.11 and Figure 6.13). When titrating, unlabeled 
OutS in to OutD-Cter*, the intense peaks, which are residues correspond to OutD-Cter-
cleaved, all remained unchanged, (Figure 6.13A). Whereas the residues behave in a 
slow exchange regime are all the peaks with relatively weak intensities, which are 
residues on OutD686-710 region (Figure 6.13). exchange in the titration. Hence, the 
interaction region on OutD-Cter is further located on OutD691-710. As many of residues 
located on OutD691-710 present in the crowded region of the 1H-15N HSQC spectra 
(Figure 6.13A) and are over shadowed with intense peaks from OutD649-685 region the 
E708 is the last observable shifted peak.  To confirm that the OutD-Cter-cleaved, does  
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Figure 6.12 1H-15N HSQC spectrum of OutS in the absence (red), with presence of 0.5 equivalents of 
OutD-Cter (blue) and 1.3 equivalents OutD-Cter (green). 15N OutS was at 25 uM. Spectra were 
acquired on Bruker 600MHz at 15oC in 20mM Tris 150mM NaCl (pH 7.0) and 10% 2H2O. 
not interactwith OutS, OutS was titrated in Looking closely at Figure 6.13A, the E708 is 
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the last observable shifted peak.  To confirm that the OutD-Cter-cleaved, does not 
interactwith OutS, OutS was titrated in Looking closely at Figure 6.13A, G688, G699 
and N690 do not behaves as in slow to OutD-Cter-cleaved (Figure 6.13B). In the 
presence of two equivalent of OutS, which is sufficient to saturate the OutD-Cter to 
OutS bound state, no change in the spectra was observed. Therefore, the OutD-Cter-
cleaved  peptide does not interact with OutS. This highlights the last 20 residues of 
OutD, OutD691-710,  as those that bind OutS. 
 
The J-pred secondary structure prediction predicts helix from residues 694 to 704. 
Therefore OutD-Cter is probably interacting with OutS with a helix formed between 
these residues.  
 6.8	  OutD692-­‐708	  interacting	  with	  OutS	  
The studies described above strongly suggest the OutD691-710 peptide interacts with 
OutS. To confirm this an 18 residue peptide was purchased from Generon and tested in 
NMR titration experiments.  
 
The CD experiment showed the 18 residues OutD692-708 peptide was unstructured 
(Figure 6.14).  This result is expected and consistent with the CD result for the OutD-
Cter. The OutD692-708 was subsequently used for NMR titration studies. OutD692-708 was 
titrated against 15N OutS. With addition of OutD692-708, many peaks of on OutS spectra 
shifted in a slow exchange manner as previously seen for the OutD-Cter titration 
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Figure 6.13 OutD-Cter* and OutD-Cter-cleaved titration with OutS. (A) 2D1H-15N HSQC of 
15NOutD-Cter* (B) 2D1H-15N HSQC of 15NOutD-Cter-cleaved in the absence (black) and presence 
of two equivalent of OutS(red). 15NOutD-Cter* was measured at 50mM and 15NOutD-Cter-cleaved 
was measure at 25mM. Both spectrum acquired at15°C on Bruker 700MHz at 15oC in 20mM Tris 
150mM NaCl (pH 7.0) and 10% 2H2O. 
A 
B 
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(Figure 6.15). Comparing the OutS HSQCs in the presence of OutD-Cter and OutD692-
708, the changes on the OutS spectra are very similar (Figure 6.15C) This confirms OutD 
residues 692-708 is the major region, and probably the only region, responsible for 
interacting with OutS. 
 
Figure 6.14 Far-UV CD spectra of OutD692-708. Spectra was measured at 20OC in 20mM Tris, 
150mM NaCl pH7.0. 
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Figure 6.15  Comparing effect of OutD692-708 and OutD-Cter on OutS. (A)1H-15N HSQC spectrum of 
OutS in the absence (red) and presence of OutD692-708 (black). (B) 1H-15N HSQC spectrum of OutS 
in the absence (red) and presence of OutD-Cter (green). (C) Overlay of 1H-15N HSQC spectrum of 
OutS in the presence of OutD692-708 (black) and 1H-15N HSQC spectrum of OutS in the presence of 
OutD-Cter (green). 15N OutS was measured at 100mM, OutD692-708 was measured at 100mM and 
OutD-Cter was measured at 130mM. The spectra were acquired at Varian 800MHz at 15oC in 
20mM Tris 150mM NaCl (pH 7.0) and 10% 2H2O. 
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Since OutS has only one tryptophan and there was no tryptophan in OutD691-708, 
fluorescence spectroscopy by measuring tryptophan emission is used to observing the 
interaction. Upon binding to the OutD691-708 the tryptophan signal is quenched. The 
binding between OutS and OutD691-708 appears to be very tight with dissociation 
constant (Kd) of 55.0±20nM, error was estimated by three independent measurments. 
 
Figure 6.16 OutS and OutD691-708 Kd determination by flouorescence spectroscopy. OutD691-708 
titration of OutS as monitored by tryptophan emission at 340nm. Spectra of 1µΜ  OutS was 
measured with variable OutD691-708 at 15oC in 20mM Tris, 150mM NaCl, pH 7.0. Standard 
deviation was calculated from three different measurments.  
 
The OutS has a nested four α-helices structure (Figure 6.17A),  revealed a concave 
surface formed by juxtaposition of helices 1, 3 and 4 and this structure is likely to be the 
binding site for the OutD-Cter. When OutS is compared with the P40 nucleoprotein 
(Rudolph, Kraus et al. 2003), the protein with most similar arrangement of alpha-helics, 
the corresponding site is occupied by helix 3 (Figure 6.17). This similarity suggests that 
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the concave surface formed by helices 1,3 and 4 of OutS bind a helical structure. 
Secondary structure prediction on OutD-Cter suggests that this region consists of three 
alpha-helices. Although the OutD-Cter HSQC spectrum indicates the OutD-Cter is lack 
of secondary structure, the peaks showed slow exchange during the titration experiment 
may form helices structure upon binding to the OutS. To localize the region of the 
interaction on OutD-Cter, the OutD-Cter backbone assignment was achieved. Residues 
corresponding to OutD692-708 behave as if they are in a slow exchange regime during 
titration and were located to be the region of interaction. The CD results suggesting 
OutD-Cter forming helical structure when interacting with OutS. Although OutD-Cter 
was unstructured on its own, it is predicted to have helical structure and able to form 
helical structure. Therefore, OutD-Cter C-terminus predicted helical is predicted to 
interact with the concave surface of OutS in a manner similar to helix 3 of P40 
nucleoprotein.  
   
 
 
Figure 6.17 Proposed OutS OutD binding model (A) OutS structure (megenta) with proposed OutD 
peptid (cyan) binding model.   (B) Superimposition of P40 nucleoprotein (blue, PDB:1N93), the 
OutS (magenta) and proposed OutD peptide (cyan).  The P40 nucleoprotein has been simplified to 
those elements with equivalents in OutS, with the exception of P40 helix 3 closest to the viewer.   
A B 
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6.9	  Summary	  and	  discussion	  
In this chapter, an 18 residue sequence on OutD, OutD692-708, was found to be 
responsible for interacting with OutS. Upon binding to OutS, unstructured OutD692-708 
forms a more helical structure.  
 
The pilotin lipidation is essential for its function. In type three secretion system, an 
unlipidated form of the YscW protein was not functional, although it still interacted with 
the secretin and caused mislocalization of YscC even in the presence of wild-type YscW 
(Burghout, Beckers et al. 2004). Also the type III pilotin, MxiM binding site is occupied 
by it’s own lipid acyl chain in the absence of MxiD (Lario, Pfuetzner et al. 2005). The 
binding of lipid seems playing a regulatory role, that only the secretin binding MxiM 
has the acyl chain presented to the LolA for transportation. This ensures only the 
secreting associated pilotin is transported. The binding between OutS and OutD692-708 is 
also dominated by hydrophobic interactions. Therefore, OutS binding surface is 
predicted to occupied by its own acyl lipid chain in the absence of OutD. Upon binding 
OutD C-terminus, OutS acyl lipid chain is expelled and presented to LolA for Lol 
translocation to the outer membrane (Figure 6.24).  
 
GspS is only identified in a few species (Shevchik, Robert-Baudouy et al. 1997; 
Nouwen, Ranson et al. 1999). But it maybe more wide spread. When known GspS 
sequences are used in BLAST searches, many uncharacterized proteins with similar size, 
from different species, are found. These hits are good candidates for pilotins. As 
suggested from examination of the type III pilotin, MxiM, mechanism, it is likely that 
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Figure 6.18 A model of tranlocation of GspS and GspD to the outer membrane via Lol pathway 
(Tokuda and Matsuyama 2004).  
 
GspS binds an acyl lipid in the absence of GspD. There is currently no experimental 
evidence to support this. It would be interesting to test this. If GspS does bind lipid, 
stabilizing the lipid binding could be a possibility to inhibit T2SS related diseases. The 
alternative, of course, is to inhibit interaction with secretin. 
 
In this work, an 18 residues sequence from GspD was identified that binds OutS. 
Although a predicted model is proposed, it would be useful to study the interaction in 
molecular detail, that is to solve the OutS/18 residues complex structure by NMR or 
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crystallography. GspS could be a very good drug target for several T2SS related 
diseases as blocking its binding to LolA or secretin could completely abolish T2SS 
assembly and stop bacteria secreting toxins.  
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Chapter 7 Overall Conclusions 
In the past decade, there have been great advances in understanding the molecular 
structure of the T2SS.  The structure of a great many single soluble components and 
domains have been solved.  But there still limited knowledge of how the components 
assemble to form a functional system. In this Thesis I have focussed on the elucidating 
the molecular details of the interaction of the T2SS outer membrane secretin, GspD, 
with the inner-membrane protein GspC and the pilotin GspS. 
 
In this work, I have solved the solution structure of GspC-HR by using NMR 
spectroscopy, which revealed it to have a β-sandwich fold. The structure of OutC-HRF3 
shares a very similar fold as a T4P lipoprotein PilP. PilP shares many functional roles 
with GspC-HR, which include locating on the inner membrane, extending into 
periplasm and interacting with an outer membrane secretin (Golovanov, Balasingham et 
al. 2006). Both GspC and PilP form inner-membrane subcomplexes (GspC/M/L and 
PilP/N/M) with other components of their secretion systems(Tammam, Sampaleanu et 
al. 2011). The recently released PilM-PilN complex structure (PDB:2YCH) has a 
similar ferredoxin-like fold as seen in the GspL-GspM complex (Karuppiah and Derrick 
; Abendroth, Rice et al. 2004; Abendroth, Kreger et al. 2009). Even though they have 
only 18% sequence similarity, GspC-HR and PilP should be considered as homologus 
between T2SS and T4P. I also show that, GspC-HRF3 interacts with the N0 domain of 
the secretin (GspD) subunit. Currently, there is no molecular detail on PilP and PilQ 
interaction, but it is very likely that PilP interacts with secretin PilQ in a very similar 
manner through interaction with PilQ N0 domain (Tammam, Sampaleanu et al. 2011). 
In the map from EM reconstruction of the PilP and PilQ complex (Balasingham, Collins 
et al. 2007), PilP interacts with PilQ in the periplasm and this is  where the N0 domain 
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is anticipated to reside.    
 
T2SS and T4P have long-recognized similarities. Many of T2SS components have 
homologoues counterparts in the T4P (Peabody, Chung et al. 2003). These include (1) 
the prepilin peptidase/N- methyltransferase (GspO/PilD), (2) the ATPase (GspE/PilB), 
(3) the secretin (GspD/PilQ) and (4) the multispanning transmembrane (TM) protein 
(GspF/PilC), (5) inner-membrane subcomplex proteins (GspL and M/ PilN and M). In 
this work another structure of GspC-HR was solved by using NMR spectrascopy, which 
revealed it it a homologue of PilP. Out of all the homologues, only two constituents, the 
ATPase and the TM protein were identified from sequence and phylogenetic analyses. 
Although many other protein constituents are probably homologous, extensive sequence 
divergence during evolution clouds this homology. ?
 
The structural homology between the T2SS and T4P doesnot extend to the secretin’s 
pilotin of two secretion systems.  The T2SS GspS is a much smaller protein in size than 
the T4P PilW. Recently solved GspS structure revealed a new fold different to PilW 
structure. In this work, the interaction between secretin and pilotin is studied by a series 
of biophysical techniques. The region of GspS binding site on secretin is shown to be 
limited to the C-terminal 18 residues. The unstructured GspD C-terminal 18 residues are 
also shown to form a helical structure upon binding to pilotin. It interesting to mention 
the T3SS pilotin MxiM, with a different structure  also binds to the C-terminal 18 
residues of the secretin in a similar manner where the unstructured peptide of secretin 
forming helical structure upon binging to MxiM (Okon, Moraes et al. 2008). Although 
the T2SS and T3SS pilotins do not show structural homology, they have clear 
functional and mechanistic similarities. 
References 
157 
157 
References 
Abendroth, J., A. C. Kreger, et al. (2009). "The dimer formed by the periplasmic domain of EpsL 
from the Type 2 Secretion System of Vibrio parahaemolyticus." Journal of Structural 
Biology 168(2): 313-322. 
Abendroth, J., D. D. Mitchell, et al. (2009). "The three-dimensional structure of the cytoplasmic 
domains of EpsF from the type 2 secretion system of Vibrio cholerae." Journal of 
Structural Biology 166(3): 303-315. 
Abendroth, J., P. Murphy, et al. (2005). "The X-ray Structure of the Type II Secretion System 
Complex Formed by the N-terminal Domain of EpsE and the Cytoplasmic Domain of EpsL 
of Vibrio cholerae." Journal of Molecular Biology 348(4): 845-855. 
Abendroth, J., A. E. Rice, et al. (2004). "The Crystal Structure of the Periplasmic Domain of the 
Type II Secretion System Protein EpsM From Vibrio cholerae: The Simplest Version of 
the Ferredoxin Fold." Journal of Molecular Biology 338(3): 585-596. 
Balasingham, S. V., R. F. Collins, et al. (2007). "Interactions between the Lipoprotein PilP and the 
Secretin PilQ in Neisseria meningitidis." J Bacteriol. 189(15): 5716-5727. 
Bax, A. and A. Grishaev (2005). "Weak alignment NMR: a hawk-eyed view of biomolecular 
structure." Curr Opin Struct Biol 15(5): 563-570. 
Berjanskii, M. V. and D. S. Wishart (2005). "A Simple Method To Predict Protein Flexibility Using 
Secondary Chemical Shifts." Journal of the American Chemical Society 127(43): 14970-
14971. 
Bleves, S., M. Gerard-Vincent, et al. (1999). "Structure-function analysis of XcpP, a component 
involved in general secretory pathway-dependent protein secretion in Pseudomonas 
aeruginosa." J Bacteriol 181(13): 4012-4019. 
Bouley, J., G. Condemine, et al. (2001). "The PDZ domain of OutC and the N-terminal region of 
OutD determine the secretion specificity of the type II out pathway of Erwinia 
chrysanthemi." J Mol Biol 308(2): 205-219. 
Burghout, P., F. Beckers, et al. (2004). "Role of the Pilot Protein YscW in the Biogenesis of the 
YscC Secretin in Yersinia enterocolitica." J. Bacteriol. 186(16): 5366-5375. 
Camberg, J. L. and M. Sandkvist (2005). "Molecular Analysis of the Vibrio cholerae Type II 
Secretion ATPase EpsE." J. Bacteriol. 187(1): 249-256. 
Chami, M., I. Guilvout, et al. (2005). "Structural Insights into the Secretin PulD and Its Trypsin-
resistant Core." Journal of Biological Chemistry 280(45): 37732-37741. 
References 
 
158 
 
Cianciotto, N. (2005). "Type II secretion: a protein secretion system for all seasons." Trends in 
Microbiology 13(12): 581-588. 
Collin, S., I. Guilvout, et al. (2011). "Sorting of an integral outer membrane protein via the 
lipoprotein-specific Lol pathway and a dedicated lipoprotein pilotin." Molecular 
Microbiology 80(3): 655-665. 
Condemine, G. and V. E. Shevchik (2000). "Overproduction of the secretin OutD suppresses the 
secretion defect of an Erwinia chrysanthemi outB mutant." Microbiology 146(3): 639-647. 
Corbett, M., S. Virtue, et al. (2005). "Identification of a New Quorum-Sensing-Controlled 
Virulence Factor in Erwinia carotovora subsp. atroseptica Secreted via the Type II 
Targeting Pathway." Molecular Plant-Microbe Interactions 18(4): 334-342. 
Cordier, F. and S. Grzesiek (1999). "Direct Observation of Hydrogen Bonds in Proteins by 
Interresidue 3hJNC‚Äò Scalar Couplings." Journal of the American Chemical Society 
121(7): 1601-1602. 
Crago, A. M. and V. Koronakis (1998). "Salmonella InvG forms a ring-like multimer that requires 
the InvH lipoprotein for outer membrane localization." Molecular Microbiology 30(1): 47-
56. 
d'Enfert C, Ryter A, et al. (1987). "Cloning and expression in Escherichia coli of the Klebsiella 
pneumoniae genes for production, surface localization and secretion of the lipoprotein 
pullulanase." EMBO J. 6(11): 3531-3538. 
Daefler, S., I. Guilvout, et al. (1997). "The C-terminal domain of the secretin PulD contains the 
binding site for its cognate chaperone, PulS, and confers PulS dependence on pIVf1 
function." Molecular Microbiology 24(3): 465-475. 
Davis, B. M., E. H. Lawson, et al. (2000). "Convergence of the Secretory Pathways for Cholera 
Toxin and the Filamentous Phage, CTXœï." Science 288(5464): 333-335. 
Delaglio, F., S. Grzesiek, et al. (1995). "NMRPipe: a multidimensional spectral processing system 
based on UNIX pipes." J Biomol NMR 6(3): 277-293. 
Dominguez, C., R. Boelens, et al. (2003). "HADDOCK: a protein-protein docking approach based 
on biochemical or biophysical information." J Am Chem Soc. 125(7): 1731-1737. 
Douet, V., L. Loiseau, et al. (2004). "Systematic analysis, by the yeast two-hybrid, of protein 
interaction between components of the type II secretory machinery of Erwinia 
chrysanthemi." Research in Microbiology 155(2): 71-75. 
 
References 
 
159 
 
Drake, S. L., S. A. Sandstedt, et al. (1997). "PilP, a pilus biogenesis lipoprotein in Neisseria 
gonorrhoeae, affects expression of PilQ as a high-molecular-mass multimer." Mol 
Microbiol 23(4): 657-668. 
Driessen, A. (1992). "Precursor protein translocation by the Escherichia coli translocase is directed 
by the protonmotive force." EMBO J 11(3): 847-853. 
Durand, E., D. Verger, et al. (2009). "Structural Biology of Bacterial Secretion Systems in Gram-
Negative Pathogens- Potential for New Drug Targets " Infectious Disorders - Drug 
Targets(9): 518-547. 
Fries, M., J. Ihrig, et al. (2007). "Molecular basis of the activity of the phytopathogen pectin 
methylesterase." EMBO J 26(17): 3879-3887. 
Genin, S. and C. A. Boucher (1994). "A superfamily of proteins involved in different secretion 
pathways in gram-negative bacteria: modular structure and specificity of the N-terminal 
domain." Molecular and General Genetics MGG 243(1): 112-118. 
Golovanov, A. P., S. Balasingham, et al. (2006). "The Solution Structure of a Domain from the 
Neisseria meningitidis Lipoprotein PilP Reveals a New [beta]-Sandwich Fold." Journal of 
Molecular Biology 364(2): 186-195. 
Goo, E., Y. Kang, et al. (2010). "Proteomic Analysis of Quorum Sensing-Dependent Proteins in 
Burkholderia glumae." Journal of Proteome Research 9(6): 3184-3199. 
Guilvout, I., M. Chami, et al. (2006). "Bacterial outer membrane secretin PulD assembles and 
inserts into the inner membrane in the absence of its pilotin." EMBO J 25(22): 5241-5249. 
Guilvout, I., N. N. Nickerson, et al. "Multimerization-defective variants of dodecameric secretin 
PulD." Research in Microbiology 162(2): 180-190. 
Hardie, K. R., S. Lory, et al. (1996). "Insertion of an outer membrane protein in Escherichia coli 
requires a chaperone-like protein." EMBO J 15(5): 978-988. 
Hardie, K. R., A. Seydel, et al. (1996). "The secretin-specific, chaperone-like protein of the general 
secretory pathway: separation of proteolytic protection and piloting functions." Mol 
Microbiol 22(5): 967-976. 
Hayashi, S. and H. C. Wu (1990). "Lipoproteins in bacteria." Journal of Bioenergetics and 
Biomembranes 22(3): 451-471. 
He, S. Y., M. Lindeberg, et al. (1991). "Cloned Erwinia chrysanthemi out genes enable Escherichia 
coli to selectively secrete a diverse family of heterologous proteins to its milieu." Proc Natl 
Acad Sci U S A 88(3): 1079-1083. 
References 
 
160 
 
Hobot, J. A., E. Carlemalm, et al. (1984). "Periplasmic gel: new concept resulting from the 
reinvestigation of bacterial cell envelope ultrastructure by new methods." J Bacteriol. 
160(1): 143-152. 
Holm, L. and P. Rosenstrom (2010). "Dali server: conservation mapping in 3D." Nucleic Acids Res 
38(Web Server issue): W545-549. 
Jaravine, V. A., A. V. Zhuravleva, et al. (2008). "Hyperdimensional NMR Spectroscopy with 
Nonlinear Sampling." Journal of the American Chemical Society 130(12): 3927-3936. 
Karuppiah, V. and J. P. Derrick "Structure of the PilM-PilN Inner Membrane Type IV Pilus 
Biogenesis Complex from Thermus thermophilus." Journal of Biological Chemistry 
286(27): 24434-24442. 
Kay LE, T. D., Bax A. (1989). "Backbone dynamics of proteins as studied by 15N inverse detected 
heteronuclear NMR spectroscopy: application to staphylococcal nuclease." Biochemistry. 
14(28): 8972-8979. 
Kim, K., J. Oh, et al. (2006). "Crystal structure of PilF: Functional implication in the type 4 pilus 
biogenesis in Pseudomonas aeruginosa." Biochemical and Biophysical Research 
Communications 340(4): 1028-1038. 
Koo J, T. S., Ku SY, Sampaleanu LM, Burrows LL, Howell PL. (2008). "PilF Is an Outer 
Membrane Lipoprotein Required for Multimerization and Localization of the 
Pseudomonas aeruginosa Type IV Pilus Secretin." J Bacteriol. 190(21): 6961-6969. 
Korotkov, K. V., T. Gonen, et al. (2011). "Secretins: dynamic channels for protein transport across 
membranes." Trends in Biochemical Sciences. 
Korotkov, K. V. and W. G. J. Hol (2008). "Structure of the GspK-GspI-GspJ complex from the 
enterotoxigenic Escherichia coli type 2 secretion system." Nat Struct Mol Biol 15(5): 462-
468. 
Korotkov, K. V., T. L. Johnson, et al. (2011). "Structural and Functional Studies on the Interaction 
of GspC and GspD in the Type II Secretion System." PLoS Pathog 7(9): e1002228. 
Korotkov, K. V., B. Krumm, et al. (2006). "Structural and functional studies of EpsC, a crucial 
component of the type 2 secretion system from Vibrio cholerae." J Mol Biol 363(2): 311-
321. 
Korotkov, K. V., E. Pardon, et al. (2009). "Crystal structure of the N-terminal domain of the 
secretin GspD from ETEC determined with the assistance of a nanobody." Structure 
17(2): 255-265. 
References 
 
161 
 
 
Koster, M., W. Bitter, et al. (1997). "The outer membrane component, YscC, of the Yop secretion 
machinery of Yersinia enterocolitica forms a ring-shaped multimeric complex." Molecular 
Microbiology 26(4): 789-797. 
Lario, P. I., R. A. Pfuetzner, et al. (2005). "Structure and biochemical analysis of a secretin pilot 
protein." EMBO J 24(6): 1111-1121. 
Lee, H.-M., J.-R. Chen, et al. (2004). "Functional Dissection of the XpsN (GspC) Protein of the 
Xanthomonas campestris pv. campestris Type II Secretion Machinery." J. Bacteriol. 
186(10): 2946-2955. 
Lee, H.-M., K.-C. Wang, et al. (2000). "Association of the Cytoplasmic Membrane Protein XpsN 
with the Outer Membrane Protein XpsD in the Type II Protein Secretion Apparatus of 
Xanthomonas campestris pv. Campestris." J. Bacteriol. 182(6): 1549-1557. 
Lindeberg, M., G. P. C. Salmond, et al. (1996). "Complementation of deletion mutations in a cloned 
functional cluster of Erwinia chrysanthemi out genes with Erwinia carotovora out 
homologues reveals OutC and OutD as candidate gatekeepers of species-specific secretion 
of proteins via the type II pathway." Molecular Microbiology 20(1): 175-190. 
Linderoth, N. A., M. N. Simon, et al. (1997). "The Filamentous Phage pIV Multimer Visualized by 
Scanning Transmission Electron Microscopy." Science 278(5343): 1635-1638. 
Linge, J. P., M. Habeck, et al. (2003). "ARIA: automated NOE assignment and NMR structure 
calculation." Bioinformatics 19(2): 315-316. 
Liwang, A. C. and A. Bax (1997). "Solution NMR characterization of hydrogen bonds in a protein 
by indirect measurement of deuterium quadrupole couplings." J Magn Reson 127(1): 54-
64. 
Login, F. H., M. Fries, et al. (2010). "A 20-residue peptide of the inner membrane protein OutC 
mediates interaction with two distinct sites of the outer membrane secretin OutD and is 
essential for the functional type II secretion system in Erwinia chrysanthemi." Mol 
Microbiol 76(4): 944-955. 
Login, F. H. and V. E. Shevchik (2006). "The single transmembrane segment drives self-assembly 
of OutC and the formation of a functional type II secretion system in Erwinia 
chrysanthemi." J Biol Chem 281(44): 33152-33162. 
Martin, S. R. and M. J. Schilstra (2008). "Circular Dichroism and Its Application to the Study of 
Biomolecules." METHODS IN CELL BIOLOGY 84: 263-293. 
References 
 
162 
 
 
Michel, G. r., S. Bleves, et al. (1998). "Mutual stabilization of the XcpZ and XcpY components of 
the secretory apparatus in Pseudomonas aeruginosa." Microbiology 144(12): 3379-3386. 
Miller, M. B. and B. L. Bassler (2001). "Quorum sensing in bacteria " Annual Review of 
Microbiology 55: 165-199. 
Mühlradt, P. and J. Golecki (1975). "Asymmetrical distribution and artifactual reorientation of 
lipopolysaccharide in the outer membrane bilayer of Salmonella typhimurium." Eur J 
Biochem. 51(2): 343-352. 
Nikaido, H. (2003). "Molecular Basis of Bacterial Outer Membrane Permeability Revisited." 
Microbiol. Mol. Biol. Rev. 67(4): 593-656. 
Nouwen, N., N. Ranson, et al. (1999). "Secretin PulD: Association with pilot PulS, structure, and 
ion-conducting channel formation." Proceedings of the National Academy of Sciences of 
the United States of America 96(14): 8173-8177. 
Nouwen, N., H. Stahlberg, et al. (2000). "Domain structure of secretin PulD revealed by limited 
proteolysis and electron microscopy." EMBO J 19(10): 2229-2236. 
Okon, M., T. F. Moraes, et al. (2008). "Structural Characterization of the Type-III Pilot-Secretin 
Complex from Shigella flexneri." Structure (London, England : 1993) 16(10): 1544-1554. 
Peabody, C. R., Y. J. Chung, et al. (2003). "Type II protein secretion and its relationship to 
bacterial type IV pili and archaeal flagella." Microbiology 149(11): 3051-3072. 
Pellecchia, M., P. Sebbel, et al. (1999). "Pilus chaperone FimC-adhesin FimH interactions mapped 
by TROSY-NMR." Nat Struct Mol Biol 6(4): 336-339. 
Perombelon, M. C. (1991). "The Prokaryotes." 2899-2921. 
Piddock, L. J. V. (2006). "Multidrug-resistance efflux pumps ? not just for resistance." Nat Rev 
Micro 4(8): 629-636. 
Possot, O. M., G. Vignon, et al. (2000). "Multiple Interactions between Pullulanase Secreton 
Components Involved in Stabilization and Cytoplasmic Membrane Association of PulE." 
J. Bacteriol. 182(8): 2142-2152. 
Pugsley, A. P. (1993). "The complete general secretory pathway in gram-negative bacteria." 
Microbiology and Molecular Biology Reviews 57(1): 50-108. 
Ramachandran, G. N., C. Ramakrishnan, et al. (1963). "Stereochemistry of polypeptide chain 
configurations." Journal of Molecular Biology 7(1): 95-99. 
References 
 
163 
 
Reichow, S. L., K. V. Korotkov, et al. (2010). "Structure of the cholera toxin secretion channel in its 
closed state." Nat Struct Mol Biol 17(10): 1226-1232. 
Rückert, M. and G. Otting (2000). "Alignment of Biological Macromolecules in Novel Nonionic 
Liquid Crystalline Media for NMR Experiments." J. Am. Chem. Soc. 122(32): 7793-7797. 
Rudolph, M. G., I. Kraus, et al. (2003). "Crystal Structure of the Borna Disease Virus 
Nucleoprotein." Structure 11(10): 1219-1226. 
Sambrook, J. (2001). "Molecular Cloning: A Laboratory Manual 3rd Ed." Cold Spring Harbor 
Laboratory Press. Cold Spring Harbor, NY. 
Sandkvist, M. (2001). "Biology of type II secretion." Molecular Microbiology 40(2): 271-283. 
Sandkvist, M. (2001). "Type II Secretion and Pathogenesis." Infection and Immunity 69(6): 3523-
3535. 
Sandkvist, M., M. Bagdasarian, et al. (1995). "Interaction between the autokinase EpsE and EpsL 
in the cytoplasmic membrane is required for extracellular secretion in Vibrio cholerae." 
EMBO J. 14(18): 1664-1673. 
Sandkvist, M., J. M. Keith, et al. (2000). "Two Regions of EpsL Involved in Species-Specific 
Protein-Protein Interactions with EpsE and EpsM of the General Secretion Pathway in 
Vibrio cholerae." J. Bacteriol. 182(3): 742-748. 
Schuch, R. and A. T. Maurelli (2001). "MxiM and MxiJ, Base Elements of the Mxi-Spa Type III 
Secretion System of Shigella, Interact with and Stabilize the MxiD Secretin in the Cell 
Envelope." J. Bacteriol. 183(24): 6991-6998. 
Shen, Y. and A. Bax (2007). "Protein backbone chemical shifts predicted from searching a database 
for torsion angle and sequence homology." Journal of Biomolecular NMR 38(4): 289-302. 
Shen Y, D. F., Cornilescu G, Bax A. (2009). "TALOS+: a hybrid method for predicting protein 
backbone torsion angles from NMR chemical shifts." J Biomol NMR. 44(4): 213-223. 
Shevchik, V. E. and G. Condemine (1998). "Functional characterization of the Erwinia 
chrysanthemi OutS protein, an element of a type II secretion system." Microbiology 144 ( 
Pt 11): 3219-3228. 
Shevchik, V. E., J. Robert-Baudouy, et al. (1997). "Specific interaction between OutD, an Erwinia 
chrysanthemi outer membrane protein of the general secretory pathway, and secreted 
proteins." EMBO J 16(11): 3007-3016. 
 
References 
 
164 
 
Spreter, T., C. K. Yip, et al. (2009). "A conserved structural motif mediates formation of the 
periplasmic rings in the type III secretion system." Nat Struct Mol Biol 16(5): 468-476. 
Takeda, K., H. Miyatake, et al. (2003). "Crystal structures of bacterial lipoprotein localization 
factors, LolA and LolB." EMBO J 22(13): 3199-3209. 
Tammam, S., L. M. Sampaleanu, et al. (2011). "Characterization of the PilN, PilO and PilP type 
IVa pilus subcomplex." Molecular Microbiology 82(6): 1496-1514. 
Tauschek, M., R. J. Gorrell, et al. (2002). "Identification of a protein secretory pathway for the 
secretion of heat-labile enterotoxin by an enterotoxigenic strain of Escherichia coli." 
Proceedings of the National Academy of Sciences 99(10): 7066-7071. 
Thanassi, D. G. and S. J. Hultgren (2000). "Multiple pathways allow protein secretion across the 
bacterial outer membrane." Current Opinion in Cell Biology 12(4): 420-430. 
Tokuda, H. (2009). "Biogenesis of Outer Membranes in Gram-Negative Bacteria." Biosci. 
Biotechnol. Biochem. 73: 465-473. 
Tokuda, H. and S.-i. Matsuyama (2004). "Sorting of lipoproteins to the outer membrane in E. coli." 
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1693(1): 5-13. 
Tseng, T., B. Tyler, et al. (2009). "Protein secretion systems in bacterial-host associations, and their 
description in the Gene Ontology." BMC Microbiol. 19(9). 
Warrena, J. J. and P. B. Moore (2002). "A Maximum Likelihood Method for Determining DaPQ 
and R for Sets of Dipolar Coupling Data." Journal of Magnetic Resonance 149(2): 271-275. 
Wishart, D. S. and B. D. Sykes (1994). "Chemical shifts as a tool for structure determination." 
Methods in enzymology 239: 363-392. 
Wooldridge, K. (2009). "Bacterial secreted proteins: secretory mechanisms and role in 
pathogenesis." Caister Academic Press. 
Yakushi, T., N. Yokota, et al. (1998). "LolA-dependent Release of a Lipid-modified Protein from 
the Inner Membrane of Escherichia coli Requires Nucleoside Triphosphate." Journal of 
Biological Chemistry 273(49): 32576-32581. 
Yamagata, A. and J. A. Tainer (2007). "Hexameric structures of the archaeal secretion ATPase 
GspE and implications for a universal secretion mechanism." EMBO J 26(3): 878-890. 
Yamaguchi, K., F. Yu, et al. (1988). "A single amino acid determinant of the membrane localization 
of lipoproteins in E. coli." Cell 53(3): 423-432. 
 
 
Appendices 
 
165 
 
Appendices 
Appendix	  1	  Protein	  sequences	  used	  for	  assignment.	  	  
	  OutC-­‐HRF3	  (pET14b	  after	  thrombin	  cleavage)	  sequence:	  
        10         20         30         40         50         60  
GSHMLEMAGA LDASQMSNLP PSTLNLSLTG VMAGDDDSRS IAIISKDNEQ FSRGVNEEVP  
 
        70         80         90        100  
GYNAKIVSIR PDRVVLQYQG RYEVLGLYSQ EDSGSDGVPG AQVR  
 
 OutD-­‐N0	  (pET20b)	  sequence:	  
        10         20         30         40         50         60  
MAEFSASFKG TDIQEFINTV SKNLNKTVII DPTVRGTISV RSYDMMNEGQ YYQFFLSVLD  
 
        70         80         90        100  
VYGFSVVPMD NGVLKVIRSK DAKSSSVDKL AAALEHHHHH H  
 
 	  OutD-­‐Cter	  (pGEX-­‐6p-­‐2	  after	  PreScission	  protease	  cleavage)	  sequence	  
        10         20         30         40         50         60  
GPLGSPNSRV DPGQFQEASI NKYRSFNNEQ QQQRGEGNGV LDNNTLRLSG GNTYTFRQVQ  
 
        70  
SSISDFYKPE GRHHHHHH  
 
 OutD691-­‐708	  (synthesized	  peptide	  by	  Generon)	  sequence	  
        10  
TYTFRQVQSS ISDFYKPE  
 
 OutS	  (pET20b)	  sequence	  
        10         20         30         40         50         60  
VKNTASRSAA SVPANEQISQ LASLVAASKY LRVQCERSDL PDDGTILKTA VNVAVQKGWD  
 
        70         80         90        100  
TGRYQSLPQL SENLYQGLLK DGTPKATQCS SFNRTMTPFL DAMRTVR  
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Appendix	  2	  ARIA	  1.2	  run	  setup	  script	  for	  structure	  calculation.	  	  
<html> 
<head> 
<title>ARIA - start</title> 
</head> 
<body bgcolor=#ffffff> 
<h2>Parameters for the start:</h2> 
<BR> 
<h4><!-- ARIA --> 
ARIA_DIR=/dms/prog/bin/aria1.2<BR> 
ASPECTRUM_1=N15<BR> 
ASPECTRUM_2=C13<BR> 
HBOND_FILE=/dms/home/shuang/ARIA_TEST/Shuang_H_bond_correct5.tbl<BR>  
HET1_1=1<BR> 
HET1_2=1<BR> 
HET1_3=N<BR> 
HET1_4=N<BR> 
HET1_5=N<BR> 
HET2_1=N<BR> 
HET2_2=N<BR> 
HET2_3=N<BR> 
HET2_4=N<BR> 
HET2_5=N<BR> 
PPMDHET1_1=0.75<BR> 
PPMDHET1_2=0.75<BR> 
PPMDPRO1_1=0.035<BR> 
PPMDPRO1_2=0.035<BR> 
PPMDPRO2_1=0.04<BR> 
PPMDPRO2_2=0.04<BR> 
PRO1_1=2<BR> 
PRO1_2=3<BR> 
PRO1_3=N<BR> 
PRO1_4=N<BR> 
PRO1_5=N<BR> 
PRO2_1=3<BR> 
PRO2_2=2<BR> 
PRO2_3=N<BR> 
PRO2_4=N<BR> 
PRO2_5=N<BR> 
PROJECT_DIR=/dms/home/shuang/ARIA_TEST<BR> 
RDC1_FILE=/dms/home/shuang/ARIA_TEST/HRF3_rdc.tbl<BR> 
RUN_NUMBER=43_rdc19_test32_5_22_88_18_100<BR> 
SEQ_PDB_FILE=/dms/home/shuang/ARIA_TEST/HRF3.seq<BR> 
TALOS_ERROR=20.0<BR> 
TALOS_FACTOR=2.0<BR> 
TALOS_FILE=/dms/home/shuang/HRF3_talos_plus/talos+_C3.tab<BR> 
UNAMBIG_TBL=/dms/home/shuang/ARIA_TEST/HRF3_UNAMBIG_13_4.tbl<BR> 
WHICH_PEAKS_1=all<BR> 
WHICH_PEAKS_2=all<BR> 
WHICH_PEAKS_3=all<BR> 
WHICH_PEAKS_4=all<BR> 
WHICH_PEAKS_5=all<BR> 
WHICH_SETUP=XEASY<BR> 
XPEAKS_1=/dms/home/shuang/SGU_ARIA/N15_no_diag_ReNo_Relax_D_C.peaks<BR> 
XPEAKS_2=/dms/home/shuang/SGU_ARIA/C13_no_diag_ReNo_2_Relax22_88_C.peaks<BR> 
XPROT_1=/dms/home/shuang/ARIA_TEST/HRF3_correct3_22-88.prot<BR> 
XPROT_2=/dms/home/shuang/ARIA_TEST/HRF3_correct3_22-88.prot<BR> 
submit_save=Save updated parameters<BR> 
</h4><!-- ARIA --> 
</body> 
</html>. 
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Appendix	  3	  Hydrogen	  bond	  restrains	  for	  OutC-­‐HRF3	  
assign (resid 45 and name HN )(resid 27 and name O ) 2.1 0.5 0.5  
assign (resid 45 and name N  )(resid 27 and name O ) 3.0 0.5 0.5  
assign (resid 76 and name HN )(resid 83 and name O ) 2.1 0.5 0.5  
assign (resid 76 and name N  )(resid 83 and name O ) 3.0 0.5 0.5  
assign (resid 32 and name HN )(resid 41 and name O ) 2.1 0.5 0.5  
assign (resid 32 and name N  )(resid 41 and name O ) 3.0 0.5 0.5  
assign (resid 78 and name HN )(resid 81 and name O ) 2.1 0.5 0.5  
assign (resid 78 and name N  )(resid 81 and name O ) 3.0 0.5 0.5  
assign (resid 85 and name HN )(resid 74 and name O ) 2.1 0.5 0.5  
assign (resid 85 and name N  )(resid 74 and name O ) 3.0 0.5 0.5  
assign (resid 74 and name HN )(resid 85 and name O ) 2.1 0.5 0.5  
assign (resid 74 and name N  )(resid 85 and name O ) 3.0 0.5 0.5  
assign (resid 70 and name HN )(resid 73 and name O ) 2.1 0.5 0.5  
assign (resid 70 and name N  )(resid 73 and name O ) 3.0 0.5 0.5  
assign (resid 75 and name HN )(resid 68 and name O ) 2.1 0.5 0.5  
assign (resid 75 and name N  )(resid 68 and name O ) 3.0 0.5 0.5  
assign (resid 41 and name HN )(resid 32 and name O ) 2.1 0.5 0.5  
assign (resid 41 and name N  )(resid 32 and name O ) 3.0 0.5 0.5  
assign (resid 34 and name HN )(resid 36 and name O ) 2.1 0.5 0.5  
assign (resid 34 and name N  )(resid 36 and name O ) 3.0 0.5 0.5  
assign (resid 44 and name HN )(resid 51 and name O ) 2.1 0.5 0.5  
assign (resid 44 and name N  )(resid 51 and name O ) 3.0 0.5 0.5  
assign (resid 66 and name HN )(resid 57 and name O ) 2.1 0.5 0.5  
assign (resid 66 and name N  )(resid 57 and name O ) 3.0 0.5 0.5  
assign (resid 43 and name HN )(resid 30 and name O ) 2.1 0.5 0.5  
assign (resid 43 and name N  )(resid 30 and name O ) 3.0 0.5 0.5  
assign (resid 53 and name HN )(resid 42 and name O ) 2.1 0.5 0.5  
assign (resid 53 and name N  )(resid 42 and name O ) 3.0 0.5 0.5  
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Appendix	  4	  Residual	  dipolar	  coupling	  restrains	  for	  OutC-­‐HRF3	  
! resid 999 contains the four atoms which define the tensor 
! the coordinates of resid 999 are appended to the pdb 
! use our pdf file for the tensor 
! 
! the data are in the format: 
! assign (atomselection) value error 
       ( resid 12  and name HN  )   -1.86  0.500  
       ( resid 13  and name HN  )    4.25  0.500  
       ( resid 14  and name HN  )    12.62  0.500  
       ( resid 15  and name HN  )   -3.02  0.500  
       ( resid 16  and name HN  )   -2.36  0.500  
       ( resid 22  and name HN  )   -7.21  0.500  
       ( resid 26  and name HN  )   -3.4  0.500  
       ( resid 27  and name HN  )    -3.42  0.500  
       ( resid 28  and name HN  )    -0.69  0.500  
       ( resid 29  and name HN  )    7.97  0.500  
       ( resid 30  and name HN  )    -1.03  0.500  
       ( resid 31  and name HN  )    -1.29  0.500  
       ( resid 32  and name HN  )    -4.21  0.500  
       ( resid 33  and name HN  )     4.25  0.500 
       ( resid 35  and name HN  )   -7.1  0.500  
       ( resid 36  and name HN  )   -0.34  0.500  
       ( resid 38  and name HN  )   0.37  0.500  
       ( resid 39  and name HN  )   -0.88  0.500  
       ( resid 42  and name HN  )  3.66  0.500  
       ( resid 43  and name HN  )   -0.44  0.500  
       ( resid 44  and name HN  )    7.29  0.500  
       ( resid 45  and name HN  )    -2.57  0.500  
       ( resid 46  and name HN  )    -9.19  0.500  
       ( resid 47  and name HN  )    -5.28  0.500 
       ( resid 48  and name HN  )   -3.99  0.500  
       ( resid 49  and name HN  )    -13.55  0.500  
       ( resid 50  and name HN  )    -1.81  0.500  
       ( resid 51  and name HN  )    -1.68  0.500  
       ( resid 53  and name HN  )    5.51  0.500  
       ( resid 54  and name HN  )   -0.96  0.500 
       ( resid 55  and name HN  )   -8.81  0.500  
       ( resid 56  and name HN  )   6.03   0.500 
       ( resid 57  and name HN  )   -1.47  0.500 
       ( resid 58  and name HN  )   -3.03  0.500         
       ( resid 61  and name HN  )   7.82  0.500  
       ( resid 62  and name HN  )   -8.65  0.500  
       ( resid 63  and name HN  )   -5.78  0.500  
       ( resid 64  and name HN  )   -1.59  0.500  
       ( resid 66  and name HN  )   -2.16  0.500  
       ( resid 69  and name HN  )   15.01  0.500  
       ( resid 70  and name HN  )   5.41  0.500  
       ( resid 72  and name HN  )   1.98  0.500  
       ( resid 74  and name HN  )   10.41  0.500  
       ( resid 75  and name HN  )   -1.01  0.500  
       ( resid 76  and name HN  )   6.34  0.500  
       ( resid 77  and name HN  )   -5.94  0.500  
       ( resid 78  and name HN  )   -3.34  0.500  
       ( resid 79  and name HN  )   -1.97  0.500  
       ( resid 80  and name HN  )   -6.4  0.500  
       ( resid 81  and name HN  )   0.35  0.500  
       ( resid 82  and name HN  )   -5.12  0.500  
       ( resid 83  and name HN  )   0.43  0.500 
       ( resid 84  and name HN  )   1.54  0.500  
Appendices 
 
169 
 
       ( resid 85  and name HN  )   11.97  0.500  
       ( resid 86  and name HN  )   0.94  0.500  
       ( resid 87  and name HN  )   0.74  0.500  
       ( resid 88  and name HN  )   0.61  0.500  
       ( resid 91  and name HN  )   -5.4  0.500  
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Appendix	  5	  Dihedral	  angle	  restraints	  for	  OutC-­‐HRF3	  
	  
  13 A  -58.509  -33.955    5.576    8.313   10.197 10 Good 
  14 S  -63.786  -35.411    8.127   11.832    9.263 10 Good 
  15 Q  -69.240  -34.819    8.748   13.788    8.082 10 Good 
  28 L  -95.855  114.273   12.294   10.098   17.738 10 Good 
  31 V -135.764  135.817   14.646   15.265   26.342 10 Good 
  32 M -111.572  122.096   19.252   10.052   17.522 10 Good 
  33 A  -88.860  132.354   28.151   16.517   19.236 10 Good 
  37 D  -60.678  -34.532    3.960    8.178   19.693 10 Good 
  38 S  -68.758  -21.450    9.195   17.939   13.606 10 Good 
  42 A -117.713  127.344   11.759   12.941   18.709 10 Good 
  43 I -101.268  127.373   14.046    8.984   19.332 10 Good 
  44 I -116.449  134.994   11.823   12.515   17.177 10 Good 
  45 S -112.405  123.524   12.521    7.200   15.218 10 Good 
  46 K -138.046  125.749   12.479    9.752   30.817 10 Good 
  48 N   70.351   10.815   10.372   13.646   37.868 10 Good 
  49 E -113.579  144.558   15.571   15.022   29.882 10 Good 
  50 Q -105.667  137.701   18.447   13.934   15.890 10 Good 
  51 F -132.786  146.504   21.942   16.036   13.969 10 Good 
  52 S -109.918  122.316   13.050    9.667   22.850 10 Good 
  53 R -123.582  155.819    9.168    9.456   31.207 10 Good 
  62 Y -123.379  152.031   11.947   13.574   35.852 10 Good 
  64 A -109.287  136.763   22.377   24.116   21.921 10 Good 
  65 K -125.234  136.228   20.830   14.924   19.047 10 Good 
  66 I  -78.586  126.444   11.711   14.383   17.935 10 Good 
  68 S -154.836  149.824    8.922   10.961   20.075 10 Good 
  69 I -125.245  120.470   21.015   12.099   26.141 10 Good 
  70 R  -96.782  127.157   22.680   28.512   61.187 10 Good 
  74 V -129.757  142.284   16.583   19.211   21.654 10 Good 
  75 V -114.601  123.436   11.309   10.422   15.597 10 Good 
  76 L -113.988  138.792   12.672   16.023   12.848 10 Good 
  77 Q -118.803  123.987   14.595   10.902   16.668 10 Good 
  79 Q   52.520   43.379    3.762    3.833   42.229 10 Good 
  80 G   73.402    9.413    9.489   12.054   36.762 10 Good 
  81 R -112.242  150.472   16.410   15.550   32.751 10 Good 
  82 Y -124.155  140.285   14.232   15.704   22.066 10 Good 
  83 E -138.683  158.208   14.629   11.432   16.346 10 Good 
  84 V -128.124  132.775   16.185   13.197   16.336 10 Good 
  85 L -116.602  133.278   15.302   15.774   24.463 10 Good 
  87 L  -89.803  138.927   24.140   16.407   24.403 10 Good 
  88 Y  -94.083  129.382   19.055    9.613   19.985 10 Good 
  89 S  -99.219  138.600   28.685   12.731   16.789 10 Good 
  92 D  -83.143  -20.845   22.359   23.961    9.961 10 Good 
  96 D  -94.542  -12.761   21.488   24.294   22.030 10 Good 
  97 G   81.596   14.899    8.139   18.877   29.391 10 Good 
  98 V  -90.361  120.495   24.230   27.602   68.050 10 Good 
  99 P  -58.852  140.560    6.688   12.172   64.785 10 Good 
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Appendix	  6	  OutC-­‐HRF3	  best	  20	  structures	  PROCHECK	  Ramachamdran	  plot	  
 
 
Appendices 
 
172 
 
Appendix	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Abstract
Gram-negative bacteria secrete virulence factors and assemble fibre structures on their cell surface using specialized
secretion systems. Three of these, T2SS, T3SS and T4PS, are characterized by large outer membrane channels formed by
proteins called secretins. Usually, a cognate lipoprotein pilot is essential for the assembly of the secretin in the outer
membrane. The structures of the pilotins of the T3SS and T4PS have been described. However in the T2SS, the
molecular mechanism of this process is poorly understood and its structural basis is unknown. Here we report the
crystal structure of the pilotin of the T2SS that comprises an arrangement of four a-helices profoundly different from
previously solved pilotins from the T3SS and T4P and known four a-helix bundles. The architecture can be described as
the insertion of one a-helical hairpin into a second open a-helical hairpin with bent final helix. NMR, CD and
fluorescence spectroscopy show that the pilotin binds tightly to 18 residues close to the C-terminus of the secretin.
These residues, unstructured before binding to the pilotin, become helical on binding. Data collected from crystals of
the complex suggests how the secretin peptide binds to the pilotin and further experiments confirm the importance of
these C-terminal residues in vivo.
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Introduction
The secretins are an important group of bacterial membrane
proteins whose function is to facilitate the transport of secreted
proteins and macromolecular complexes across the outer
membrane [1].They are essential components of the type II
and type III secretion systems (T2SS and T3SS respectively) and
play a key role in the assembly of type IV pili (T4P) and release
of filamentous bacteriophages. Determination of the structure of
secretins has been confined to low-resolution transmission
electron microscopy and cryo EM studies [2–5] which show
membrane penetrating ring structures with 12–14 fold rotational
symmetry. A specialized class of small lipoprotein pilotins bind
their cognate secretins and facilitate oligomerization, insertion
and proper assembly in the outer bacterial membrane. In this
paper we explore the structure and function of the pilotin from
D. dadantii (OutS), several other pilot proteins have been
described [6–12]. Pilotins whose structures have been deter-
mined are MxiM (PDB code: 1Y9L) of the T3SS of Shigella
flexneri and PilW/PilF (PDB codes: 2VQ2)/2FI7 and 2HO1) of
the T4P of Neisseria meningitidis or Pseudomonas aeruginosa [13,14].
The cracked b-barrel structure of MxiM has been solved in
complex with an 18 residue peptide from the cognate secretin
MxiD (PDB code: 2JW1) and the authors propose a model for
the way MxiM assists MxiD assembly [10,15]. The other known
pilot structure, PilW/PilF, appears to perform a broadly similar
function to MxiM, ensuring multimerization of the secretin PilQ
into the outer membrane, but has a different architecture
comprising six serial a-helical tetratricopeptide repeats [9,12]. A
third auxiliary secretin-binding protein has been characterised
structurally, PilP, which is also involved in the assembly or
stability of the secretin PilQ of Pseudomonas aeruginosa [16], the
structure comprises a sandwich of two sheets each with three
anti-parallel b-strands.
The type II secretion system spans both the inner and outer
bacterial membranes [17,18]. It consists of an inner membrane
subcomplex, periplasmic pseudopilins and the outer membrane
secretin [19]. There have been considerable recent advances in
our understanding of the T2SS secretin. First the structure of the
N-terminal periplasmic domains N0, N1, and N2 in complex with
a nanobody [20] was elucidated (PDB code 3EZJ) and secondly a
cryo EM reconstruction of the secretin itself has been described
[3]. In the absence of pilotin the D. dadantii secretin (OutD)
mislocates to the inner membrane [21]. The pilotin possesses at its
N-terminus the characteristic lipoprotein signal sequence (LAAC),
with the signal peptidase LspA cleaving site just before the cysteine
to which the lipid is covalently attached. The pilotin (OutS) binds
to the C-terminal 62 residues of the secretin (OutD) [11,19]. Here
we elucidate the structure of the T2SS pilotin and show that it
binds tightly to 18 residues close to the C-terminus of the secretin
subunit causing this unstructured region to become helical on
forming the complex.
PLoS Pathogens | www.plospathogens.org 1 February 2012 | Volume 8 | Issue 2 | e1002531
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Results/Discussion
Structure of the T2ss Pilotin
To ensure authentic folding and production of soluble Dickeya
dadantii pilotin (OutS) in the E. coli periplasm, the PelB secretion
sequence was substituted in place of the N-terminal lipidation
sequence thereby preventing lipidation of the pilotin. This
substitution facilitated protein production and crystallization
without compromising secretin-binding [11]. Cleavage of the
secretion signal accompanies transport in to the periplasm. The
crystal structure of the pilotin was determined using the
anomalous scattering from a potassium tetrachloroplatinate
derivative and the structure refined at 1.65 A˚ resolution
(Table 1). The two copies of the pilotin subunit in the
asymmetric unit of the crystal are virtually identical in structure
(root mean square deviation of 94 a-carbon atoms, residues 38
to 132, is 0.243 A˚). The structure is clearly defined in the
electron density map except for the N-terminal residues
preceding Val 38 which presumably form a flexible linker to
the lipidation site. The architecture of the pilotin is the
remarkable insertion of one a-helical hairpin into a second
open a-helical hairpin with bent final helix (Figure 1); this is
unlike the two other pilotin structures solved and is profoundly
different from any previously described four helix bundle. The
first helix of five turns (residues 40–60), is connected to the
second of four turns (residues 69–82) by an 8 residue loop. The
second loop of 10 residues connects to the third helix of four
turns (residues 93–106) which packs against helix one. A short
three residue loop which connects helices three and four and the
disulfide bridge, between Cys 115 in the second turn of helix
four and Cys 61 the first residue of the helix one to helix two
loop (Figure 1B), sets the scene for the packing of helix four
(residues 111–130). The pronounced bend of 65u in helix four is
important for the architecture; the helix has three large
hydrophobic residues which are at least partially buried by
interactions with hydrophobic residues on the other three
helices: Phe 118, Met 122, and Phe 125. The requirement to
pack conserved Phe 125 appears to dictate the severe bend of
this helical element. In the crystal the pilotin subunits form a
dimer, with Arg 63 and Asn 119 (Figure 1B) involved in an
electrostatic interface, between subunits, however there is
currently no evidence that dimerization occurs in solution or
in vivo.
Sequence Similarity and Structural Similarity
The majority of the 13 absolutely conserved residues in the
sequence alignment (Figure S1A) appear to be of structural rather
than of direct functional significance. The two highly conserved
cysteine residues, 61 and 115, form the disulfide bridge between
helices a1 and a4 that stabilizes the correct nested a-helical
protein fold of the pilotin is functionally relevant. When a reducing
agent was used in pull-down assays or in bacterial two-hybrid tests,
the pilotin was unable to bind the cognate secretin (Figure S6).
Presumably this is because the disulfide is reduced and the pilotin
did not fold correctly in the cytoplasm. Interestingly, the previous
mutagenesis analysis revealed several structurally or functionally
relevant residues of pilotin (OutS), notably conserved Leu 57, Arg
63 and Ser 97 [11]. Substitution each of these prevented secretin
(OutD) targeting to the outer membrane. Conserved Cys 21
covalently attaches to the lipid and this residue is essential for
targeting the pilotin to the outer membrane. Conserved Gln 46, on
the solvent exposed surface of helix 1 (Figure 1), must also be of
functional rather than structural significance and maps to the
extremity of the concave surface of the pilotin formed by helices
a1, a3 and a4; it is plausible that this concave surface is the
binding site for the secretin (Figure 1B). Conserved residues
including: Gln 46 and Leu 104 and semi-conserved Leu/Val/Ile
50, Phe/Leu 118 are also in this region. Residues 49, 52 and 53 on
the solvent exposed surface of helix a1 are Ser/Ala for the former
two and Ala/Gly for the latter, respectively (Figure S1A). This
conservation of small residues at these positions is consistent with
this region being important in binding as there is no structural
reason why larger residues could not be accommodated at these
sites unless the secretin binds tight up against the first helix
(Figure 1). A DaliLite database search revealed that P40
nucleoprotein has a similar arrangement of a-helices to that of
the pilotin. The Dali score was 6.0 and sequence identity 5%. The
P40 nucleoprotein domain architecture is however substantially
more complex with seven helices instead of the pilotin’s four. The
concave surface of the corresponding helices of P40 nucleoprotein
is occupied by a helix supporting the view that this is the binding
site for an a-helix. Mutations of the pilotin binding surface confirm
the importance for binding of some of the residues decorating the
concave surface (Table S1). Mutating Ser 49 to Arg has a
profound effect on binding and the mutants Leu 96 Ala, Leu 100
Ala and Gln 114 Ala have a substantial effect on binding as
expected if this is the binding surface (Figure 1B).
Secretin-Binding to the Pilotin in Solution
It had previously been shown that the C-terminal 62 residues of
the secretin bound to the pilotin [11]. This secretin peptide was
produced with 15N-label as a fusion to GST and then released with
PreScision protease. The backbone amide protons were poorly
dispersed in the 1H-15N HSQC spectra revealing the C-terminal
62 residues are unstructured in solution (Figure S4). NMR cross-
titration studies revealed that only peaks corresponding to residues
691–708 of the secretin peptide were shifted on addition of
unlabelled pilotin (Figure S2; with assignment of secretin peptide
shown in Figure S3). When the pilotin was 15N-labelled, good
dispersion of the backbone amides protons was observed as
expected given its folded structure (Figure 2). Titration of the
unlabelled 62 residue secretin peptide into the 15N-labelled pilotin
produced a large number of peak shifts (Figure 2A). Shift
perturbations are extremely sensitive indicators of structural
changes and the extent of the changes observed is compatible
with the secretin peptide decorating the surface of the pilotin and
causing subtle structural rearrangements, perhaps in packing
interactions in the hydrophobic core, reflected in chemical shift
Author Summary
Pathogenic bacteria deliver toxins and virulence proteins
into host cells and tissues using specialised secretion
systems such as the type II and type III secretion systems.
These secretion systems have a pore formed by secretin
protein subunits through which the disease causing
protein effectors and toxins pass. The secretin must be
targeted to and assembled in the outer-membrane and a
pilotin protein facilitates this process. In the absence of the
pilotin the secretin is degraded or mislocates to the inner-
membrane, in either case the secretion system in non-
functional and the bacterium cannot cause disease. Here
we show how the pilotin and the secretin of the type II
secretion system interact, these insights may be useful for
the development of antibacterial compounds to interfere
with secretin targeting and assembly and defeat patho-
genic bacteria such as Vibrio cholerae and enterotoxigenic
E. coli which infect man and Dickeya dadantii which
threatens food security.
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changes across much of the structure. The secretin peptide binds
to the pilotin in a 1:1 stoichiometric ratio as determined from the
NMR titration where the intensity of the shifted peaks of the
complex saturate at an equimolar ratio of OutD to OutS. Since
only residues 691–708 of the secretin were affected by interaction
with pilotin (Figure S2), a synthetic 18 residue peptide corre-
sponding in sequence to these residues was assessed. The pattern
of shifts in 1H-15N HSQC pilotin spectrum observed using this
synthetic 18 residue peptide was identical to that using the 62
residue secretin peptide (Figure 2B, C) confirming that it is these
18 residues that are those principally involved in binding to the
pilotin. Circular dichroism measurements also showed the
unstructured nature of the secretin peptide and provided evidence
that the peptide becomes helical on binding (Figure 3A). The
signal saturates at a stoichiometric ratio of secretin peptide to
pilotin. The CD spectra of the pilotin and secretin peptide together
correspond to more helical structure than the spectra of the pilotin
and secretin peptide summed. The additional helical content can
be quantified as 12 residues assuming all secretin and pilotin
molecules are in complex, a reasonable assumption given the high
affinity of complex formation (see below). The most plausible
explanation for this is that 12 residues of the secretin peptide
become helical on binding to the pilotin. The helical propensity of
the 18 residue secretin peptide was apparent from secondary
structure predictions (Jpred [22] and shown on Figure S1B). To
estimate the binding affinity of pilotin for the secretin peptide,
fluorescence spectroscopy was used. Since the 18 residue secretin
peptide has no tryptophan residues, quenching of the fluorescence
signal from the single tryptophan residue in the pilotin on addition
of the secretin peptide, was used to determine the affinity of
binding. The 1:1 stoichiometric binding ratio can be seen from the
saturation of the fluorescence quenching of OutS by an equimolar
quantity of the secretin peptide (Figure 3B). The binding of the 18
residue peptide is tight with Kd of 55620 nM (Figure 3B) and is
comparable to that of the T3SS pilotin-secretin complex [10,15].
3JHNHA spectra of the complex showed peaks coupled by less
than 5 Hz (Figure S5) confirming that at least four residues of the
secretin peptide become helical on binding to the pilotin, there
may be more, but they are hidden by overlapping peaks.
Model of the Pilotin/Secretin Peptide Complex
Crystals of the pilotin/secretin complex were grown, they
belong to space group P65 but are twinned (Table S2) and have
solvent channels with disordered density within. Nevertheless four
Table 1. Crystallographic data and refinement statistics for pilotin.
Data Collection Native Tetrachloroplatinate derivative
Space group P212121 P212121
Cell parameters (A˚) a = 49.7, b = 53.1, c = 98.7 a = 49.8, b = 51.8, b = 97.9
Molecules per asymmetric unit 2 2
Platinum sites/au 0 4
Wavelength (A˚) 1.0718 1.0718
Resolution (A˚) 46.78–1.65 (1.71–1.65)a 52.81–2.90 (3.06–2.90)a
Number of unique reflections 32440 (4652)a 6121 (873)a
Multiplicity 7.8 (6.8)a 12.6 (13.4)a
Completeness (%) 100.0 (99.9)a 99.9 (100.0)a
Rmerge (%)
b 0.200 (0.336)a 0.103 (0.214)a
Mean I/sigma (I) 6.9 (2.6)a 19.2 (12.3)a
Rpim (%)
c 0.063 (0.140)a 0.033 (0.062)a
MSANd - 1.20
Wilson B-factor (A˚2) 21.4 60.1
Refinement
Resolution limits (A˚) 46.8–1.65
Reflections (work/test) 30555/1578
R-factor/R-freee (%) 0.197/0.249
rmsd bond(A˚)/angle (u) 0.006/0.918
Number of protein (solvent) atoms 1465 (195)
Average B-factor protein (solvent) (A˚2) 30.9 (46.0)
Ramachandran plot statistics (%)
Residues in most favoured regions 98.4%
Residues in additional allowed regions 1.6%
aThe parameter values for the range 1.85–1.76 A˚ and 3.06–2.90 A˚ are given in parentheses for native and heavy metal derivative data, respectively.
bRmerge =Shkl Si|Ii2,I.|/_Shkl SIi, where Ii is the intensity of the i
th observation, ,I. is the mean intensity of the reflection, and the summations extend over all unique
reflections (hkl) and all equivalents (i), respectively.
cRpim =Shkl [n/(n21)]
1/2 Si|Ii(hkl)2,I(hkl).|/Shkl Si Ii(hkl), where n is the multiplicity, other variables as defined for Rmerge [46].
dMSAN is the Mid slope of Anomalous normal probability.
eR-factor =Shkl|Fo2Fc|/Shkl Fo, where Fo and Fc represent the observed and calculated structure factors, respectively. The R-Factor is calculated using 95% of the data
included in refinement and R-free the 5% excluded.
doi:10.1371/journal.ppat.1002531.t001
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pilotin subunits can be found by molecular replacement and
density for peptide can be seen occupying the concave surface of
the pilotin. The evidence that suggests residues 694 to 704 of the
secretin adopt a helical conformation in the electron density map,
a part of the simulated annealed omit map is shown in Figure 3C.
Ten residues are in helical conformation and the hydrophobic
surface of the amphipatic helix interacts with the hydrophobic
surface of the pilotin (Figure 3D, E). In this model the methyl
groups of T692 and V697 interact with L100 and L104, I701
interacts with L50 and M122; F704 (with L47, V79 and F125) and
F694 (with F118, L104 and Q114) interactions occur either side of
these central interactions. D107 is the N-terminal helix capping
residue, stabilizing the helix dipole of the bound secretin peptide.
The peptide binds tight up against Q46, S49, A52 and A53,
providing an explanation for their conservation or presence only
as small residues in the case of the latter three. Interestingly, the
same dimer as described for the non-complexed secretin is seen in
these crystals too suggesting that the interaction may have some
biological relevance. The quality of the refinement is relatively
poor because of the disordered protein and for that reason the
structure is being referred to as a model of the secretin peptide/
pilotin interaction.
Intrinsically disordered regions of proteins such as these C-
terminal residues of the secretin subunit facilitate binding by
increasing their capture radius for cognate partner, the so-called
fly-casting mechanism [23]. Initial weak binding may draw the
secretin and pilotin together and as the secretin peptide folds on
the pilotin surface the binding becomes tighter, locking the two
together.
Assessment of the Pilotin/Secretin Interaction In Vivo
A series of in vivo experiments were used to test the proposed
model of secretin binding to the pilotin. The 62 residue C-
terminus of secretin possesses three putative a-helices (Figure 4A)
[22]. If the region consisting of the first two C-terminal helices
were deleted, the truncated OutDDC1 behaves like wild type
secretin. Firstly, OutDDC1 was barely detectable in the absence
but was well produced in the presence of pilotin OutS (Figure 4B).
Secondly, with pilotin, the mutant secretin was mainly recovered
in the outer membrane fractions (Figure 4C). Consistent with the
outer membrane location, expression of OutDDC1 in the presence
of OutS results in a rather low level of pspA induction. Phage shock
protein (psp) response helps to maintain proton motive force in
cells under pmf-dissipating stress and is indicative of mislocaliza-
tion of the secretins in the inner membrane [8,11]. These results
are consistent with the NMR experiments demonstrating that it is
the 18 residue C-terminus of OutD which binds tightly to the
pilotin. Despite its outer membrane location, OutDDC1 was
unable to restore pectinase secretion in D. dadantii DoutD A3559
strain (data not shown) indicating an important functional
relevance of the deleted region. Deletion of the extreme C-
terminus of secretin resulted in partial stabilization of the
truncated OutDDC2 secretin as judged from the quantity
produced in the absence of the pilotin, but prevented its correct
targeting to the outer membrane (Figure 4B,C). In the presence of
pilotin, the amount of OutDDC2 was increased indicating that the
pilotin can still stabilize and hence interact with the truncated
secretin but is not able to target it to the outer membrane. In
agreement with this, expression of OutDDC2 strongly induced
pspA even in the presence of pilotin. Deletion of the full 62 residue
C-terminus of OutD resulted in neither stabilization nor the
correct targeting of the truncated secretin OutDDC3 as judged by
low protein content but high pspA level (Figure 4B).
Conclusion
The type II secretin/pilotin complex from Klebsiella oxytoca has
been imaged by cryo electron microscopy at modest resolution
[24]. The secretin subunits form a dodecameric ring with relatively
weak radial arms that the authors tentatively assign as the pilotin
or pilotin bound to the secretin C-terminus [4,24]. Comparing the
envelope of the complex with that determined by Reichow et al.
(2010) of the secretin only [3], the radial arms are located either in
the periplasm or in the inner leaflet of the outer membrane. This is
the position anticipated from the observation in this work that the
Figure 1. Structure of the pilotin. The crystal structure of Dickeya dadantii OutS consists of four a-helices, the last of which is bent. (A) a3 and
bent a4 wrap around the anti-parallel hairpin formed by a1 and a2. Conserved residues (see Figure S1 for sequence alignment) are represented as
sticks. (B) Rotated about the y-axis by 90u, this view reveals the concave surface formed between helix a1 and helices a3and a4. The disulfide can be
seen linking a1 and a4. (C) Rotated around the x-axis by 90u, a1 is surrounded by the other three helices. A52, A53, S49 and D107 are not strictly
conserved but the first three are always small and 107 is either D or E suggesting some functional constraint on this region. Q46 is absolutely
conserved and may map the other extremity of the binding site. Figure 1 and panels D and E of Figure 3 were produced using PYMOL.
doi:10.1371/journal.ppat.1002531.g001
The Pilot-Secretin Complex of the T2SS
PLoS Pathogens | www.plospathogens.org 4 February 2012 | Volume 8 | Issue 2 | e1002531
Appendices 
 
187 
 
 
 
 
 
 
 
pilotin interacts tightly with 18 residues close to the C-terminus of
the secretin subunit, so it is entirely plausible that the radial arms
seen in the cryo-EM map correspond to the unusual four helix
bundle of the type II secretion pilotin bound to the induced C-
terminal helix of the secretin subunit.
Recent structural studies have revealed striking structural
similarities between components from distant secretion systems
and other bacterial cell machines. Besides the expected structural
homologies between several conserved components of ancestrally
related T2SS and T4P [25–27] several other remarkable structural
similarities should be mentioned. Notably, the extreme N-terminal
N0 domain is shared by secretins from the T2SS, T3SS and T4P
but is also structurally related to a domain of lipoprotein DotD
from the T4SS, a domain of VgrG from the T6SS and from a
TonB dependent receptor FpvA [20,28–30]. Similarly the N1/N2
domains of secretins show a significant structural homology with
several ring-forming proteins from the T3SS [20,31,32]. It is
therefore becoming common to attribute similar function to the
proteins or domains of a related structure. Given this background
it is remarkable then that the T2SS pilotin described here is
profoundly different in architecture to the T3SS pilotin but has
similar function. Both the T2SS and the T3SS pilotin bind the
extreme C-terminal region of their cognate secretins and this
previously unstructured part of the secretin becomes an ordered a-
helix on binding. It is therefore remarkable that the corresponding
pilotins are different in architecture, one an open b-barrel (T3SS;
MxiM) the other an unusual helical bundle (T2SS; OutS). These
striking structural differences show that in these systems the
pilotins have been evolved independently to play similar roles.
Materials and Methods
Plasmid Construction, Expression, Purification and
Protein Analysis
The pET-20b(+) plasmid expressing non-lipidated OutS
(residues 26 to 132) fused to N-terminal PelB signal peptide has
been constructed previously [11] at a manner as the sequence of
mature non-lipidated OutS after cleavage by the signal peptidase
LepB is: MDP26VKNT etc. To fuse a C-terminal 6His tag to non-
lipidated OutS, SalI site was introduced at the end of outS sequence
by using the primer (59-ctt gac gcc atg cgc acc gtc gac tga ggg gga
agc aac tgc) and the reverse complementary one (mutated bases
are underlined). Then, by SalI/XhoI digestion the sequence coding
for non-lipidated OutS was fused with that coding for 6His.
Mutants of OutS were made using Strategene QuikChange and
confirmed by sequencing.
To generate OutD truncated derivatives, an Eco47III site and
V678A substitution were introduced using the primer (59-
gcgcggcgaaggcaacggagcgctggataacaacaccctgc) and the reverse com-
plementary one. This site and naturally existing NruI and PsiI sites
were used to generate OutDDC1 (D650–678), OutDDC2 (D679–
705) and OutDDC3 (D650–705) derivatives. To fuse the C-terminal
segments of OutD to GST, the corresponding gene fragments were
subcloned from pTdB-OD plasmids expressing either OutD, or
OutDDC1, or OutDDC2, or OutDDC3 into pGEX-6P-3 or
pGEX-3X vectors in frame with the GST coding sequence.
Protein Expression, Purification and Analysis
E. coli BL21(DE3) strain (Stratagene) was used to produce non-
lipidated pilotin (OutS) and GST-secretin (OutD) derivatives.
Non-lipidated OutS was released from the periplasm by osmotic
shock as described previously [33] and purified by size-exclusion
chromatography Superdex S75 10/300 GL (GE Healthcare). The
OutD peptide was purified and then released from GST-OutD
fusion as described previously [34]. For NMR spectroscopy,
uniformly 15N- and 13C-labeled pilotin and secretin peptides were
produced by growing cell cultures in M9 minimal medium that
contained 15N-ammonium chloride and 13C-D-glucose (Cambridge
Isotope Laboratories Inc.) as the sources of nitrogen and carbon,
respectively. The 18 residue synthetic secretin peptide (residues
691 to 708 inclusive) was purchased from Generon. Cell
membrane fractionation by sucrose density gradient centrifugation
was performed as described previously [11] with steady-state
cultures of E. coli NM522 (Stratagene) expressing OutD derivatives
from pTdB-OD and OutS from pACT-S plasmid. The location of
outer membrane porins was determined by staining with
Coomassie G-250. The position of inner membrane fractions
was estimated by immunoblotting with TolA antibodies and
NADH oxidase activity. E. coli MC3 strain carrying a pspA-lacZ
fusion [35] was used to estimate miss location of OutD derivatives.
To assess functionality of OutD derivatives, complementation
assays with D. dadantii DoutD A3559 strain were used as previously
described [36]. SDS-PAGE and immunoblotting were performed
Figure 2. Elucidation of secretin-pilotin interactions. Titration of
secretin peptides into 15N labelled pilotin. 1H-15N-HSQC spectra of the
pilotin in the absence of secretin (red spectra), in the presence of 62
residue secretin peptide (green) and in the presence of 18 residue
peptide (black). Protein concentration was 100 mM. (A) Pilotin in the
absence and presence of 62 residue secretin peptide. (B) Pilotin in the
absence and presence of the 18 residue secretin peptide. (C) Overlay of
the two complexes with secretin peptides showing the 18 residue
peptide is behaving in a closely similar way to the 62 residue peptide.
doi:10.1371/journal.ppat.1002531.g002
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as previously [19]. Anti-OutD rabbit serum was raised against
entire OutD purified from a recombinant E. coli strain. Anti-TolA
serum was kindly provided by J.C. Lazzaroni.
Crystallisation and Structure Determination
Hampton Research sparse matrix screen was used to search for
crystallization conditions. Crystals were grown using hanging drop
vapour equilibration using 10 mg/ml OutS and a reservoir of 2 M
ammonium sulphate, 2% PEG 400 and 0.1 M HEPES pH 7.5.
Vitrification of crystals in liquid nitrogen was achieved using the
reservoir solution with 2.1 M ammonium sulphate and augmented
with 15–25% glycerol. Data were collected at ESRF ID23-1 and
processed using MOSFLM [37] and scaled using SCALA [38].
SAD data were collected from a crystal soaked in 25 mM
potassium tetrachloroplatinate (K2PtCl4) for 4 days. The structure
was solved using PHENIX [39] and COOT [40] and refined using
the native data at 1.65 A˚ resolution and non-crystallographic
symmetry restraints. The final model comprises 188 amino acid
residues and 208 water molecules. DALILITE [41] was used to
search for similar structures, CLUSTALW [42] for sequence
alignment and JPRED for secondary structure predictions [22].
Crystals of the complex were grown using a 1.0:1.1 molar ratio of
pilotin: secretin peptide and crystallized using a reservoir of 2 M
ammonium sulphate, 0.1 M Tris, pH 8.5. Around 100 complex
crystals were screened before a well-diffracting reasonable ordered
crystal was found. The pilotin/secretin complex was solved by
molecular replacement using data collected at DLS I02 and
CCP4/PHENIX/COOT. These crystals appear to be P6522 but
are most likely twinned P65 with four pilotin molecules in the
asymmetric unit. The packing of the molecules is such that there
are large solvent channels running through the crystal lattice.
These solvent channels appear to have disordered protein present
the modelling of which hampers refinement. The disordered
regions do not gain clarity if the lower symmetry space group P32
is used (for more details see Table S2).
Preparation of Proteins for Nmr Spectroscopy and
Acquisition of Nmr Spectra
Samples of 0.05 to 0.5 mM labelled proteins in 90% H2O, 10%
2H2O containing 20 mM Tris (pH 7.0) and 150 mM NaCl. All
Figure 3. The secretin-pilotin complex. (A) The far uv circular dichroism spectra of the 18 residue secretin peptide alone (black), pilotin alone
(pink) and a stoichiometric ratio of both pilotin (OutS) and secretin peptide (OutD691–708) together (blue). The difference between the secretin/pilotin
complex and the pilotin only is shown in red. As forming the stoichiometric ratio diluted both proteins by half, these data were multiplied by two to
compensate for the dilution factor. The concentration of both pilotin and secretin peptide were 0.55 mM. 3JHNHA evidence of helical conformation is
presented in Figure S5. (B) Measurement of the binding affinity of the pilotin OutS for the 18 residue secretin peptide determined using fluorescence
spectroscopy. 1 mM pilotin was titrated with 50 mM secretin peptide in to 1 mM pilotin so that there was no dilution of pilotin. The stoichiometry can
be seen to be 1:1 within experimental error. The Kd is 55620 nM. Details of the equation fitted can be found in Table S1. (C) Part of the simulated
annealed omit map showing the quality of the electron density map used to derive the models shown in (D) and (E). (D) Model of the secretin
peptide bound to the pilotin, D107 acts as an N-terminal helical cap. (E) Close up showing the hydrophobic nature of the complementary side chains
involved in forming the complex.
doi:10.1371/journal.ppat.1002531.g003
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Figure 4. In vivo determination of secretin interactions with pilotin. Removal of the extreme C-terminal region of the secretin results in
mislocalization of the secretin to the inner membrane (A) Sequence of the C-terminus of Dickeya dadantii secretin (OutD) along with the secondary
structure prediction for this region; the predicted three helices are marked ‘‘H’’. The sequences of the three secretin deletion mutants (OutDDC1 to
OutDDC3) and the C-terminal secretin peptides used are shown. (B) Stabilization of truncated derivatives of the secretin (OutD) by pilotin (OutS) in
vivo. E. coli MC3 cells expressing an OutD derivative (indicated above) and either OutS (+) or empty pACT3 vector (2) were grown for 12 h at 30uC in
LB medium and then analyzed by immunoblotting with OutD antibodies. In the same cultures, b-galactosidase activity was assessed to estimate
expression of pspA-lacZ. An elevated level of pspA reflects mislocalization of the corresponding secretin derivative to the inner membrane. Equivalent
amounts of cell extracts were loaded into each well and used for activity measurement. (C) Pilotin promotes the outer membrane location of the full-
length secretin OutD and truncated secretin OutDDC1 but not OutDDC2. The whole membrane fraction from E. coli NM522 cells coexpressing the
indicated secretin derivatives and pilotin was separated by flotation sucrose gradient centrifugation and analyzed by immunoblotting with OutD-
antibodies or stained with Coomassie G-250 to detect the major porins, which reflect the position of the outer membrane. Immunoblotting with
TolA-antibodies and NADH-oxydase activity indicate the position of the inner membrane fractions. OmpA is indicated by a triangle and OmpC/F by a
dot.
doi:10.1371/journal.ppat.1002531.g004
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NMR spectra were acquired at 15uC using Bruker Avance 700-
and 600-MHz spectrometers. Assignment of 1H, 15N, and 13C
resonances of the backbone was achieved by analysis of
HNCACB, CBCA (CO)NH triple resonance experiments [43].
Circular Dichroism
Far-UV CD measurements were made using a Jasco J-715
spectropolarimeter equipped with a PTC-348WI temperature
controller. Spectra were recorded in 20 mM Tris, 150 mM NaCl
(pH 7.0) at 15uC using 1 mm path length fused silica cuvettes. The
spectra are presented as differential absorbance after baseline
subtraction. Calculations employed CONTIN, SELCON, and
CDSSTR [44].
Fluorescence Spectroscopy
Fluorescence data were collected using a Jasco FP-6300
Spectrofluorometer. To avoid exciting tyrosyl side chains, an
excitation wavelength of 290 nm was used. Emission spectra were
recorded at 15uC in steps of 2 nm from 310 to 400 nm. The
fluorescence signal at 340 nm was plotted to calculate Kd. Pilotin
spectra was measured at 1 mM. 50 mM of secretin peptide
prepared in 1 mM pilotin was titrated into pilotin solution (for
more information see also Table S1 and reference [45]).
Accession codes. Coordinates and structure factor
amplitudes have been deposited in the protein databank with
the accession codes 3UTK and 3UYM. The sequences of OutS
and OutD are available in the UniProt database with accession
codes Q01567 and Q01565, respectively.
Supporting Information
Figure S1 Sequence alignment of pilotins and the C-terminal
region of their cognate secretins. The alignment of the pilotins is
shown in panel (A) and alignment of the C-terminal region of their
cognate secretins in panel (B). The position of the a-helices is
indicated by H in the secondary structure row (predicted by Jpred
for GspD). Shown are the OutS and OutD homologs of Dickeya
dadantii (Erwinia chrysanthemi 3937), Q01567 and Q01565; Pecto-
bacterium carotovorum, C6DAR0 and C6DAQ5; Escherichia coli
O157:H7, Q7BSV3 and Q9ZGU0; Klebsiella oxytoca, P20440 and
P15644; Yersinia mollaretii, C4S9G3 and C4S9F5; Serratia odorifera,
D4E1I4 and A8GJQ5. Identical residues are in red, residues
similar in character are green. Conserved residues are mapped on
to the OutS pilotin structure in Figure 1 of the main text.
(DOC)
Figure S2 Spectroscopic analyses of secretin binding to the
pilotin. 2D 1H-15N HSQC of 15N labelled secretin peptide (OutD
residues 649–685 and residues 649–710 for the major proteolytic
fragment and minor full-length peptide, respectively) in the
absence (black) and presence of pilotin (red). The concentration
of secretin and pilotin were 50 mM and 100 mM, respectively. Both
spectra were acquired using a Bruker 700 MHz at 15uC in buffer
comprising 20 mM Tris pH 7.0, 150 mM NaCl and 10% 2H2O.
(DOC)
Figure S3 Assignment of the backbone amide protons for the C-
terminal secretin peptide. The data were acquired at 15uC using
peptide in 20 mM Tris at pH 7.0, 150 mM NaCl and 10% 2H2O
and a Bruker 700 MHz.
(DOC)
Figure S4 The C-terminus of the 62 residue secretin peptide
(OutD648–710) is unstructured. 1H-15N HSQC spectra of recombi-
nantly produced 15N-labelled secretin peptide (70 mM peptide in
20 mM Tris pH 7.0 with 150 mM NaCl at 15uC) acquired using a
Bruker 700 MHz spectrophotometer. The low dispersion of the
main chain amides reveals the peptide is intrinsically unstructured.
The spectra are cleaner than those shown previously (Figure S2
and S3) because the spectra were acquired quickly. During more
lengthy experiments the 62 residue secretin peptide is slowly
cleaved degrading the quality of the spectra.
(DOC)
Figure S5 3JHNHA spectra of 15N-labelled secretin peptide
(OutD680–710) in the absence (red) and presence (black) of pilotin
(OutS). The spectra were acquired using a Bruker 700 MHz
spectrophotometer at measured at 15uC. The new peaks, arrowed,
have HN-HA coupling constants less than 5 Hz revealing that
these residues are helical when bound. The 3JHNHA coupling
constant was calculated according to measurement of the
diagonal-peak to cross-peak intensity ratio in a 3D 15N separated
quantitative J-correlation spectra. These spectra show that at least
four residues of the secretin peptide become helical on binding to
the pilot.
(DOC)
Figure S6 Reducing environment prevents interaction of OutS
with the C-terminal peptide of OutD. (A) GST pull-down assay
shows that non-lipidated OutS does not bind to the GST-
OutD649–710 in reducing conditions. Soluble cell extracts of E. coli
BL21(DE3) producing either GST alone (lane 1) or GST-
OutD649–710 (lanes 2 and 3) were combined with a periplasmic
extract containing non-lipidated OutS, then loaded on Glutathi-
one Agarose for 1 h and washed. The incubations were performed
in either TBS (lanes 1 and 2) or TBS with 5 mM DTT (lane 3).
Bound proteins were eluted with Laemmli sample buffer,
separated by Tricine-SDS-PAGE and either stained (upper panel)
or probed with OutS antibodies (lower panel). Asterisk indicates a
degradation product of GST-OutD649–710. (B) Bacterial two-
hybrid assay (Karimova et al., 1998) shows that OutS does not
interact with GST-OutD649–710 in the reducing conditions of the
bacterial cytoplasm. The region coding for mature OutS (residues
26 to 137) was fused to the C-terminus of T18 subunit of Cya
(pUT18-OutS) and the region coding for GST-OutD649–710 was
fused to the C-terminus of T25 subunit of Cya (pKT25-GST-Dct).
When pUT18-OutS and pKT25-GST-Dct were coexpressed in E.
coli DHP1 cya strain, the corresponding fusion proteins were well
produced as shown by immunoblotting with anti-OutS and anti-
GST antibodies, respectively. However, once plated on MacCon-
key-maltose agar, these bacteria generated white colonies (as did
the empty vectors) and not red colonies (as produced by the known
interacting OutC/OutC couple which was used as a positive
control). T18-OutC is indicated by a dot and T25-GST-Dct by a
triangle.
(DOC)
Table S1 Dissociation constants of secretin peptide from pilotin
and pilotin mutants determined using fluorescence spectroscopy.
(DOC)
Table S2 Crystallographic data and refinement statistics for
pilotin/secretin peptide complex.
(DOC)
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